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Retinal detachment: history, pathophysiology and 
surgical treatment Retinal	  detachment	  is	  a	  sight-­‐threatening	  condition,	  which	  requires	  immediate	  treatment	  in	  order	  to	  prevent	  blindness.	   The	  photoreceptor	  of	   the	  retina	  becomes	  separated	  from	  the	  retinal	  pigment	  epithelium	  (RPE)	  with	   gluid	  accumulation	   in	  the	   intervening	   space.	  Sight	   deteriorates	   particularly	   when	   the	   centre,	   the	   macula1,	   is	   involved	   in	   the	   retinal	  detachment.	   Treatment	   should	   take	   place	   within	   one	   week	   after	   the	  macula	   becomes	  detached	   to	   prevent	   further	   deterioration	   in	   sight.1	   The	   annual	   incidence	   of	   retinal	  detachment	   is	   5	   to	   18.2	   per	   100,000	   persons2-­‐10	   and	   the	   average	   age	   is	   70	   years.	  Symptoms	  comprise	  glashes	  of	   light	   in	   the	  extreme	  periphery	   of	  the	  eye,	   gloaters,	   visual	  gield	   loss	   and	   veiled	   vision.11	   There	   are	   several	   treatment	   options,	   which	   all	   have	  advantages	  and	  disadvantages.12-­‐18In	  order	  to	  determine	  the	  best	  possible	  treatment,	  the	  aim	  of	  this	  study	  was	  to	  answer	  the	  following	  questions:	  Why	  do	  patients	  with	  retinal	  detachment	  delay	  consulting	  a	  doctor?	  What	  is	   the	  best	  treatment	   for	  patients	  with	  rhegmatogenous	  retinal	   detachment?	  Does	  the	  treatment	  have	  side-­‐effects	  and	  what	  are	  the	  consequences	  for	  the	  rest	  of	  the	  eye?
Aims and outlines of the thesisThe	   !irst	   chapter	   describes	   the	   anatomy	   and	   physiology	   of	   the	   eye,	   with	   particular	  attention	   to	   the	  retina	  and	   retinal	   detachment.	   This	   is	   followed	  by	  a	  description	  of	   the	  various	  treatments	  available	  for	  retinal	  detachment.
Chapter	  2	   analyses	  the	  reason	  why	  patients	  with	  symptoms	  of	  retinal	  detachment,	  such	  as	  glashes	  of	  light,	  gloaters	  or	  visual	  gield	  loss,	  delay	  seeking	  medical	  treatment.Treatment	   for	   rhegmatogenous	   retinal	   detachment	   with	   scleral	   buckling	   surgery	   is	  analysed	   in	   Chapter	   3.	   Attention	   is	   paid	   to	   functional	   recovery	   and	   risk	   factors	   that	  hinder	  recovery.
Chapters	  4	  and	   5	  describe	  the	   anterior	   chamber	  depth,	   axial	   length	  and	  diplopia	   after	  scleral	  buckling	  surgery	  for	  rhegmatogenous	  retinal	  detachment.
Chapter	  6	   analyses	   vitrectomy	  with	  silicone	   oil	   tamponade	  as	   the	   best	   treatment	   for	  a	  giant	   retinal	   tear	   and	   addresses	   the	   question	   of	   whether	   an	   encircling	   element	   is	  necessary.
Chapter	   7	   describes	   the	   anatomical	   and	   functional	   results	   following	   removal	   of	   the	  silicone	  oil	  and	  the	  risks	  in	  the	  case	  of	  re-­‐detachment	  and	  deterioration	  in	  visual	  outcome.
Chapter	  8	   investigates	  whether	   vitrectomy	  with	  silicone	  oil	   tamponade	  causes	   changes	  to	   the	  endothelial	   cell	  density	  of	  the	  cornea	   in	  different	  groups	  of	  patients	   in	  whom	  the	  lens	  had	  been	  left	  in	  situ,	  replaced	  or	  removed.
Chapter	  9	  contains	  a	  general	  discussion	  and	  a	  summary	  of	  the	  results.
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The anatomy of the eyeThe	   eye	   is	   a	   sensory	   organ	   that	   receives	   signals	   from	   the	   environment	   and	   transmits	  them	  to	  the	  brain	  where	  they	  are	  converted	  into	  perceptions	  and	  committed	  to	  memory.	  From	  the	  outside,	  particularly	  the	  eyelids,	  cornea,	  iris	  and	  sclera	  are	  visible	  (Figure	  1.1).
The	  corneaThe	   cornea	   is	   the	   transparent	   anterior	   part	   of	   the	   eye.	   It	   borders	   with	  the	   sclera	   that	  covers	  the	  rest	  of	  the	  eyeball.	  The	  cornea	  has	  a	  thickness	  of	  about	  500	  micrometres	  and	  is	  composed	  of	   give	   layers.	   The	   surface	   layer	   comprises	   thin	  epithelium.19	   Just	  below,	   lies	  Bowman’s	   membrane.	   The	  middle	   layer	   is	   the	   stroma,	   which	   consists	   of	   a	   network	   of	  water	  and	  collagen	  gibres;	  it	  forms	  90%	  of	  the	  thickness	  of	  the	  cornea.	  The	  next	  layer,	  the	  Descemet	  membrane,	  is	  tough	  and	  thin.	  Resting	  on	  this	  Descemet	  membrane	  is	  the	  inner	  layer,	  the	  endothelium	  (see	  Figure	  1.2).The	   endothelium	   forms	   the	   posterior	   side	   of	   the	   cornea	   and	   is	   one	   cell	   layer	   thick.	  Endothelial	  cells	  generally	  have	  a	  hexagonal	  shape.	   In	  addition,	  the	  endothelium	  contains	  pumps	  that	  eject	   gluid	  from	  the	  cornea	  to	  maintain	  a	  clear,	   transparent	  area	  where	  light	  can	   enter	   the	   eye.20	   With	   increasing	   age,	   the	   number	   of	   endothelial	   cells	   and	   the	  symmetry	   of	   their	   pattern	  decreases.19	   Very	   limited	   cell	   division	   occurs	   in	   endothelial	  cells	  and	  this	   too	  decreases	  with	  age	  by	  an	  average	  of	  0.3-­‐0.6%	  per	  year.	  After	  treatment	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Figure	  1.1:	  Anatomy	  of	  the	  eye	  
for	   cataracts,	   the	   decrease	   is	   2.5%	   per	   year.	   A	   normal	   cornea	   generally	   has	   about	  2,500-­‐3,000	  cells	  per	  mm2.	  If	  the	  number	  of	  cells	  decreases	  to	  700-­‐500	  cells	  per	  mm2,	  the	  pumps	  no	  longer	  function	  adequately	  and	  the	  cornea	  can	  become	  thickened	  by	  oedema.
The	  lensThe	  lens,	   or	  crystalline	  lens,	   lies	   immediately	  behind	  the	  iris.	  Within	  the	  eye,	   the	  lens	   is	  situated	  between	   the	  cornea	   and	  the	   retina,	   or	  more	  specigically	   behind	   the	   iris	   and	  in	  front	   of	   the	   corpus	   vitreum.	   The	   lens	   is	   a	   virtual	   barrier	   between	   the	   anterior	   and	  posterior	  chambers	  of	  the	  eye.	  It	  consists	  of	  a	  lens	  capsule,	   a	  cortex	  and	  a	  nucleus.	  With	  advanced	  age,	  the	  lens	  becomes	  opaque	  in	  many	  people,	  so-­‐called	  cataract	  development.	  
Corpus	  vitreumBehind	  the	   lens	   there	  is	   a	   cavity	  that	   is	  completely	  gilled	  with	  gel-­‐like	  vitreous	   humour	  (corpus	   vitreum,	   vitreous	   body)	   that	   gills	   about	   80	   per	   cent	   of	   the	   eye	   volume.	   The	  vitreous	   body	   is	   acellular	   apart	   from	   a	   few	   cells	   (hylocytes)	   and	   is	   composed	   of	   an	  extracellular	   matrix	   of	   98%	   water	   and	   macromolecules.	   These	   macromolecules	   are	  structural	   proteins	   and	   glycosaminoglycans	   (GAGs).21	   The	   structural	   proteins	   comprise	  collagen	  gibres	  and	  non-­‐collagen	  proteins.	  The	  gibres	   run	  parallel	   to	  each	  other	  and	  are	  connected	   together	   as	   a	   sort	   of	  branching	  meshwork	   by	   chondroitin	  sulphate	   bridges.	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Figure	  1.2:	  Corneal	  layers
There	   are	   different	   types	   of	   collagen	   gibre.	   The	   vitreous	   body	  mainly	   contains	   type	   II	  gibres,	   but	   to	   a	   smaller	   extent	   also	   type	   V/XI	   (hybrid	   type)	   and	   type	   IX.	   The	   average	  protein	  concentration	  of	  the	  healthy	  corpus	  vitreum	  is	   0.5	  mg/mL,	   consisting	  largely	  of	  albumin	   (60–70%).22	   GAGs	   are	  molecules	  with	   a	   sponge-­‐like	   function.	   Water	   sticks	   to	  them	  and	  this	  contributes	  to	  the	  pressure-­‐volume	  relationship.	  The	  most	  important	  GAG	  is	  hyaluronic	  acid,	   followed	  by	  chondroitin	  sulphate	  and	  heparin	  sulphate;	  the	  latter	  two	  are	  proteoglycans	   that	  bind	  to	  protein.23,	   24	  This	  vitreous	  body	  is	  contained	  within	  a	  thin	  membrane	  called	  the	  hyaloid	  membrane.The	   vitreous	   body	   is	   known	   to	   have	   three	   divisions:	   a	   central	   part	   (core	   vitreous),	   a	  peripheral	   part	   and	   the	   vitreous	   base.	   The	   peripheral	   part	   lies	   against	   the	   retina	   and	  comprises	  the	  outer	  layer	  of	  the	  vitreous.	  At	  this	  location	  the	  vitreous	  body	  has	  a	  thicker	  consistency	  than	  in	  the	  core.	  The	  collagen	  gibres	  are	  more	  densely	  packed	  together.	  The	  thin	  layer	  of	  vitreous	  body	  is	  about	  100-­‐200	  micrometres	  thick.	  On	  the	  anterior	  side,	  just	  behind	  the	  lens,	   lies	   the	  anterior	  boundary	  of	  the	  vitreous,	   the	  so-­‐called	  anterior	  hyaloid	  membrane.21	   The	   vitreous	   base	   is	   an	   area	   at	   the	   equator	  where	   the	  vitreous	   is	   girmly	  anchored	  to	  the	  eyeball.	  On	  the	  posterior	  side,	  the	  posterior	  hyaloid	  membrane	  forms	  the	  boundary	  between	  the	  vitreous	  body	  and	  the	  retina.The	  collagen	  gibres	  in	  the	  posterior	  part	  of	  the	  vitreous	  are	  connected	  to	  the	  inner	  layer	  of	  the	   retina	   (the	   so-­‐called	   internal	   limiting	   membrane)	   by	   laminin	   and	   gibronectin.	  Clinically,	  this	  complex	  is	  referred	  to	  as	  the	  vitreoretinal	  interface.	  For	  the	  greater	  part,	   the	  peripheral	   cortical	   vitreous	   is	  not	   attached	  girmly	   to	   the	   inner	  layer	  of	   the	  retina.	   However,	   at	   several	   locations	   there	  are	  foci	   of	  strong	   adhesions,	   for	  example	   around	   the	   optic	   disc.	   Weak	   adhesions	   are	  present	   around	   the	   fovea	   that	   are	  easily	   broken.	   In	  addition,	   there	  are	  weak	  adhesions	  around	  the	  blood	  vessels	  and	  very	  strong	   adhesions	   at	   the	   vitreous	   base.	   At	   this	   location,	   the	   vitreous	   cannot	   become	  completely	   detached	  due	   to	   the	   strong	   adhesions.	   The	   vitreous	   base	   lies	   over	   the	   ora	  serrata	  (the	  junction	  between	  the	  retina	  and	  ciliary	  body):	  1	  to	  2	  mm	  on	  the	  anterior	  side	  and	  3	  to	  4	  mm	  on	  the	  posterior	  side	  of	  the	  ora	  serrata.In	  the	  case	  of	  abnormal	  pathological	  structures,	  such	  as	  scarring	  and	  weak	  retinal	  regions,	  the	  vitreous	  is	  more	  girmly	  attached.With	   increasing	   age,	   there	   is	   decreasing	   elasticity	   of	   the	   gibres	   in	   the	   vitreous.	   The	  collagen	   gibres	   are	   partly	   broken	   down,	   they	   lose	   their	   structural	   pattern	   (unequal	  distances	  between	  the	  gibres)	  and	  they	  clump	  together.	  Diverse	  pockets	  of	  gluid	  develop	  in	   the	  vitreous.	   At	  the	   age	   of	  about	   60	  years,	   the	  vitreous	   body	   starts	   to	   condense	   and	  liquefy.	   The	  macromolecular	  structure	  of	   the	  vitreous	   body	  changes.	   Liquefaction	  of	  the	  vitreous	  is	  also	  known	  as	  synchysis.25
The	  retinaThe	  inside	  of	  the	  eye	  is	  lined	  by	  the	  retina,	  the	  light-­‐sensitive	  layer	  of	  the	  eye.	  The	  retina	  comprises	  about	  126	  million	  sensory	  cells.	  These	  cells	  absorb	  the	  light	  that	  enters	  the	  eye.	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They	   can	   be	   divided	   into	   rods	   and	   cones:	   the	   former	   are	   sensitive	   to	   dark	   and	   light	  changes,	   while	   the	   latter	   can	   detect	   colour	   differences.	   During	   daylight	   hours,	   vision	  occurs	  with	  the	  central	  point	  of	  the	  retina,	   the	  macula	  lutea,	  where	  most	  of	  the	  cones	  are	  located.	   The	  macula	   enables	   us	   to	   perceive	   tiny	   details.	   In	   the	   dark,	   our	   vision	  moves	  slightly	  to	  the	  periphery	  of	  the	  central	  point	  where	  there	  are	  more	  rods	  and	  fewer	  cones.	  The	  retina	  outside	  the	  macula	  is	  commonly	  divided	  into	  a	  few	  general	  regions.	  The	  retina	  around	  the	   equator	   is	   called	   the	   equatorial	   retina,	   while	   the	   region	   anterior	   to	   this	   is	  called	   the	   anterior,	   or	   peripheral	   retina.	   In	   the	   far	   periphery,	   the	   border	   between	   the	  retina	  and	   the	  pars	   plana	  is	   called	  the	  ora	   serrata.	   The	   layers	   of	  the	  retina	  can	  be	  seen	  clearly	   in	   cross-­‐sectional	   histological	   preparations.	   Their	   order	   from	   the	   inner	   to	   the	  outer	  retina	  is	  (Figure	  1.3	  ):	  internal	  limiting	  membrane	  (ILM),	  nerve	  gibre	  layer	  (NFL;	  the	  axons	  of	  the	  ganglion	  cell	   layer),	  ganglion	  cell	  layer,	   inner	  plexiform	   layer,	   inner	  nuclear	  layer,	   outer	   plexiform	   layer,	   outer	   nuclear	   layer	   (the	   nuclei	   of	   the	   photoreceptors),	  external	  limiting	  membrane	  (ELM),	  rod	  and	  cone	  inner	  and	  outer	  segments.
The	  extraocular	  musclesEach	  eye	  has	  six	  muscles:	  four	  recti	  and	  two	  oblique.	  The	  four	  recti	  muscles	  are	  attached	  to	   the	  superior,	   inferior,	   lateral	   and	  medial	   sides	   of	  the	   eyeball.	   They	  move	   the	   eye	   in	  superior,	   inferior,	   lateral	   and	   medial	   directions.	   The	   oblique	   muscles	   move	   the	   eyes	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Figure	  1.3:	  Retinal	  layers.	  Adapted	  from	  thesis	  Dr.	  L.P.J.	  Cruysberg,	  with	  permission.
obliquely	  upwards	  or	  downwards.	  One	  end	  of	  an	  extraocular	  muscle	  is	  attached	  to	  a	  ring	  (annulus	  tendineus)	  at	  the	  back	  of	  the	  orbit,	  while	  the	  other	  end	  is	  attached	  to	  the	  eyeball.Eye	  movements	  are	  generally	  well-­‐conjugated,	   i.e.	  both	  eyes	  move	  simultaneously	  in	  the	  same	  direction,	   so	   that	   the	  image	  of	  the	  world	   is	   projected	  onto	   corresponding	  areas	  of	  both	   retinas.	   The	   muscles	   work	   in	   combination	   to	   coordinate	   sight	   in	   both	   eyes	   and	  prevent	  double	  vision.	  In	  addition,	  this	  produces	  deep	  sight	  that	  enables	  the	  estimation	  of	  speed	  and	  distance.
Pathophysiology
Posterior	  vitreous	  detachment	  With	   aging,	   the	   vitreous	   body	   shrinks	   and	   liquegied	   pockets	   develop.	   Other	   changes	  include	  cross-­‐linkage	  between	  the	  collagen	  gibres,	   damage	  from	  free	  oxygen	  radicals	  and	  thinning	   of	   the	  network	   of	   collagen	   gibres.	   This	   decreases	   the	   stability	   of	   the	  vitreous	  body	  and	  causes	  the	  cortex	  to	   shrink	  away	  from	  the	  internal	  limiting	  membrane	  (ILM)	  of	  the	   retina.	   Once	   the	   gel	   has	   become	   liquegied,	   water	   can	   seep	   through	   the	   cortex	   and	  accumulate	   behind	   the	   vitreous	   membrane.	   The	   vitreous	   gel	   gradually	   shrinks	   and	  ultimately	   collapses.	   Detachment	   of	   the	   vitreous	   is	   referred	   to	   as	   vitreous	   collapse	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Figure	  1.4:	  Posterior	  vitreous	  detachment
(syneresis),	  or	  acute	  posterior	  vitreous	  detachment	  (PVD)26,	  27	  (Figure	  1.4).	  The	  condition	  is	   acute	   and	   patients	   see	   gloaters,	   which	   comprise	   the	   posterior	   side	   of	   the	   vitreous	  membrane	  (a	  Weiss	  ring).	  Due	  to	  traction	  of	  the	  vitreous	  on	  the	  retina,	   patients	  also	  see	  glashes	  of	  light.
Retinal	  tears	  and	  retinal	  detachmentIf	  the	  vitreous	   gel	   sticks	  to	   the	  vitreous	  base,	   traction	  can	  occur	  due	   to	   spontaneous	  or	  traumatic	   PVD	   and	   cause	   retinal	   tears	   (Figure	   1.5).	   About	   15%	   of	   patients	   with	  acute	  symptomatic	   PVD	   have	   one	   or	   more	   retinal	  tears.28,	   29	   Tears	   in	   symptomatic	   eyes	   run	   a	  high	  risk	   of	  rhegmatogenous	   (rhegma	   means	  tear	   in	   Greek)	   retinal	   detachment	   (RRD).	   In	  the	   case	   of	  RRD,	   the	   liquegied	   vitreous	   leaks	  through	   the	   tear	   into	   the	   subretinal	   space	  between	   the	   photoreceptor	   layer	   and	   the	  retinal	   pigment	  epithelium	  (RPE).	   If	   the	  gluid	  collects	  under	  the	  retina,	  this	  is	  referred	  to	   as	  subretinal	  gluid	  (Figure	  1.6).	  Gradual	  sight	  loss	  occurs	   from	   the	   periphery	   to	   the	   centre.	  Further	  seepage	  of	   the	   gluid	  under	  the	   retina	  may	  cause	  detachment	  of	  the	  macula.	  Patients	  become	   acutely	   aware	   of	   losing	   their	   sight	   if	  the	   macula	   also	   becomes	   detached.	   The	  condition	   causes	   considerable	   irreparable	  visual	   acuity	   loss,	   possibly	  because	   the	   fovea	  loses	   its	   own	   retinal	   blood	   supply	   and	  becomes	   completely	   dependent	   on	  the	  blood	  vessels	   in	   the	   choroid.	   Tears	   differ	   from	  one	  patient	   to	   another.	   The	   most	   common	   tears	  are	   horseshoe	   tears.	   There	   are	   also	   wide	  differences	  in	  the	  number	  and	  size	  of	  the	  tears	  between	   patients.	   If	   a	   very	   large	   tear	   spans	  more	   than	   three	   clock	   hour	   positions,	   then	  this	  is	  referred	  to	  as	  a	  giant	  retinal	  tear.30,	  31Risk	   factors	   for	   developing	   rhegmatogenous	  retinal	   detachment	   are:	   myopia,	   trauma,	  cataract	   surgery,32	   family	   history	   and	   retinal	  detachment	   surgery	   to	   the	   contralateral	   eye.32-­‐34
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Figure	  1.5:	  Retinal	  tear	  due	  to	  posterior	  vitreous	  detachment
Figure	   1.6:	   Retinal	   detachment.	   Fluid	  collection	   beneath	   the	   retina	   is	  referred	   to	  as	  subretinal	  gluid
Treatment for retinal detachment Several	   treatments	   are	   available	   for	   retinal	   detachment.	   The	   choice	   of	   treatment	   is	  determined	   for	   each	   patient	   individually.	   Treatment	   options	   comprise:	   pneumatic	  retinopexy,	  scleral	  buckling	  surgery	  or	  vitrectomy.
Pneumatic	  retinopexyIn	  pneumatic	  retinopexy,	   a	  bubble	  of	  gas	   is	   injected	  into	  the	   eye	  and	  cryocoagulation	  is	  performed	   at	   the	   location	   of	   the	   tear	   in	   cases	   of	   highly	   localised	   retinal	   detachment	  without	   any	   other	   abnormalities.16,	   35-­‐42	   This	   procedure	   in	   a	   slightly	  different	   form	  was	  girst	   performed	   by	   Vogt	   and	   Gonin	   in	   1919	   using	   electrodiathermy	   instead	   of	  cryocoagulation.43	   In	  1933,	  cryocoagulation	  was	  introduced	  by	  Deutschman	  and	  Bietti.43	  Some	  years	  later,	  in	  1952,	  Rosengren	  progressed	  with	  the	  injection	  of	  intravitreal	  air.44	  In	  1980,	  surgeons	  started	  to	  use	  expandable	  gas,	  e.g.	  sulphur	  hexagluoride	  (SF6).
Scleral	  buckling	  surgeryAt	   the	   majority	   of	   clinics,	   scleral	   buckling	   is	   performed	   in	   patients	   with	   less	   complex	  retinal	   detachment.45-­‐49	   Suitable	   candidates	   are,	   for	   example,	   patients	   with	   phakia	  who	  have	  retinal	  detachment	  in	  one	  or	  two	  quadrants,	  often	  with	  one	  horseshoe	  tear	  or	  one	  or	  two	   small	   tears.	   In	   this	   procedure,	   an	   encircling	   band	   is	   sutured	   around	   the	  circumference	  of	  the	  sclera,	   under	  the	  ocular	  muscles.	  A	   grooved	  buckle	  is	  placed	  under	  the	  band	  at	  the	   level	  of	  the	   tear	  to	   create	  an	  indentation	   in	  the	  eye	  wall	   that	   causes	   the	  underlying	  choroid	  and	  sclera	   to	  press	  against	  the	  retinal	   tear	  and	  close	  it.	  Explants	  are	  made	  of	  either	  solid	  silicone	  rubber	  or	  silicone	  sponges.	  Buckles	  come	  in	  various	   types,	  for	   example,	   the	   radial	   that	   compresses	   the	   tear,	   or	   the	   circumferential	   that	   indents	   a	  larger	  area	  (Figure	  1.7).	   To	   reduce	  the	   volume	  of	  subretinal	  gluid,	  transscleral	  puncture	  can	  be	  performed.	   Adhesion	   of	   the	   retina	   is	   achieved	  by	  applying	  cryocoagulation	  around	  the	   tear.	  A	  bubble	  of	  expandable	   gas	   can	  be	   injected	   into	  the	   eye	   to	   achieve	   stronger	   adhesion.	   The	  current	   technique	   is	   derived	   from	   scleral	  resection	  that	   was	   girst	   described	   by	  Müller	   in	  1903.50	   Further	  variations	  of	  altering	   the	  globe	  wall	   to	   push	   the	   choroid	   closer	   to	   the	   retina	  have	   been	   used	   in	   retinal	   re-­‐attachment	  procedures.	   In	   1918,	   Jules	   Gonin	   made	   the	  revolutionary	   hypothesis	   that	   retinal	   tears	  caused	   by	   vitreous	   traction	   constitute	   the	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Figure	  1.7:	  Scleral	  buckling	  surgery
pathogenic	  mechanism	  in	  retinal	  detachments.51	  This	  laid	  the	  groundwork	  for	  developing	  various	  techniques	  to	   release	  the	  vitreous	   traction	  by	  creating	  scleral	  indentation.	  These	  techniques	   include	  the	  use	  of	  polyethylene	  tubes,	   sutures,	  gelatine,	  human	  sclera,	   fascia	  lata	  and	  plantaris	  tendon.Scleral	  buckling	  surgery	  was	  girst	  performed	  by	  Jess	  in	  1937.	  To	  create	  an	  indentation,	  he	  sutured	   material	   to	   the	   sclera,	   which	   was	   removed	   after	   14	   days.	   In	   1952,	   Custodis	  presented	   his	   form	   of	   scleral	   buckling	   surgery,	   which	   comprised	   the	   creation	   of	   an	  indentation	  by	  placing	  a	  rod-­‐shaped	  piece	  of	  the	  elastic	  material	  (polyviol,	   polymerized	  alcohol)	  on	  to	  the	  sclera	  and	  securing	  it	  with	  strong	  Supramid	  (non-­‐absorbable	  synthetic)	  sutures.	   In	  accordance	  with	  his	   expectations,	   the	   tears	  were	  sealed	  mechanically	  by	   the	  protruding	  choroid.	  The	  subretinal	   gluid	  was	   resorbed	  so	   quickly	  that	  in	  most	  cases,	   the	  retina	  became	  re-­‐attached	  within	  12	  to	  24	  hours,	  which	  made	  it	  possible	  to	  mobilize	  the	  patient	   on	   the	   second	  or	   third	  postoperative	   day.	   This	   approach	   revolutionized	   retinal	  detachment	  surgery	  and	  postoperative	  care.52	  
VitrectomyPars	  plana	   vitrectomy	   (PPV)	  is	  generally	   performed	  in	  the	  more	   complicated	  cases,	   e.g.	  severe	  preoperative	  proliferative	  vitreoretinopathy	  (PVR),53	  giant	  retinal	  tears	  (GRT)36	  37	  and	  vitreous	  haemorrhage.	  Currently,	   there	   are	  discussions	  about	  whether	   it	   should	  be	  applied	  more	  often	  to	  treat	  RRD.54-­‐58PPV	   is	   the	   surgical	   removal	   of	  vitreous	   through	  three	  small	   openings	   in	  the	   pars	  plana	  (Figure	  1.8).	  The	  openings	  are	  made	  3-­‐5	  mm	  from	  the	  corneal	  limbus.59,	  60	  They	  can	  be	  of	  various	   sizes	   and	   entered	   with	   or	   without	  trocars;	  they	  can	  be	  self-­‐sealing	  or	  non-­‐self-­‐sealing.	  One	  of	  the	  openings	  is	  used	  for	  gluid	  infusion	  to	  maintain	  pressure	  within	  the	  eye.	  The	  other	   two	  openings	   enable	  the	  surgeon	  to	   work	   bimanually.	   An	   implantable	   high	  intensity	   gibre	  optic	   light	   source	   is	   used	   to	  illuminate	   the	   inside	   of	   the	   eye	   during	  surgery.	   It	   can	   be	   inserted	   through	   one	   of	  the	   openings,	   or	   a	   so-­‐called	   chandelier	   can	  be	   used	   if	   the	   surgeon	   wishes	   to	   use	   two	  instruments	   simultaneously.	   This	   high	  intensity	   gibre	   optic	   light	   source	   does	   not	  induce	   thermal	   damage	   or	   phototoxicity.61	  The	   surgeon	   uses	   a	   specialised	   surgical	  microscope	   with	   a	   contact	   lens	   or	   a	   wide	  viewing	   system,	   which	   provides	   increased	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Figure	  1.8:	  Vitrectomy
magnigication	  of	  the	  retina	  and	  vitreous.	  During	  the	  operation,	   the	  retina	  can	  be	  glattened	  using	  gas	   or	  gluids,	   such	  as	  pergluorocarbon	  liquid.	  In	  order	  to	  re-­‐attach	  the	  retina	  after	  the	   procedure	   and	   to	   create	   scar	   tissue,	   endolasercoagulation	   can	   be	   used,	   or	  cryocoagulation.	   To	  maintain	  some	  degree	  of	  pressure	  on	  the	   retina,	   a	  gas	   bubble	  or	  oil	  can	  be	  injected.	  Silicone	  oil	  is	  used	  to	  ensure	  continuous	  complete	  support	  of	  the	  retina.Various	  intraocular	  tamponades	  can	  be	  used,	  which	  include	  air	  or	  expandable	  gases,	  such	  as	  short-­‐acting	  or	  long-­‐acting	  gas.	  The	  gases	  are	  gradually	  resorbed,	  so	  no	  further	  surgery	  is	   required.	   Silicone	   oil,	   however,	   does	   have	   to	   be	   removed	   surgically.	   This	   can	   be	  accomplished	  in	  various	  ways,	  but	  the	  pressure	  within	  the	  eye	  must	  be	  maintained.	  One	  method	  is	  to	  place	  an	  infusion	  via	  the	  pars	  plana,	  or	  via	  the	  anterior	  chamber.	  The	  latter	  is	  only	  possible	  in	  patients	  with	  aphakia.Surgical	   instruments	  to	  perform	  PPV	  were	  invented	  by	  Machemer.	  He	  girst	  used	  them	  in	  1970	   to	   operate	   on	   a	   patient	   with	   vitreous	   haemorrhage.43,	   44,	   46-­‐48	   Since	   then,	   further	  developments	  have	  been	  made	  and	  in	  1982,	  Grieshaber	  introduced	  a	  new	  instrument	  (the	  
Grieshaber	   instrument)	   that	   simultaneously	   cuts	   and	   aspirates.43,	   48-­‐55	   Progress	   has	  continued	  with	  a	  succession	  of	  new	  vitrectomy	  instruments,	  while	  PPV59,	  60,	  62,	   63	  has	  been	  followed	  by	  one	  of	  the	  most	  revolutionary	  developments	  in	  vitreoretinal	  surgery	  over	  the	  past	   few	  years:	   transconjunctival	   sutureless	   PPV.	   The	   introduction	  of	   transconjunctival	  microincision	  vitrectomy	  surgery	  with	  23,	  25	  or	  27	  gauge	   instrumentation	  has	  potential	  advantages	   over	   traditional	   20-­‐gauge	   PPV.	   These	   advantages	   include	   faster	   wound	  healing,	  less	  conjunctival	  scarring,	  shorter	  surgical	  procedure,	  elimination	  of	  astigmatism,	  improved	  patient	  comfort	  and	  less	  postoperative	  inglammation.64-­‐70
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Aims:	   To	   quantify	   and	   evaluate	   the	   causes	   for	   treatment	   delay	   in	   patients	   with	  rhegmatogenous	  retinal	  detachment	  who	  were	  scheduled	  to	  undergo	  retinal	  detachment	  surgery.	  Treatment	  delay	  must	  be	  kept	  to	  a	  minimum	  in	  progressive	  vision-­‐threatening	  conditions.
Material	   and	   methods:	   Consecutive	   patients	   (n=205)	   with	   symptoms	   of	   primary	  rhegmatogenous	   retinal	   detachment	   were	   interviewed	   at	   the	   tertiary	   referral	   centre	  between	   June	   2006	   and	   June	   2007.	   Five	   categories	   of	   delay	   were	   identigied:	   “patient	  delay”,	   “general	   practitioner	   delay”,	   “referring	   ophthalmologist	   delay”,	   ”delay	   at	   the	  tertiary	   referral	   centre”	  and	  “delay	  until	   surgery	   at	   the	  tertiary	  referral	  centre”.	   Overall	  delay	  was	  also	  calculated.	  
Results:	   186	  eyes	  were	  included	  in	  the	  analysis.	  Median	  overall	  delay	  between	  the	  initial	  symptoms	  and	  surgery	  was	  10	  days.	  Almost	  60%	  of	  the	  overall	  delay	  was	  caused	  by	   the	  patient	  or	  the	  general	  practitioner.	  In	  more	  than	  50%	  of	  the	  patients,	  the	  delay	  was	  due	  to	  unawareness	   and/or	   unfamiliarity	   with	   the	   symptoms.	   Median	   patient	   delay	   was	  signigicantly	  lower	  in	  the	  patients	  with	  vitreous	  haemorrhage	  and	  in	  the	  patients	  with	  a	  history	  of	  rhegmatogenous	  retinal	  detachment	  in	  the	  fellow	  eye.
Conclusion:	   The	  major	  cause	  for	  delay	  was	   the	  patients’	  unawareness	   and	  unfamiliarity	  with	  the	  symptoms	  of	  retinal	  detachment.	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IntroductionRhegmatogenous	  retinal	  detachment	  (RRD)	  is	  caused	  by	  a	  retinal	  tear	  and	  the	  subsequent	  leakage	  of	  intraocular	  gluid	  and	  liquegied	  vitreous	   into	  the	   subretinal	   space.	   This	  causes	  separation	   of	   the	   neuro-­‐retina	   from	   the	   retinal	   pigment	   epithelium.1	   If	   left	   untreated,	  most	  RRDs	  will	  progress	  to	  complete	  detachment	  and	  vision	  loss	  in	  the	  affected	  eye.1	  The	  annual	  incidence	  of	  RRD	  is	  about	  10	  per	  100,000	  persons.2,	   3	  Predictors	  of	  functional	  and	  anatomical	  success	  after	  primary	  RRD	  repair	  were	  found	  to	  be:	  more	  than	  6	  days	  of	  vision	  loss,4	   macular	   involvement	   and	   the	   size	   of	   the	   detachment	   area.3-­‐9	   As	   the	   interval	  between	   the	  girst	   symptoms	  noted	  by	   the	  patient	  and	  the	   timing	  of	  surgery	   is	   of	  critical	  importance	   to	   all	   these	   factors,	   our	   aim	  was	   to	   investigate	   the	   reasons	   for	   treatment	  delay.	  
Subjects and MethodsIn	   this	   prospective	  study,	   we	  included	   all	   consecutive	  patients	   with	  primary	   RRD,	  who	  were	  referred	  to	  the	  Department	  of	  Ophthalmology	  at	  the	  University	  Hospital	  Maastricht	  between	   June	   2006	   and	   June	   2007.	   This	   hospital	   department	   functions	   as	   a	   tertiary	  referral	   centre	   (TRC),	   especially	   for	   retinal	   detachment	   cases.	   Patients	   with	   secondary	  retinal	  detachment	  were	  excluded.	  The	  study	   was	   approved	  by	   the	   institutional	   ethics	   committee.	   Patients	   were	   informed	  about	   the	   study	   procedure	   and	   gave	   informed	   consent.	   The	   study	   was	   conducted	   in	  accordance	  with	  the	  ethical	  standards	  laid	  down	  in	  the	  1964	  Declaration	  of	  Helsinki.Preoperative	  clinical	  characteristics	  of	  the	  patients	  were	  collected:	  age,	  sex,	  preoperative	  visual	   acuity,	   myopia	   (degined	  as	   spherical	   equivalent	   of	  -­‐6	  dioptres	  or	  more),	   previous	  intraocular	  surgery	  (i.e.	  cataract	  and	  retinal	  detachment	  in	  the	  fellow	  eye),	  the	  number	  of	  retinal	   quadrants	   detached,	   central	  macular	   (foveal	   region)	   involvement	   (measured	  by	  optical	   computer	   tomography	   (OCT))	   and	   the	  number	  of	   days	   of	  macular	   involvement.	  The	   latter	  was	   degined	  as	   the	  subjective	   duration	  of	  the	   sudden	  deterioration	   in	   visual	  acuity	   and/or	   visual	   gield	   loss.	   Clinical	   gindings	   were	   also	   noted:	   the	   presence	   of	  proliferative	  vitreoretinopathy	  (PVR)	  graded	  according	  to	  the	  classigication	  of	  RRD,10	   the	  type	   and	   localization	   of	   the	   retinal	   tear,	   the	   number	  of	   tears,	   the	   presence	   of	   vitreous	  haemorrhage	  and	  the	  type	  of	  surgery	  (scleral	  buckling	  or	  vitrectomy).	  Patients	   were	   interviewed	   preoperatively	   by	   the	   author	   or	   co-­‐authors	   (F.G.,	   J.H.,	   L.K.)	  using	  a	  questionnaire	  (see	  Table	  2.1).	   If	  and	  when	  necessary,	  the	  questions	  were	  clarigied	  by	   the	   interviewers.	   Patients	   were	   requested	   to	   carefully	   estimate	   the	   time	   interval	   in	  days	  since	  their	  initial	  symptoms.	  We	  helped	  them	  to	  relate	  their	  answers	  to	  a	  signigicant	  event,	  such	  as	   a	  birthday.	  This	  method	  enabled	  more	  precise	  estimation	  of	  the	  delay,	   at	  least	   to	   within	   a	   few	   days,	   even	  when	   the	   event	   had	  occurred	  more	   than	   two	  months	  previously.	  Patients	  who	  could	  not	  give	  clear	  answers,	  or	  were	  uncertain,	  were	  excluded.	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Table	  2.1:	  Questionnaire
Have	  you	  experienced	  any	  	  glashes?	  	  	  	  	  	  Have	  you	  experienced	  any	  	  gloaters?	  	  	  	  	  	  	  Have	  you	  experienced	  any	  	  visual	  gield	  loss?	  Have	  you	  experienced	  an	  acute	  sight	  loss?	  	  
Yes/No	  Yes/No	  	  Yes/No	  	  Yes/No	  	  When	  did	  you	  girst	  contact	  the	  general	  practitioner	  /	  ophthalmologist?................................	  days	  agoReason	  for	  delay:
Patient-­‐related	  delay	  ..................................................days
When	  did	  your	  general	  practitioner/ophthalmologist	  refer	  you?................................	  days	  agoReason	  for	  delay:
General	  practitioner	  delay.........................................days
When	  did	  the	  ophthalmologist	  refer	  you	  to	  our	  hospital?................................	  days	  agoReason	  for	  delay:
Referring	  ophthalmologist	  delay............................days
When	  did	  the	  retinal	  surgeon	  at	  the	  University	  Hospital	  Maastricht	  (UHM)	  decide	  to	  operate	  (ask	  retinal	  surgeon)	  ?
……………………………..	  days	  agoReason	  for	  delay:
Our	  out-­‐patient	  clinic	  delay	  …….........................….days
On	  what	  date	  did	  the	  surgery	  take	  place	  ?	  (this	  information	  was	  retrieved	  from	  the	  admission	  documents)
……………………………..	  days	  agoReason	  for	  delay:
Delay	  before	  surgery	  	  	  ………..…................…............days
Total	  delay…...................................................................days
To	  be	  Tilled	  in	  after	  ophthalmological	  examination	  by	  the	  ophthalmologist	  or	  retinal	  surgeon:Visual	  acuity…………………………………………………………….Funduscopic	  examination:	  PVR	  A	  /	  PVR	  B	  /	  PVR	  CFoveal	  involvement	  Yes/No?	  (how	  long).......................................daysNumber	  of	  tears…………./	  horseshoe/hole/oral	  dialysis/giant	  retinal	  tearOphthalmological	  history;………………………….……….……………………………………………………………………………Pseudophakia?	  Yes/NoFellow	  eye	  retinal	  detachment	  Yes/NoMyopia?	  	  Yes/No	  dioptres:	  SE…………Note:	  all	  interviews	  were	  conducted	  by	  the	  same	  three	  residents	  (FG,	  JH,	  LK)
For	  how	  long?.....................daysFor	  how	  long?.....................daysFor	  how	  long?.....................daysFor	  how	  long?.....................days
Five	  different	   categories	   of	  delay	   were	   identigied:	   “patient	   delay”,	   “general	   practitioner	  (GP)	  delay”,	   “referring	  ophthalmologist	  (RO)	  delay”,	   “delay	  at	   the	   TRC”	  and	  “delay	  until	  surgery	   at	   the	   TRC”.	   In	   addition,	   the	   overall	   (i.e.	   cumulative)	   delay	  was	   calculated	  per	  patient	  (see	  Table	  2.2).	  Information	   on	   three	   out	   of	   the	   give	   categories	   could	   be	   obtained	   from	   the	   patient	  (patient	  delay,	   GP	  delay,	  RO	  delay).	   “Delay	  at	  the	  TRC”	  was	  determined	  using	  admission	  documents.	  The	  exact	  date	  of	  surgery	  was	  derived	  from	  the	  surgical	  report.	  An	  example	  of	  a	  patient’s	  time	  schedule	  (in	  days)	  is	  shown	  in	  Figure	  2.1.	  During	  the	   interviews,	   it	   became	  apparent	   that	   the	   patients	  had	  little	   or	  no	   knowledge	  and/or	   experience	  with	   the	   symptoms	   of	  posterior	  vitreous	   detachment	   (PVD)	  and/or	  retinal	  detachment	  (RD).	  For	  example,	  they	  explained	  to	  the	  interviewer	  that	  they	  had	  not	  considered	  the	  symptoms	  of	  glashes,	   gloaters	  or	  visual	  gield	  loss	  to	  be	  serious,	  so	  they	  had	  not	  made	  any	  immediate	  effort	  to	  consult	  a	  physician.Statistical	   analysis	   was	   performed	   with	   the	   assistance	   of	   a	   statistician,	   using	   the	   SPSS	  software	  13.0.	   The	  duration	  of	  delay	  (in	  days)	  was	   converted	  into	  a	  logarithmic	   scale	  to	  create	   an	   equal	   distribution.	   After	   this	   conversion,	   statistical	   analysis	   was	   performed	  using	  the	  independent	  sample	  T-­‐test	  (signigicance	  was	  degined	  as	  P	  <	  0.05).
ResultsA	  total	  of	  206	  eyes	  in	  205	  patients	  with	  RRD	  (134	  men	  (65.5%)	  and	  71	  women	  (34.5%))	  were	  eligible	  for	  this	  study.	  No	   reliable	  answers	  could	  be	  obtained	  from	  seven	  out	  of	  the	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Table	  2.2:	  Definitions	  used	  in	  this	  study	  to	  specify	  the	  different	  categories	  of	  delay
Categories	  of	  delay De!ined	  as	  number	  of	  days	  	  	  	  	  from….until….Patient	  delay from	  the	  girst	  symptoms	  (glashes	  /	  gloaters/	  visual	  acuity	  loss	  and/or	  visual	  gield	  loss)	  noted	  by	  the	  patient	  until	  the	  date	  of	  the	  girst	  appointment	  with	  the	  GP,	  the	  RO,	  or	  the	  TRCGeneral	  practitioners	  (GP)	  delay from	  the	  girst	  date	  of	  the	  appointment	  with	  the	  GP	  until	  referral	  to	  either	  an	  RO	  or	  the	  TRCReferring	  ophthalmologist	  (RO)	  delay from	  the	  date	  moment	  the	  patient	  or	  GP	  contacted#	  the	  RO	  until	  the	  date	  the	  RO	  referred	  the	  patientDelay	  at	  the	  tertiary	  referral	  centre	  (TRC) from	  the	  date	  the	  patient,	  GP	  or	  RO	  girst	  contacted#	  the	  department	  until	  the	  patient	  was	  scheduled	  for	  surgeryDelay	  until	  surgery	  at	  TRC from	  the	  date	  was	  scheduled	  for	  surgery	  until	  the	  actual	  interventionOverall	  delay from	  the	  girst	  symptoms	  noted	  by	  the	  patient	  until	  the	  actual	  interventionNote:	  contacted#	  =	  GP	  or	  RO	  telephoned/patient	  visited
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Gender Male 121 65.1Female 65 34.9Eye Right 99 53.2Left 87 46.8Quadrants	  involved 1 57 30.52 93 50.03 22 11.84 14 7.5PVR None 69 37.1PVR	  A 45 22.6PVR	  B 48 25.8PVR	  C 24 12.9Macular	  involvement Yes 103 44.1No 82 55.4Not	  known 1 0.5Retinal	  tear Horseshoe 96 51.6Hole 47 25.3Oral	  dialysis 4 2.2Tear	  >2	  clock	  hours 10 5.4Missing 29 15.6Cumulative	  size	  of	  the	  retinal	  tear 1 106 57.0in	  disc	  diameters 2 33 17.73 10 5.4>3 5 2.7Missing 29 15.6Pseudophakic	  eye Yes 69 37.1No 117 62.9Fellow	  eye	  RD Yes 15 8.1No 171 91.9Myopia	  of	  >	  6	  Dioptres	   Yes 33 17.7No 151 81.2Unknown 2 1.1Type	  of	  surgery Scleral	  buckle 138 74.2Pars	  plana	  vitrectomy 48 25.8PVR:	  proliferative	  vitreoretinopathy,	  RD:	  retinal	  detachment
205	  patients.	   In	  two	  of	  these	  patients,	   the	  RRD	  was	   found	  by	  coincidence,	   so	   they	  were	  unable	   to	   recall	   the	  onset	   of	   their	   symptoms.	   In	   give	   other	   patients,	   the	   results	   of	   the	  interviews	  were	  unreliable	  due	  to	  dementia	  or	  confusion.	  Another	  12	  patients	  were	  also	  excluded	   (primary	   symptomatic	   PVD	   but	   no	   retinal	   tears;	   retinal	   tear	   treated	   with	  photocoagulation;	   no	   RRD	   present	   at	   initial	   visit	   –	   retinal	   tear	   appeared	   later).	   After	  excluding	   these	  19	  patients,	   a	   total	   of	  186	   eyes	   were	   included	   in	   the	   analysis.	   Clinical	  characteristics	  of	  the	  186	  patients	  are	  summarized	  in	  Table	  2.3.	  There	  were	  99	  right	  eyes	  (53.2%)	  and	  87	  left	  eyes	  (46.8%).	  The	  male	  versus	  female	  pseudophakic	  ratio	  was	  51	  to	  18	  (3:1).	  Mean	  patient	  age	  was	  59	  years	  (range:	  18-­‐87	  years).	  Fifteen	  fellow	  eyes	  (8.1%)	  had	   a	  history	   of	  RRD;	   33	   eyes	   (17.9%)	  were	  myopic.	   Surgical	   interventions	   comprised	  scleral	   buckling	   surgery	   in	   138	  eyes	   (74.2%)	  and	  primary	  pars	  plana	   vitrectomy	   in	   48	  eyes	  (25.8%).	  The	   girst	   symptoms	   experienced	   by	   the	   patients	   were:	   glashes	   (n=70;	   37.6%),	   gloaters	  (n=112;	  60.2%),	   visual	   gield	  defects	  (n=145;	  78.8%)	  and	  vision	   loss	  (n=131;	  70.4%).	   In	  patients	  complaining	  of	  glashes,	   gloaters,	   visual	   gield	  defects	   and	  sudden	  vision	  loss,	   the	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Figure	  2.1:	  Example	  of	   the	   symptoms	  and	  different	  categories	  of	   delay	  in	  one	  patient	  over	  a	  period	  of	  8	  days	  The	  girst	  symptoms	  were	   glashes,	   followed	  by	  gloaters,	  visual	  gield	  loss	  and	  sudden	  vision	  loss.	  “Patient	   delay”	   was	   two	  days;	   “general	   practitioner	  (GP)	   delay”	   was	  also	  two	   days;	   “Referring	   ophthalmologist	   (RO)	   delay”	   was	  one	   day;	   “tertiary	  referral	   centre	   (TRC)	   delay”	  was	  also	  one	   day;	   “delay	  until	  surgery	  at	  the	  TRC”	  was	  2	  days.	  Cumulative	  (or	  overall)	  delay	  was	  8	  days	  TRC:	  our	  tertiary	  referral	  centre
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Table	  2.4:	  Reasons	  for	  delay
Categories	  of	  delay Cause	  related	  to Number	  
n	  	  	  (%)
Median±	  SD	  days Mean	  delay	   Min-­‐maxPatient	  delay No	  delay 24	  (13%) 0 0 0(n=186) “Thought	  nothing	  serious” 104	  (56%) 6	  ±	  31 17 1-­‐230Wait	  until	  next	  working	  day 34	  (18%) 1	  ±	  4 3 1-­‐20Symptoms	  started	  on	  holiday 6	  (3%) 7	  ±	  1 6 5-­‐8Wait	  for	  appointment 6	  (3%) 6	  ±	  4 6 1-­‐11Other 11	  (6%) 7	  ±	  17 15 2-­‐50Total 186	  (100%) 4	  ±	  25 12 0-­‐230General	  practitioner	  (GP)	  delay(n=119)
No	  delay 78	  (66%) 0 0 0First	  available	  appointment 18	  (15%) 1	  ±	  2 1 1-­‐7Incorrect	  diagnosis 20	  (17%) 14	  ±	  42 30 1-­‐173Other 3	  (3%) 1	  ±	  1 1 1-­‐2Total 119	  (100%) 0	  ±	  20 5 0-­‐173Referring	  ophthalmologist	  (RO)	  delay(n=127)
No	  delay 73	  (57%) 0 0 0Next	  day 16	  (13%) 1 1 1GP	  referral	  without	  urgency 17	  (13%) 4	  ±	  12 9 2-­‐45First	  had	  other	  treatment	  or	  additional	  diagnostic	  procedure	  ‡	   9	  (7	  %) 21	  ±	  56 52 8-­‐180Ophthalmology	  patient,	  made	  own	  appointment 6	  (5%) 15	  ±	  12 18 7-­‐35Patient	  was	  not	  able	  to	  come	  earlier 7	  (6%) 4	  ±	  11 9 1-­‐30Total 127	  (100%) 0	  ±	  20 6 0-­‐180Delay	  at	  our	  tertiary	  referral	  centre	  (TRC)(n=186)
No	  delay 145	  (78%) 0 0 0Appointment	  next	  day 18	  (10%) 1 1 1Not	  referred	  as	  urgent 12	  (6%) 1	  ±15 7 1-­‐53First	  had	  other	  treatment	  or	  additional	  diagnostic	  procedure	  ‡ 1	  (1%) 2 2 2Other 10	  (5%) 3	  ±	  3 4 1-­‐10Total 186	  (100%) 0	  ±	  4 1 0-­‐53Delay	  before No	  delay 5	  (3%) 0 0 0surgery	  at	  (TRC) Next	  day 83	  (45%) 1	  ±	  0 1 1Over	  weekend 26	  (14%) 2	  ±	  1 2 1-­‐4(n=198) Scheduled	  within……days 36	  (20%) 7	  ±	  6 8 1-­‐33Emergency	  surgery	  not	  possible	  on	  that	  day	  * 25	  (13%) 2	  ±	  1 2 1-­‐3Other 11	  (6%) 2	  ±	  7 7 2-­‐20Total 186	  (100%) 1	  ±	  4 3 0-­‐33‡	  Eyes	  with	  a	  PVD	  alone	  at	  girst	  visit,	  	  which	  developed	  a	  RRD	  before	  next	  appointmentEyes	  with	  retinal	  tears	  which	  were	  girst	  photocoagulated,	  but	  later	  developed	  a	  RD* operating	  theatre	  was	  not	  available,	  or	  patients	  were	  unsuitable	  for	  surgery	  under	  local	  and/or	  general	  anesthesiaFor	  explanations	  and	  deginitions	  of	  categories	  of	  delay	  see	  Table	  2.2
median	  patient	  delay	  was	  6	  days	   (SD	  ±	  27),	   15	  days	   (SD	  ±	  41),	   5	  days	  (SD	  ±	  15)	  and	  5	  days	  (SD	  ±	  16),	  respectively.	  Median	   overall	  delay	  in	  all	   186	  eyes	  was	  10	  days	   (SD	   ±	  35).	   Expressed	  as	  percentages,	  mean	  overall	  delay	  was	  51%	  (SD	  ±	  32),	  GP	  delay	  was	  9%	  (SD	  ±	  21),	  RO	  delay	  was	  9%	  (SD	  ±	  20).	  TRC	  delay	  was	  5%	  (SD	  ±	  15),	  delay	  until	   surgery	  was	  26%	  (SD	  ±	  25).	  Almost	  60%	  of	  the	  overall	  delay	  was	  caused	  by	  patient	  delay	  and	  GP	  delay.	  Median	  patient	  delay	  was	  4	  days	   (SD	  ±	  24.5;	   n=186);	   median	  GP	  delay	  was	   0	  days	   (SD	   ±	   20.0;	  n=119).	   Median	  RO	  delay	  was	  0	  days	   (SD	  ±	  20.2;	  n=127);	  median	  TRC	  delay	  was	  0	  days	   (SD	  ±	  4.2;	   n=186).	  Median	  delay	  until	  surgery	  was	  1	  day	  (SD	  ±	  4.2;	  n=186)	  (Table	  2.4).	  In	   104	  patients	   (55.9%)	  we	   found	   that	   patient	   delay	  was	   due	   to	   unawareness	   and/or	  unfamiliarity	  with	  the	  RRD	  symptoms.	  Median	  patient	  delay	  in	  this	  subgroup	  was	  6	  days	  (SD	  ±	  31).	  Reasons	  for	  GP,	  RO	  and	  TRC	  delay	  are	  shown	  in	  Table	  2.4.	  Median	   patient	   delay	   was	   longer	   in	   the	   patients	   with	   a	   detached	   macula	   than	   in	   the	  patients	  without	  macular	   detachment:	   4	   days	   (SD	   ±	   30	   days)	  versus	   4	  days	   (SD	   ±	   14	  days),	   although	   this	   ginding	   was	   not	   statistically	   signigicant	   (P=0.67).	   Patients	   with	   a	  history	   of	   retinal	   detachment	   in	   the	   fellow	   eye	   (n=15)	   sought	   medical	   treatment	  signigicantly	  earlier.	   Their	  median	  patient	  delay	  was	  1.0	  day	  (SD	  ±	  8.0	  days),	  whereas	  in	  the	  group	  without	  a	  history	  of	  retinal	  detachment	  (n=171)	  patient	  delay	  was	  4	  days	  (SD	  ±	  25	   days)	   (P=0.015).	   Median	   patient	   delay	   in	   the	   patients	   with	   vitreous	   haemorrhage	  (n=7)	  was	   signigicantly	   shorter	  than	   that	   in	   the	  patients	  without	  vitreous	   haemorrhage	  (P=0.032):	  1	  day	  (SD	  ±	  1	  day)	  versus	  4	  days	  (SD	  ±	  25	  days).	  This	  difference	  only	  applied	  to	  the	  category	  patient	  delay,	  but	  not	  to	  the	  other	  four	  delay	  categories	  (see	  Table	  2.5).	  No	   statistically	   signigicant	   differences	   in	   delay	   were	   found	   in	   relation	   with	   myopia,	  affected	  eye	  (right	  or	  left),	  age	  or	  symptoms.Nine	  patients	  were	  delayed	  because	  the	  RO	  had	  made	  an	  incorrect	  diagnosis	  and	  the	  RRD	  had	   been	   overlooked.	   In	   one	   case,	   the	   initial	   decision	   at	   our	   centre	   was	   to	   apply	  alternative	  interventions	  (see	  Table	  2.4),	  which	  were	  degined	  as	  ultrasonography.	  In	  one	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Table	  2.5:	  Delay	  in	  days	  in	  RD	  patients	  with	  or	  without	  concomitant	  vitreous	  haemorrhage
Categories	  of	  delay With	  vitreous	  
haemorrhage	  (n=7)	  
Median	  ±	  SD	  (range)	  days	  
Without	  vitreous	  
haemorrhage	  (n=179)
Median	  ±	  SD	  (range)	  daysPatients	  delay‡ 1	  ±	  1.1	  (0-­‐3) 4.0	  ±	  24.9	  (0-­‐230)General	  practitioner	  (GP)	  delay 0.0	  ±	  0.4	  (0-­‐1) 0	  ±	  20.6	  (0-­‐173)Referring	  ophthalmologist	  (RO)	  delay 0.5	  ±	  1.9	  (0-­‐4) 0.0	  ±	  20.5	  (0-­‐180)Delay	  at	  TRC 0.0	  ±	  0.4	  (0-­‐1) 0.0	  ±	  4.3	  (0-­‐53)Delay	  until	  surgery	  at	  TRC 2.0	  ±	  7.8	  (1-­‐20) 1.0	  ±	  4.0	  (0-­‐33)Overall	  delay 3	  ±	  8.9	  (3-­‐22) 10	  ±	  34.9	  (1-­‐231)‡	   p<0.05	   for	   patient	   delay	   between	  RD	   patients	   with	   (n=7)	   and	  without	   (n=179)	   concomitant	   vitreous	  haemorrhageFor	  explanations	  and	  deginitions	  of	  categories	  of	  delay	  see	  Table	  2.2
patient,	  the	  delay	  was	  probably	  due	   to	  a	  misunderstanding	  between	  the	  patient	   and	  the	  administration	  staff.
DiscussionMedian	   overall	   delay	   between	   the	   girst	   subjective	   symptoms	   and	   surgical	   intervention	  was	  10	  days.	  Almost	  60%	  of	  this	  overall	  delay	  was	  due	  to	  patient	  delay	  and	  GP	  delay.	   In	  more	   than	  50%	  of	  the	  patients,	   the	  delay	  was	  due	  to	   unawareness	   and/or	  unfamiliarity	  with	  the	  symptoms	  of	  PVD	  and/or	  RRD.	   For	  example,	   some	  patients	   explained	  that	   they	  did	  not	  consider	  the	  symptoms	  of	  glashes,	   gloaters	  or	  visual	  gield	  reduction	  to	  be	  serious,	  so	   they	   did	  not	  make	   an	  urgent	   appointment	  with	  a	  physician.	  Mean	  patient	   delay	  was	  signigicantly	  shorter	  in	  the	  patients	  with	  vitreous	  haemorrhage	  and	  in	  the	  patients	  with	  a	  history	  of	  RRD	   in	  the	  fellow	  eye.	   The	  acute	  vision	  loss	   (acuity	  and	  gield)	  in	  the	  patients	  with	  vitreous	   haemorrhage	  was	   probably	   the	  reason	  why	   they	   sought	   immediate	   help.	  Patients	  who	   had	  a	  history	   of	   treatment	   for	   RRD	   in	  the	  fellow	   eye	  were	  more	   likely	   to	  recognize	   the	   symptoms	   of	   impending	   retinal	   detachment	   and	   go	   to	   a	   doctor	   straight	  away.	  Our	   data	   were	   collected	   by	   interviewing	   the	   patients	   using	   a	   questionnaire.	   In	   our	  experience,	   this	  method	  results	   in	  more	  accurate	   information	  than	  if	  a	  questionnaire	   is	  used	   without	   an	   interview.	   Quinn	   et	   al	   (United	   Kingdom)11	   also	   used	   interviews	   to	  evaluate	   the	   referral	   route	   of	   patients	   with	  RRD	   from	   primary	   care	   to	   a	   tertiary	   care	  ophthalmic	  unit.	  They	  reported	  that	  more	  than	  50%	  of	  the	  patients	  had	  signigicant	  delay	  due	   to	   ignorance,	   which	   was	   comparable	   with	   our	   percentage.	   The	   majority	   of	   their	  patients	  with	  RRD	  had	  been	   referred	  by	  optometrists	   and	  GPs	   (about	   two	   thirds	  of	   the	  referrals).11	  Contrastingly,	  86%	  of	  the	  patients	  in	  the	  Netherlands	  girst	  visited	  their	  GP.	  In	  our	   study,	   the	   GPs	  made	  an	  incorrect	   diagnosis	   in	  10%	  of	  the	   cases	   (n=20)	   (see	  Table	  2.4),	  which	  resulted	  in	  a	  median	  GP	  delay	  of	  0	  ±	  20	  days.	  Although	  the	  median	  patient-­‐related	  delay	  was	  4	  days,	  the	  median	  GP	  and	  RO	  delay	  was	  0	  days.	   We	   excluded	   all	   the	   patients	   who	   girst	   presented	   to	   the	   retinal	   surgeon	   with	  symptomatic	   PVD	   alone,	   i.e.	   without	  RRD.	   A	   routine	   re-­‐examination	  was	   scheduled	   for	  these	  patients	  within	  6	  weeks.	   The	  reason	  why	  we	  excluded	  these	  patients	  was	  because	  they	  had	  symptoms	  of	  PVD	  or	  retinal	  tears,	  but	  not	  RRD.	  These	  patients	  developed	  RRD	  in	  the	  interval	  before	  this	  scheduled	  visit,	  but	  found	  no	  reason	  to	  consult	  the	  retinal	  surgeon	  earlier.Van	  Overdam	  et	  al12,	   13	  found	  that	  5%	  of	  their	  patients	  developed	  a	  new	  retinal	  tear	  after	  the	  initial	  examination.	   In	  the	  present	  study,	  3%	  (n=6)	  of	  the	  patients	   (2	  referred	  by	  an	  ophthalmologist	  and	  4	   from	  our	  centre)	  developed	  RRD	  after	   the	  initial	   examination	  in	  which	   PVD	   alone	   had	   been	   diagnosed.	   These	   patients	   were	   excluded	   from	   the	   study.	  Another	  six	  patients	  (4	  referred	  by	  an	  ophthalmologist	  and	  2	  from	  our	  centre)	  were	  also	  excluded,	   because	  they	   had	  girst	  undergone	  photocoagulation,	   but	  did	  not	  develop	  RRD	  until	   later.	   Inclusion	  of	  these	  patients	  would	  have	  resulted	  in	  a	  relatively	  long	  RO	  delay	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and	  biased	  the	  delay	  of	  the	  RO.	  We	  also	  excluded	  a	  group	  of	  patients	  who	  presented	  with	  vitreous	   haemorrhage	   (another	   form	   of	   symptomatic	   PVD),	   in	   whom	   successive	  ultrasound	   examinations	   had	   been	   performed	   by	   the	   RO	   or	   at	   the	   TRC;	   they	   did	   not	  develop	  RRD	  until	  a	  few	  days	  later.Posterior	  vitreous	  detachment	  (PVD)	  is	  a	  common	  age-­‐related	  degenerative	  condition,14,	  15	   in	   which	   patients	   experience	   light	   glashes	   and/or	   gloaters.16	   These	   symptoms	   are	  specigic	   to	  PVD,	   but	  not	  all	   patients	   suffer	   from	  them.	   A	   study	  by	   Hikichi	  and	  Trempe16	  reported	  89%	  sensitivity	  for	  gloaters	  and	  glashes,	  with	  a	  specigicity	  of	  25%.	  This	  supports	  the	  statement	  made	  by	  Green	  and	  Sebag	  that	  posterior	  vitreous	  detachment	   is	  one	  of	  the	  least	  accurate	  diagnosis	  employed	  by	  ophthalmologists	  on	  a	  daily	  basis.17	  These	  gindings	  also	   congirm	  our	  results	   that	  there	  were	  no	   signigicant	  differences	  in	  delay	  between	   the	  patients	   with	   or	   without	   glashes,	   or	   between	   the	   patients	   with	   or	   without	   gloaters.	  Nevertheless,	  PVD	  is	  associated	  with	  an	  increased	  risk	  of	  developing	  retinal	  tears.12	  In	  the	  literature,	  7.3-­‐14%	  of	  patients	  with	  PVD	  had	  retinal	  tears.6	  Although	  RRD	  may	  be	  present	  or	  may	  develop	  following	  PVD,	  subjective	  glashes	  and/or	  gloaters	  are	  often	  absent.	  Owing	  to	  the	  observation	  that	  many	  patients	  with	  RRD	  in	  the	  Netherlands	  initially	  consult	  their	  GP,	   it	   is	  important	  that	  GPs	  are	  familiar	  with	  the	  complexity	  and	  variations	  of	  symptoms	  associated	   with	   RRD	   and	   have	   adequate	   knowledge	   of	   the	   implications	   of	   these	  symptoms.In	   this	   study,	   we	   found	   a	   striking	  male	   to	   female	   ratio	   of	   134	  men	   to	   71	  women.	   Our	  pseudophakic	  male	  to	   female	   ratio	  was	   51	  to	  18	  (3:1),	   which	  closely	  matched	  the	  ratio	  reported	  in	  a	  study	  by	  Sheu	  et	  al.18	  Their	  cumulative	  6-­‐year	  pseudophakic	  RRD	  rates	  were	  1.9%	   in	   the	  male	   subgroup	   compared	   to	   0.56%	   in	   the	   female	   subgroup	   at	   the	   end	   of	  follow-­‐up.18In	  summary,	  the	  median	  overall	  delay	  between	  the	  initial	  symptoms	  and	  surgery	  was	  10	  days.	   Almost	   60%	   of	   the	   overall	   delay	   was	   caused	   by	   the	   patient	   or	   the	   general	  practitioner.	   In	  more	  than	  50%	  of	  the	  patients,	  the	  delay	  was	  due	  to	  unawareness	  and/or	  unfamiliarity	  with	  the	  symptoms.	  Patient	  and	  GP	  education	  may	  therefore	  form	  primary	  goals	   to	   improve	  the	  functional	  outcome	  of	  RRD	  surgery.	   In	  every	  symptomatic	   patient,	  complete	  funduscopic	  examination	  should	  be	  performed	  by	  an	  ophthalmologist,	  including	  3-­‐mirror	   contact	   lens	   examination;	   re-­‐examinations	   should	   take	   place	  within	   6	   weeks.	  Patients	  should	  also	  be	  well-­‐instructed	  to	  return	  earlier	  if	  their	  symptoms	  deteriorate.	  It	  is	   vital	   that	   they	   realise	   the	   importance	   of	  the	   symptoms	  of	   glashes,	   gloaters	   and	   visual	  gield	  loss	  and	  contact	  an	  ophthalmologist	  promptly.	  The	  education	  of	  patients	  who	  are	  at	  risk	  of	  RRD	  (e.g.	  patients	  with	  myopia)	  can	  start	  at	  their	  girst	  visit	   to	  an	  ophthalmologist	  (irrespective	  of	  the	   reason	   for	   consultation)	  and	  be	  backed-­‐up	  by	  brochures.	   GPs	  must	  also	   be	   made	   aware	   of	   the	   different	   symptoms	   that	   can	   lead	   to	   PVD	   and/or	   RRD.	  Education	  can	  be	  provided,	  for	  example,	  in	  the	  form	  of	  articles	  in	  national	  or	  GP	  journals.
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Purpose:	   This	   study	   aimed	   to	   analyse	   the	   long-­‐term	   effects	   of	   scleral	   buckling	   (SB)	  surgery	  for	  rhegmatogenous	  retinal	  detachment	  (RRD)	  by	  following	  patients	  for	  at	  least	  6	  months.	   In	   the	   literature,	   preoperative	   and	   intraoperative	   clinical	   variables	   associated	  with	  re-­‐detachment	  and/or	  poor	  visual	  outcome	  have	  mainly	  been	  studied	  in	  the	  short-­‐term.	  
Methods:	   In	   a	   retrospective	   survey,	   we	   evaluated	   data	   on	   436	   eyes	   after	   SB	   surgery.	  Postoperative	  data	  were	  collected	  at	  3	  monthly	  intervals.
Results:	  After	  a	  mean	  follow-­‐up	  of	  51	  months,	   anatomical	  re-­‐attachment	  was	  achieved	  in	  76%	  after	  one	  SB	  procedure,	  with	  an	  ultimate	  re-­‐attachment	  rate	  of	  97%	  after	  additional	  vitreoretinal	  procedures.	  A	  total	  of	  104	  eyes	  developed	  re-­‐detachment	  during	  follow-­‐up.	  After	   more	   than	   six	   and	   twelve	   months	   follow-­‐up,	   32	   eyes	   (7%)	   and	   20	   eyes	   (5%)	  developed	   re-­‐detachment,	   respectively.	   Multivariate	   regression	   analysis	   showed	   that	  recurrent	   re-­‐detachment	   and	  more	  than	   seven	  days	   of	  visual	   gield	   loss	  were	   signigicant	  predictors	  of	  poor	  postoperative	  visual	  outcome	  at	  12	  months.	  A	   signigicant	  predictor	  of	  recurrent	  RRD	  was	  a	  cumulative	  tear	  size	  of	  more	  than	  3	  disc	  diameters.
Conclusion:	  Conventional	  SB	  surgery	  was	  a	  reliable	  procedure	  in	  a	  selected	  group	  of	  eyes	  with	  primary	  RRD.	  However,	  in	  eyes	  with	  a	  retinal	  tear	  that	  has	  a	  cumulative	  size	  of	  more	  than	   3	   disc	   diameters,	   primary	   vitrectomy	   is	   probably	   a	   better	   option.	   Based	   on	   our	  ginding	  that	  7%	  of	  the	  eyes	  developed	  re-­‐detachment	  after	  6	  months,	   a	  longer	  follow-­‐up	  period	  seems	  necessary	  to	  evaluate	  the	  anatomical	  and	  visual	  outcomes	  after	  SB	  surgery.
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IntroductionWith	   the	   introduction	   of	   improved	   vitreoretinal	   surgical	   techniques,	   there	   is	   on-­‐going	  debate	   about	  which	  patients	   with	   rhegmatogenous	   retinal	   detachment	   (RRD)	   are	   good	  candidates	   for	   a	   simple	   scleral	   buckling	   (SB)	   procedure.1-­‐5	   Although	   the	   majority	   of	  vitreoretinal	   surgeons	   still	   perform	   SB	   surgery	   in	   uncomplicated	   RRD,1,	   6-­‐11	   others	  propagate	  primary	  vitrectomy	  in	  such	  cases.12-­‐15	  Those	  in	  support	  of	  primary	  vitrectomy	  (PPV)	   argue	   that	   PPV	   has	   potential	   advantages	   over	   SB	   surgery,	   including	   shorter	  surgery,	  more	  accurate	  diagnosis	   of	   tears,	   no	   postoperative	  axial	   length	   changes	  and	  a	  higher	  re-­‐attachment	  rate	  after	  one	  procedure.13,	  16	  In	  a	  consecutive	  series	  of	  eyes	  that	  underwent	  SB	  surgery	  for	  primary	  RRD,	  we	  evaluated	  which	   preoperative	   and	   intraoperative	   clinical	   variables	   were	   associated	   with	   an	  increased	  risk	  of	  re-­‐detachment	  and/or	  poor	  visual	  outcome	  after	  a	  minimum	  follow-­‐up	  of	  6	  months.	  Our	  aim	  was	  to	  identify	  patients	  with	  good	  results	  after	  SB	  surgery,	   in	  order	  to	  improve	  the	  preoperative	  selection	  criteria.
Materials and methodsMedical	   records	   were	   reviewed	   of	   all	   patients	   with	   RRD	   who	   underwent	   primary	   SB	  surgery	  without	  vitrectomy.	  All	  the	  patients	   included	  in	  the	  study	  had	  been	  operated	  on	  by	  the	  same	  surgeon	  (ELH).	   In	   the	  period	  between	  January	  1997	  and	  October	   2004,	   SB	  surgery	   was	   performed	   on	   primary	   clear	   media	   non-­‐traumatic,	   non-­‐uveitic	   retinal	  detachments	   with	   limited	   proliferative	   vitreoretinopathy	   (PVR),	   except	   for	   three	   eyes	  that	  underwent	  pneumatic	  retinopexy.	  None	  of	  the	  eyes	  in	  the	  study	  sample	  had	  primary	  vitrectomy.	  We	  excluded	  all	   the	  eyes	  with:	  a	  follow-­‐up	  of	  less	  than	  6	  months	  (17	  eyes),	  a	  history	  of	   uveitis	   or	   trauma,	   PVR	   grade	  C2	  or	   higher17,	   18	   and	   complicated	  RRD	   due	   to	  vitreous	   haemorrhage	   that	   obscured	   fundus	   details.	   The	   study	   was	   conducted	   in	  accordance	   with	   the	   ethical	   standards	   laid	   down	   in	   the	   1964	  Declaration	   of	   Helsinki.	  When	   present,	   PVR	   was	   graded	   according	   to	   the	   Classigication	   of	   the	   Retina	   Society	  Terminology	  Committee.19All	  the	  patients	  were	  operated	  on	  by	  the	  same	  surgeon.	   The	  standard	  surgical	  technique	  was	   to	   git	   an	   encircling	  band.	   In	  each	   patient,	   the	   decision	   of	  whether	   to	   git	  a	   radial	   or	  segmental	  buckle	  was	  based	  on	  the	  size	  and	  location	  of	  the	  retinal	  tear.	  Drainage	  of	  sub-­‐retinal	  gluid	  was	  performed	  when	  judged	  necessary	  by	  the	  surgeon.	  Cryocoagulation	  was	  applied	  to	  almost	  all	  the	  cases.	   Intravitreal	  gas	  tamponade	  was	  used	  only	  for	  RRDs	  in	  the	  superior	  segment.	  The	   following	   preoperative	  clinical	   patient	   characteristics	  were	   collected	   for	   statistical	  analysis:	   age,	   sex,	   preoperative	   visual	   acuity,	   prior	   intraocular	   surgery,	   the	   number	   of	  detached	  quadrants	  of	   the	  retina,	   whether	  or	  not	   the	  central	   area	  of	  the	  macula	   (foveal	  region)	  was	   involved	   in	   the	   detachment,	   the	   presence	   and	   grade	  of	   PVR,	   the	   type	   and	  localization	   of	   the	   retinal	   tear,	   the	   number	   of	   tears	   and	   their	   cumulative	   size	   in	   disc	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diameters	   (DD).	   The	   type	   of	   tear	   was	   noted	   as	   an	   atrophic	   hole,	   a	   horseshoe	   tear,	   a	  combination	   of	   the	   two,	   or	   ora-­‐dialysis.	   Pre-­‐	   and	   postoperative	   Snellen	   visual	   acuities	  (also	   with	   pinhole	   correction)	   and	   pre-­‐	   and	   postoperative	   Goldmann	   applanation	  tonometry	  were	   recorded.	  During	  slit-­‐lamp	  examination,	   the	  presence	  of	  pseudophakia,	  or	   intravitreal	   pigment	   was	   identigied.	   Funduscopy	   was	   performed	   using	   indirect	  binocular	   ophthalmoscopy	   in	   combination	  with	   a	   Goldmann	   three-­‐mirror	   contact	   lens	  (without	   scleral	   depression)	   and	   with	   a	   pan	   fundus	   contact	   lens	   (Supersquad	   160°).	  Fundus	   drawings	   of	   the	   RRD	   were	  made	   in	   clock	   hours.	   By	   carefully	   interviewing	   the	  patient,	  we	  determined	  the	  approximate	  time	  of	  onset	  of	  the	  detachment.	  The	  duration	  of	  detachment	  until	  surgery	  was	  categorized	  into	  the	  following	  groups:	  0	  to	  7	  days,	  or	  more	  than	  7	  days,	  as	  described	  by	  Diederen	  et	  al.20Surgical	  SB	  reports	  were	  reviewed	  to	   retrieve	  details	  of	  the	  procedure	  used	  to	  repair	  the	  tear.	  The	  following	  surgical	  variables	  were	  recorded:	  radial	  or	  segmental	  silicone	  buckle,	  subretinal	   gluid	  drainage	   (yes/no),	   cryocoagulation	  (yes/no),	   air	  or	   intravitreal	   sulphur	  hexagluoride	   (SF6)	   gas	   as	   internal	   retinal	   tamponade	   (yes/no).	   All	   intraoperative	  complications	  were	  noted,	   such	  as	   scleral	  perforation,	   vitreous	   incarceration,	   or	   retinal	  incarceration.After	   SB	   surgery,	   we	   noted	  whether	   the	   patients	   had	  developed	  recurrent	   RRD	   and	   at	  what	   interval,	   the	   cause	   of	   the	   re-­‐detachment	   and	   the	   subsequent	   clinical	   procedures.	  Anatomical	   success	  was	  degined	  as:	   complete	  re-­‐attachment	  of	  the	  retina,	  or	   as	  a	  stable	  situation	   in	   which	   the	   retina	   was	   attached,	   with	   congined	   pockets	   of	   subretinal	   gluid.	  Recurrent	   retinal	   detachment	  was	   categorized	   as	   being	   due	   to:	   vitreous	   traction	  with	  PVR,	   new	   or	   missed	   retinal	   tears,	   persistent	   and/or	   progressive	   re-­‐accumulation	   of	  subretinal	  gluid,	  or	  progressive	  “leakage”	  of	  subretinal	   gluid	  at	  the	  edge	  of	  the	  buckle	  due	  to	   lack	  of	  indentation.	  Re-­‐detachment	  within	  6	  months	  of	  the	  primary	  SB	  procedure	  was	  degined	  as	  “early	  re-­‐detachment”.Data	  were	  collected	  at	  3-­‐monthly	   intervals	  following	  SB	   surgery.	  After	  12	  months,	  many	  of	   the	   patients	   had	   returned	   to	   their	   referring	   ophthalmologist,	   who	   we	   subsequently	  approached	  for	  the	  relevant	  follow-­‐up	  data.	   If	  patients	  had	  not	  returned	  for	  follow-­‐up	  at	  our	   department	   or	   at	   the	   ophthalmology	   practice,	   data	   on	   anatomical	   success	   were	  obtained	  by	  telephone	  and	  interview	  by	  one	  of	  the	  authors	  (FG).	  We	  asked	  these	  patients	  whether	  their	  visual	  function	  had	  deteriorated	  and	  whether	  they	  had	  noticed	  any	  signs	  or	  symptoms	   of	  (re-­‐)detachment.	   In	  the	  case	  of	  deterioration	  and/or	  symptoms,	   we	  noted	  the	  name	   of	  the	   ophthalmologist	   they	   had	  consulted	   and	  asked	   for	   their	   permission	   to	  retrieve	   the	   relevant	   data.	   Statistical	   analysis	   was	   performed	   using	   the	   SPSS	   software	  13.0.	   Snellen	  visual	   acuities	   were	   converted	   into	   a	   logarithmic	   scale	   (LogMAR,	   i.e.	   the	  logarithm	   of	  the	  minimal	   angle	  of	  resolution),	   as	   described	  previously.21	   In	  the	   present	  study,	  poor	  visual	  outcome	  was	  degined	  as:	  visual	  acuity	  of	  less	   than	  0.1	  Snellen	  lines	  at	  12	   months	   follow-­‐up.	   Missing	   data	   on	   co-­‐variables	   or	   outcome	   variables	   (when	   the	  variable	   had	   been	   measured	   at	   least	   three	   times)	   were	   inferred	   with	   the	   multiple	  imputation	   technique	   described	   by	   van	   Buuren	   et	   al,22	   using	   STATA	   8	   software.	  Comparisons	   were	  made	   between	  preoperative	  and	  postoperative	   visual	   acuities	   using	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the	  Wilcoxon	  signed	  rank	   test.	   Univariate	   analysis	   was	   performed	  with	  the	   Chi-­‐square	  test	   or	  Fisher’s	   exact	   test	   to	   determine	  whether	   preoperative	   or	   intraoperative	   clinical	  variables	   were	   associated	   with	   recurrent	   RRD	   or	   poor	   visual	   outcome.	   A	   stepwise	  forward	   multiple	   logistic	   regression	   analysis	   was	   used	   to	   determine	   the	   strongest	  predictors	   of	   poor	   visual	   outcome	   from	   the	   following	   preoperative	   variables,	   using	   a	  probability	   for	  entry	   of	  <	  0.1	  or	  recurrent	  RRD:	  age	  older	  than	  70	  years,	  pseudophakia,	  number	   of	   days	   of	   visual	   gield	   loss,	   the	   type	   of	   retinal	   tear,	   three	   or	   more	   tears,	  cumulative	  tear	  size	  of	  more	  than	  3	  DD,	   extent	  of	  total	  detachment,	  the	  presence	  of	  PVR	  (B	  or	  C)	  and	  macular	  involvement.	  A	  P-­‐value	  of	  ≤	  0.05	  was	  considered	  signigicant.
ResultsA	  total	  of	  436	  eyes	  (263	  men	  and	  173	  women,	  60.3%	  versus	  39.7%)	  in	  424	  patients	  were	  included	  in	  this	   study.	  These	  patients	  had	  a	  mean	  age	  of	  58.2	  years	  (range	  15-­‐90	  years).	  Mean	  follow-­‐up	  was	  50.6	  months	  (range	  6-­‐120	  months).	  Separated	  into	  age	  groups,	  356	  patients	  (81.7%)	  were	  70	  years	  or	  younger,	  while	  80	  (18.3%)	  were	  older	  than	  70	  years.	  There	  were	  339	  phakic	  eyes	  (77.8%)	  and	  97	  pseudophakic	  eyes	  (22.2%).	  Preoperatively,	  252	  eyes	  (57.8%)	  had	  a	  detached	  macula	  and	  184	  eyes	  (42.2%)	  had	  an	  attached	  macula.In	  this	  series	  of	  436	  eyes,	  anatomical	  success	  was	  achieved	  in	  76.1%	  (N=332)	  after	  one	  SB	  procedure.	   Re-­‐attachment	   was	   ultimately	   achieved	   in	   424	   (97.2%)	   of	   the	   eyes	   after	  multiple	   vitreoretinal	   procedures.	   A	   Kaplan	   Meijer	   survival	   curve	   of	   time	   versus	   re-­‐detachment	  is	  shown	  in	  Figure	  3.1.	  Subsequent	  vitreoretinal	  procedures	  to	  re-­‐attach	  the	  retina	  were	  performed	  in	  100	  out	  of	  the	  104	  eyes	  that	  developed	  re-­‐detachment	  after	  SB	  surgery.	  In	  four	  out	  of	  the	  104	  eyes,	  the	   patient	   and/or	   the	   surgeon	   decided	   not	   to	   proceed	   with	   any	   further	   operations,	  because	  of	  the	  poor	  prognosis	  for	  the	  eye,	   or	  the	  poor	  physical	  condition	  of	  the	  patient.	  This	  decision	  was	  ultimately	  made	  in	  nine	  (2%)	  out	  of	  the	  436	  eyes,	  although	  give	  patients	  had	  undergone	  additional	  vitreoretinal	  procedures.Data	  on	  the	  interval	  since	  SB	   surgery	  were	  available	  in	  100	  out	  of	  the	  104	  eyes	  (23.9%)	  that	  developed	  re-­‐detachment.	   Data	   on	   the	   timing	   and	   the	  cause	   of	  the	   re-­‐detachment	  were	  available	  in	  87	  eyes	  (Table	  3.1).	  Re-­‐detachment	  occurred	  after	   a	  mean	  period	  of	  54.4	  weeks	  (median	  12	  weeks,	   range	  0	  days	  to	  516	  weeks)	   in	  all	   100	  eyes.	  Within	  the	   girst	   3	  months,	   55	  (12.6%)	  eyes	  had	  re-­‐detachment.	  At	  6	  months,	  68	  out	  of	  the	  436	  eyes	  (15.6%	  of	  total)	  had	  re-­‐detachment;	  one	  year	  after	  the	  SB	  procedure,	  a	  total	  of	  80	  out	  of	  the	  436	  eyes	  (18.3%)	  eyes	  had	  recurrent	  RRD.	   Twenty	   out	   of	   the	   100	   eyes	   (4.6%	   of	   the	   total	   surgical	   series)	   developed	   re-­‐detachment	  more	  than	  one	  year	  postoperatively.	   Details	  of	  the	  timing	  and	  causes	   of	  the	  re-­‐detachments	  are	  described	  in	  Table	  3.1.	  We	   used	   telephone	   interviews	   to	   ask	   the	   patients	   whether	   their	   visual	   function	   had	  deteriorated,	   or	  whether	   they	   had	   noticed	   any	   signs	   or	   symptoms	   of	   (re-­‐)detachment.	  With	   this	   method,	   we	   found	   that	   only	   one	  patient	   had	   received	  retinal	   re-­‐detachment	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surgery	   at	   another	   hospital.	   Eight	   other	   cases,	   who	   stated	   that	   their	   visual	   acuity	   had	  changed,	  were	  seen	  at	  our	  hospital.	  However,	  none	  of	  these	  eyes	  had	  re-­‐detachment.	  Re-­‐detachment	   occurred	   in	  29	  out	  of	   the	  97	  pseudophakic	   eyes	   (30%).	   There	  were	   no	  aphakic	   eyes	   in	   the	   present	   series.	   In	   3	   eyes,	   no	   further	   operations	   were	   performed,	  because	  of	  the	  poor	  prognosis	  for	  the	  eye,	  or	  the	  poor	  physical	  condition	  of	  the	  patient.	  A	  total	  of	  26	  eyes	  underwent	  subsequent	  vitrectomy	  procedures:	  in	  20	  eyes,	  one	  vitrectomy	  with	  gas	  tamponade	  (n=6)	  or	  oil	  tamponade	  (n=14);	  in	  6	  eyes	  two	  vitrectomies:	  5	  with	  oil	  tamponade,	   and	   one	   eye	   with	   gas	   tamponade	   followed	   in	   a	   later	   procedure	   with	   oil	  tamponade.	   In	   one	   of	  the	  eyes,	   a	   total	  of	   3	  re-­‐attachment	  vitrectomies	  were	  performed	  with	  oil	  tamponade.	  The	  retina	  was	  ultimately	  attached	  in	  100%	  (26/26)	  of	  the	  26	  eyes	  that	   underwent	   subsequent	   surgery.	   However,	   two	   eyes	   with	   attached	   retinas	   were	  enucleated	  because	  of	  severe	  pain.At	   the	  end	  of	  follow-­‐up,	  visual	  acuity	  was	  hand	  motion	  or	   less	   in	  14%	  of	  the	  patients.	  A	  total	   of	   225	  eyes	   (52%)	   had	  20/20	  to	   20/40	   vision,	   148	   (34%)	  had	   20/50	   to	   20/200,	  while	   63	   eyes	   had	   less	   than	   20/200.	   In	   the	   group	   with	   20/200	   or	   less,	   37	   had	   re-­‐detachment	   (59%).	   In	  nine	  eyes	   (14%),	   the	  patient	   and/or	   the	   surgeon	  decided	  not	   to	  proceed	  with	  any	   further	  operations,	   because	  of	   the	  poor	  prognosis	   for	   the	  eye,	   or	   the	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Figure	  3.1:	  Kaplan	  Meijer	  survival	   plot	  of	   re-­‐detachment	  after	  scleral	   buckling	  surgery	  (n=436)Survival	  =	  number	  of	  eyes	  with	  an	  attached	  retina	  after	  one	  SB	  procedureThe	  curve	  shows	  a	  steep	  decline	  because	  two	  patients	  had	  re-­‐detachment	  at	  120	  months	  follow-­‐up
poor	  physical	  condition	  of	  the	  patient.	  In	  the	  subgroup	  of	  63	  eyes	  whose	  visual	  acuity	  was	  20/200	  or	  less,	  we	  were	  able	  to	  determine	  the	  cause	  in	  16	  cases:	  eight	  patients	  developed	  severe	  cataract,	  two	  patients	  had	  a	  vascular	  disease	  (one	  case	  of	  anterior	  ischaemic	  optic	  neuropathy	  and	  one	  case	  of	  central	  retinal	  vein	  occlusion),	  one	  patient	  developed	  corneal	  decompensation,	  two	  cases	  had	  amblyopia,	  one	  case	  developed	  phthisis	  bulbi,	  one	  patient	  had	  an	  epiretinal	  membrane	  and	  one	  patient	  developed	  neovascular	  glaucoma.	  Owing	  to	  the	   retrospective	   nature	   of	   the	   study	   and	   the	   fact	   that	   we	   only	   asked	   the	   referring	  ophthalmologists	  to	  provide	  visual	  acuity	  results,	   no	  data	  were	  available	  on	  the	  cause	  of	  low	  visual	  acuity	  in	  the	  other	  38	  eyes.Univariate	   analysis	   was	   performed	   on	   all	   the	   preoperative,	   intraoperative	   and	  postoperative	   clinical	   variables	   to	   obtain	   odds	   ratios	   for	   poor	   postoperative	   visual	  outcome.	  Signigicant	  risk	   factors	  were	  found	  to	   be:	  preoperative	  Snellen	  visual	   acuity	  of	  less	   than	  0.1,	  more	  than	  7	  days	  of	  visual	  gield	  loss,	  more	   than	  three	  quadrants	  of	  retinal	  detachment,	   PVR	   B	   or	   C,	   macular	   involvement	   and	   re-­‐detachment	   (Table	   3.2).	  Multivariate	   analysis	   revealed	   that	  more	  than	   7	  days	   of	   visual	   gield	   loss	   and	   recurrent	  retinal	  detachment	  were	  signigicant	  risk	  factors	  for	  poor	  visual	  outcome	  (odds	  ratios:	  2.3,	  P=0.006	  and	  5.0;	  P<0.001,	  respectively).	  Univariate	  analysis	  was	  also	  performed	  on	  all	  the	  preoperative	  and	  intraoperative	  clinical	  variables	  to	  obtain	  odds	   ratios	   for	  re-­‐detachment.	  Signigicant	  risk	   factors	  were	  found	  to	  be:	   a	   cumulative	   tear	  size	  of	  >	  3	  DDs,	  more	   than	  three	  quadrants	  of	  retinal	   detachment	  and	  PVR	  grade	  B	  or	  C	  (Table	  3.3).	  Multivariate	  analysis	  revealed	  that	  only	  the	  size	  of	  the	  tear	  was	  signigicantly	  associated	  with	  the	  occurrence	  of	  re-­‐detachment	  (P=0.009)	  (Table	  3.3).	   Further	   stepwise	   forward	  multiple	   logistic	   regression	  analysis	   on	   these	   variables,	  with	   the	   addition	   of	   the	   interval	   until	   re-­‐detachment,	   showed	   a	   signigicant	   association	  
   scleral buckling surgery   45
Table	  3.1:	  Causes	  of	  re-­‐detachment	  during	  follow-­‐up	  after	  the	  first	  scleral	  buckling	  	  procedure


























1	  -­‐	  3	  months 35	   7	   2 10	   1 55	  (12.6%) 55	  (55%)	  
3	  -­‐	  6	  months 8	   0	   1	   3	   1 68	  (15.6%) 13	  (68%)	  
6	  months-­‐1	  year 8	   0 0	   3	   1 80	  (18.3%) 12	  (80%)
>	  1	  year 4	   0	   6	   0	   10 100	  (22.9%) 20	  (100%)
Total 55	   7	   9 16	   13 104	  (23.9%) 100	  (100%)PVR:	  proliferative	  vitreoretinopathy,	  SRF:	  subretinal	  gluid
‡	  Leakage	  is	  degined	  as	  the	  accumulation	  of	  subretinal	  gluid	  at	  the	  edge	  of	  the	  buckle	  due	  to	  lack	  of	  indentation#	  Other:	  other	  causes	  of	  re-­‐detachment,	  such	  as	  removal	  of	  the	  scleral	  buckle	  in 	  two	  patients	  after	  one	  year,	  or	  not	  noted,	  or	  cause	  unknownNote:	  Data	   on	  the	   interval	  between	  SB	  surgery	   and	  re-­‐detachment	  were	  available	  in	  100 	  out	   of	   the	  104	  eyes	  (23.9%)
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Table	  3.2:	  Univariate	  and	  multivariate	  analyses	  on	  clinical	  variables	  associated	  	  with	  poor	  visual	  acuity	  (<	  0.1	  Snellen)	  at	  12	  months	  follow-­‐up
Factors Total	  no.	  of	  
Eyes
(N=436)
Univariate	  analysis	   Multivariate	  analysis
Preoperative Odds	  
ratio




≤	  70	  years 356
>	  70	  years	   80 1.56 0.65-­‐3.70 0.29	   NS
Pseudophakic	  eye





≥	  0.1 254 0.42 0.24-­‐0.74 0.004 NS
Days	  of	  visual	  !ield	  loss	  
reported‡




1	  -­‐	  3 358 1.26 0.43-­‐3.67 0.67 NS
≥	  4 39 1.93 0.89-­‐4.17 0.09 NS
Type	  of	  retinal	  tear
Round 64 1.76 0.72-­‐4.30 0.21 NS
Horseshoe 296 1.04 0.61-­‐1.77 0.90 NS
Other 37 0.92 0.19-­‐4.32 0.92 NS
None/missing 39 0.19 0.00-­‐74.78 0.49 NS
Cumulative	  size	  of	  the	  
tears	  *
<	  3	  DD 290
≥	  3	  DD 107 1.64 0.86-­‐3.16 0.13 NS
Detachment	  size
1	  -­‐	  3	  quadrants 409
>3	  quadrants 27 4.19 1.75-­‐10.06 0.001 NS
PVR
B/C 119 2.38 1.02-­‐5.56 0.0046 NS
Other 317
Macular	  status
Macular	  involvement 252 0.37 0.20-­‐0.72 0.004 NS
Macula	  not	  involved 184
Re-­‐detachment
Yes 104 5.02 2.57-­‐9.82 <0.001 5.04 2.27-­‐11.19 <0.001
No 332NS:	  not	  signigicant,	  DD:	  disc	  diameter,	  PVR:	  proliferative	  vitreoretinopathy,	  SF6:	  sulphur	  hexagluoride	  ‡	  variables	  were	  compared	  to	  the	  girst	  variable*	  Missed	  tears	  (n=39)	  were	  excluded
between	   the	   cumulative	   size	   of	   the	   tear	   of	  more	   than	  3	   DDs	   and	  early	   re-­‐detachment	  (P=0.007,	  data	  not	  shown	  in	  the	  Table).Postoperatively,	   the	  scleral	   buckle	   or	  encircling	   band	  had	  to	   be	   removed	   from	  six	   eyes.	  This	  was	  due	   to	   intolerable	  pain	   in	   four	  eyes,	   infection	  in	  one	  eye	  and	  exposure	  of	   the	  buckle	  in	  one	  eye.	  During	  follow-­‐up,	   re-­‐detachment	  developed	  in	  two	  (33%)	  out	  of	  these	  six	  eyes.
DiscussionIn	  this	  series	  of	  consecutive,	  non-­‐selected	  patients,	  anatomical	  re-­‐attachment	  of	  the	  retina	  was	   achieved	   in	   76%	   after	   one	   scleral	   buckling	   (SB)	   procedure.	   Ultimate	   anatomical	  success	  was	  achieved	  in	  97%.	  These	  percentages	  were	  comparable	  with	  those	  reported	  in	  earlier	  studies	  on	  RRD	  treated	  with	  SB	  surgery	  alone.7-­‐10,	  18,	  23-­‐28	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Table	  3.2	  (Continued)
Factors Total	  no.	  of	  
Eyes
(N=436)
Univariate	  analysis	   Multivariate	  analysis
Preoperative Odds	  
ratio




Type	  of	  buckle	  
Segmental 257 1.35 0.71-­‐2.58 0.35 NS
Radial 184 0.66 0.33-­‐1.31 0.22 NS
Combination	  of	  the	  
two
12 2.18 0.61-­‐7.81 0.23 NS
Drainage	  of	  subretinal	  
!luid




No 95 1.04 0.54-­‐2.00 0.89 NS
Use	  of	  intravitreal	  gas	  (SF6	  	  
gas)
Yes 316




No	   415 2.48 0.77-­‐7.92 0.12 NSNS:	  not	  signigicant,	  DD:	  disc	  diameter,	  PVR:	  proliferative	  vitreoretinopathy,	  SF6:	  sulphur	  hexagluoride‡	  variables	  were	  compared	  to	  the	  girst	  variable*	  Missed	  tears	  (n=39)	  were	  excluded
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Table	  3.3:	  Univariate	  and	  multivariate	  analyses	  on	  clinical	  variables	  associated	  with	  re-­‐detachment
Factors Total	  no.	  of	  
Eyes
Univariate	  analysis	   Multivariate	  analysis
Preoperative (N=436) Odds	  
ratio




≤	  70	  years 356 1.59 1.16-­‐2.19 0.143 NS
>	  70	  years	   80
Pseudophakic	  eye





≥	  0.1 254 1.14 0.87-­‐1.51 0.556 NS
Day	  of	  visual	  !ield	  loss	  
reported‡
0	  -­‐	  6	  days 230
≥7days 206 0.79 0.62-­‐1.00 0.293 NS
Number	  of	  tears‡
missing 39
1	  -­‐	  3 358 0.41 0.15-­‐1.12 0.082 NS
>3 39 0.47 0.15-­‐1.50 0.183 NS
Type	  of	  retinal	  tear
	  	  	  	  	  Round 64 0.79 0.26-­‐2.43 0.473 NS
Horseshoe 296 0.74 0.28-­‐1.95 0.197 NS
Other 37 1.26 1.11-­‐1.43 0.773 NS
Missing 39 1.36 0.41-­‐4.51 0.361 NS
Cumulative	  size	  of	  tears	  *
<	  3	  DD 290
≥	  3	  DD 107 0.50 0.24-­‐1.03 0.006 0.51 0.40-­‐0.66 0.009
Detachment	  size
1	  -­‐	  3	  quadrants 409
>	  3	  quadrants 27 0.31 0.29-­‐0.33 0.004 NS
PVR
B/C 119
Other 317 0.56 0.26-­‐1.19 0.016 NS
Macular	  status
Macular	  involvement 252 1.29 0.35-­‐4.89 0.267 NS
Macula	  not	  involved 184
Intraoperative	  factors
Type	  of	  buckle
Segmental 247 0.65 0.24-­‐1.76 0.068 NS
Radial 177 0.57 0.38-­‐7.19 0.036 NS
Combination	  of	  the	  two 12 0.62 0.33-­‐1.15 0.439 NSNS:	  not	  signigicant,	  DD:	  disc	  diameter,	  PVR:	  proliferative	  vitreoretinopathy,	  SF6:	  sulphur	  hexagluoride	  ‡variables	  are	  compared	  with	  the	  girst	  variable
After	   more	   than	   six	   and	   twelve	   months	   follow-­‐up,	   32	   eyes	   (7%)	   and	   20	   eyes	   (5%)	  developed	   re-­‐detachment,	   respectively.	   Multivariate	   regression	   analysis	   showed	   that	  recurrent	   re-­‐detachment	   and	  more	  than	   seven	  days	   of	  visual	   gield	   loss	  were	   signigicant	  predictors	   of	   poor	   visual	   outcome	   at	   12	   months.	   In	   the	   case	   of	   recurrent	   RRD,	   a	  cumulative	   tear	   size	   of	  more	   than	  3	  DDs	  was	  a	   signigicant	  predictor.	   The	  predictors	   of	  poor	   visual	   outcome	   found	   in	   the	   present	   study	   corresponded	   with	   the	   risk	   factors	  reported	  in	  previous	   studies.6,	   20,	   29,	   30	   However,	   they	   differed	   from	  a	  recently	  published	  study	  by	  Salicone	  et	  al,9	  who	  found	  that	  macular	  involvement	  was	  the	  main	  risk	  factor	  of	  poor	  visual	  outcome	  after	  SB	  surgery.	  This	  discrepancy	  may	  have	  been	  due	  to	  differences	  in	   the	   time	   intervals	   at	   which	   the	   visual	   acuity	   data	   were	   obtained.	   Several	   studies	  indicated	   that	   visual	   recovery	   after	   SB	   surgery	   increases	   over	   time.31-­‐34	   Salicone	   et	   al9	  based	   their	   conclusions	   mainly	   on	   postoperative	   visual	   acuity	   data	   obtained	   after	   a	  follow-­‐up	  of	  2	  months,	  whereas	  in	  our	  study,	  the	  conclusions	  were	  based	  on	  visual	  acuity	  data	  obtained	  at	  12	  months.	  Following	   our	   patients	   for	   a	   longer	   period	   revealed	   that	  ultimately,	   23.9%	  of	   the	   eyes	  developed	   re-­‐detachment.	   Six	   months	   after	   SB	   surgery,	   8.3%	   developed	   “late”	   re-­‐detachment;	  after	  12	  months,	  another	  4.6%	  of	  the	  eyes	  developed	  recurrent	  RRD.	  Foster	  et	  al25	  found	  recurrent	  RRD	  after	  one	  year	  in	  2.2%	  (10/453	  eyes).	  Only	   a	   few	   studies	  have	  been	   published	  that	   had	   a	   relatively	   long	  mean	  postoperative	  follow-­‐up	  period	  (Table	  3.4).11,	   25,	   27,	   32,	   35,	  36	   Schwartz	   et	  al27	   had	  a	  follow-­‐up	  of	  20	  years,	  but	  they	  only	  included	  patients	  who	  responded	  to	  a	  follow-­‐up	  call	  after	  20	  years	  and	  they	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Table	  3.3	  (continued)
Factors Total	  no.	  of	  
Eyes
Univariate	  analysis	   Multivariate	  analysis
Preoperative (N=436) Odds	  
ratio





Yes 364 813 0.26-­‐2.51 0.511 NS
No 72
Transscleral	  cryopexy
Yes 341 1.10 0.33-­‐3.60 0.715 NS
No 95
Use	  of	  intravitreal	  gas	  
(SF6	  gas)





No 415 0.61 0.31-­‐1.22 0.300 NSNS:	   not	   signigicant,	   DD:	   disc	   diameter,	   PVR:	   proliferative	   vitreoretinopathy,	   SF6:	   sulphur	   hexagluoride	  ‡variables	  were	  compared	  to	  the	  girst	  variable
did	   not	   retrieve	   any	   data	   from	   the	   referring	   ophthalmologists	   or	   by	   interviewing	   the	  patients,	  contrary	  to	  the	  present	  study.	  In	  the	  studies	  by	  Foster	  et	  al,11	  Greven	  et	  al25	  and	  Kreissig	   et	   al,36	   the	   late	   re-­‐detachment	   rates	   ranged	   from	   2.2%	   to	   6.5%,	   which	   was	  supported	  by	  the	  results	  of	  the	  present	  study	  (Table	  3.4).	  A	  cumulative	  retinal	  tear	  size	  of	  more	  than	  3	  DDs	  was	  identigied	  as	  a	  signigicant	  risk	  factor	  for	  recurrent	  RRD	  in	  the	  present	  series.	  This	  was	   in	  agreement	  with	  previous	  studies.6,	  9,	  18,	   23,	   37	  We	   also	   found	  that	   a	  large	   retinal	   tear	  was	   a	   signigicant	  risk	   factor	  for	  early	  re-­‐detachment	  (within	  6	  months	  after	  SB	  surgery).	  Kreissig	  et	  al35,	  36	  distinguished	  between	  early	   and	  late	   re-­‐detachments	   and	  observed	  that	   early	   re-­‐detachment	   (up	   to	   6	  months	  following	  SB	  surgery)	  was	  mainly	  caused	  by	  PVR,	  whereas	  late	  re-­‐detachment	  was	  caused	  by	   new	   tears	   in	   half	   of	   the	   cases.	   Although	   PVR	   can	   be	   found	   in	   patients	   with	   late	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Table	  3.4:	  Summary	  of	  long-­‐term	  results	  of	  scleral	  buckling	  surgery	  in	  patients	  with	  rhegmatogenous	  retinal	  detachment	  


















Goezinne	  et	  al 2008 436 SB 4.2	  years	  (6-­‐120	  months) 23.9% 4.6% 97.2% NN Operated	  on	  by	  same	  surgeonSasoh	  et	  al32 2005 205 SB 10	  years	   NN NN NN 20/15-­‐20/20	  76%	  in	  macula	  on	  20/15-­‐20/20	  50%	  in	  macula	  of
Only	  patients	  with	  10	  years	  F-­‐U	  (30.9%	  of	  total)	  amount	  of	  surgeon	  NNFoster	  et	  al25 2002 453	   NN 8.5	  years	  (69	  to	  140	  months) 7.8% 2.2% NN NN Study	  on	  10	  eyes	  with	  late	  re-­‐detachment,	  more	  than	  one	  surgeonSchwartz	  et	  al27 2002 227 SB 20	  years 18% NN 95% 20/40	  median	  20	  years More	  than	  one	  surgeonGreven	  et	  al11 1999 28 SB mean	  29	  months	  (6-­‐78	  months)
3.6% 3.6% 100% 20/20	  in	  32%20/25	  in	  18%20/30	  in	  25%20/40	  in	  18%20/50	  in	  7%
Asymptomatic	  retinal	  detachment,	  operated	  on	  two	  surgeonsKreissig	  et	  al35 1995 107 SB 15	  years NN NN 92.6% 20/30	  in	  group	  macula	  attached,	  20/100	  in	  group	  macula	  partially	  detached	  and	  20/400	  in	  group	  completely	  detached
Number	  of	  surgeons	  NN
Kreissig	  et	  al36 1992 107 SB (11-­‐11.5	  years) 12.1% 6.5% 92.6% NN Numbers	  of	  surgeons	  NNSB:scleral	  buckle,	  NN:	  not	  noted,	  F-­‐U:	  follow	  up
recurrent	  RRD,	  we	  believe	  that	  vitreous	  base	  traction	  is	  one	  of	  the	  main	  causative	  factors	  in	  these	  cases,	  because	  the	  PVR	  may	  well	  be	  a	  secondary	  phenomenon.25,	  36The	  occurrence	  of	  late	  re-­‐detachment	  is	  an	  argument	  in	  favour	  of	  following	  patients	  for	  at	  least	   6	  months	  after	   SB	   surgery.	   In	  addition,	   visual	   acuity	  may	  continue	  to	   improve	  for	  some	  time.	   Using	  foveal	   densitometry,	  Liem	   at	   al31	   showed	  that	   recovery	  of	  foveal	   cone	  photopigments	   could	  take	  several	  months	   after	  macular	  detachment.	   It	  was	   also	   found	  that	   subfoveal	   gluid	  may	   persist	   subclinically	   for	   several	  months	   following	   SB	   surgery,	  which	  may	  explain	  the	  slow	  visual	  recovery	  in	  some	  of	  the	  patients.38-­‐40	  A	  disadvantage	  of	  following	  patients	  over	  a	  longer	  period	  can	  be	  bias	  to	   the	  visual	  acuity	  results	   due	   to	   deterioration	   in	   the	   elderly	   patients	   who	   develop	   cataract	   or	   macular	  problems.	   Visual	   acuity	   results	   in	   the	   present	   study	  were	  therefore	   analysed	  at	   a	   gixed	  period	  of	  12	  months	  after	  primary	  surgery.Le	  Rouic	  et	  al41	   investigated	  the	  outcomes	   of	  buckle	  removal.	   They	   found	  an	  overall	  re-­‐detachment	  rate	  of	  8.8%	  in	  a	  series	  of	  90	  eyes	  after	  the	  scleral	  buckles	  had	  been	  removed.	  Re-­‐detachment	  occurred	  in	  16%	  of	  the	  eyes	  after	  solid	  silicone	  buckle	  removal,	  compared	  to	   7%	   in	   the	   eyes	   after	   silicone	   sponge	   removal.41	   In	   the	   present	   study,	   only	   six	   eyes	  underwent	   scleral	   buckle	   removal,	   which	   contrasted	   sharply	   with	   the	   larger	   series	  studied	  by	   Le	   Rouic	   et	   al.41	   Two	   out	   of	   these	   six	   eyes	   developed	   re-­‐detachment	   after	  silicone	  sponge	  removal.	  In	  one	  case,	  re-­‐detachment	  was	  due	  to	  perforation	  that	  occurred	  during	  removal	   from	  an	  eye	  with	  staphyloma.	  In	  the	  other	  case,	   there	  was	  no	  clear	  cause	  for	  the	  re-­‐detachment.Primary	   vitrectomy	   (PPV)	   has	   become	   a	   leading	   treatment	   for	   RRD.	   Several	   studies	  compared	  SB	   surgery	   to	   primary	   PPV	   in	   eyes	   with	  new	   RRD.3,	   42-­‐46	   A	   meta-­‐analysis	   on	  pseudophakic	   retinal	  detachment	   by	   Arya	  et	   al14	   revealed	   that	   PPV	  was	  more	  likely	   to	  achieve	   favourable	   anatomical	   and	  visual	   results	   than	  conventional	   SB	   surgery	   alone.14	  However,	  an	  evidence-­‐based	  analysis	  on	  uncomplicated	  RRD	  did	  not	  show	  any	  difference	  in	   retinal	   re-­‐attachment	   or	   ultimate	   VA	   between	   the	   SB	   group	   and	   PPV	   group.3	   An	  argument	   in	   favour	   of	  PPV	   instead	  of	  SB	  surgery	   is	   that	   peripheral	   tears	   can	  be	  missed	  preoperatively,	  especially	   in	  pseudophakic	  eyes.47	   In	  the	  present	  study,	   in	  which	  22%	  of	  the	   eyes	   were	   pseudophakic,	   missed	   tears	   were	   not	   signigicantly	   associated	  with	  poor	  visual	  or	  functional	  results.In	   conclusion,	   conventional	   SB	   surgery	  was	   a	   reliable	   procedure	   in	   selected	   eyes	   with	  primary	  RRD.	  Primary	  PPV	  should	  be	  considered	  if	  the	  retinal	   tear	  has	  a	  cumulative	  size	  of	  more	  than	  3	  DDs.	   In	  studies	  that	  aim	  to	  predict	  how	  macular	  detachment	  affects	  visual	  outcome	  or	  recovery,	   it	  may	  be	  an	  advantage	  to	  plan	  a	  longer	  follow-­‐up	  period	  after	  SB	  surgery	  in	  view	  of	  the	  high	  percentage	  of	  eyes	  that	  develop	  re-­‐detachment	  after	  6	  months	  and	  the	  chance	  of	  further	  visual	  recovery	  over	  time.
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Chapter
Anterior chamber depth is 
significantly decreased 
after scleral buckling 
surgery




Objective:	   to	   evaluate	   the	   duration	   of	   changes	   in	   anterior	   chamber	   depth	   (ACD)	   in	  patients	   with	   rhegmatogenous	   retinal	   detachment	   (RRD)	   after	   scleral	   buckling	   (SB)	  surgery.	  The	  SB	  surgery	  itself	  may	  result	  in	  decreased	  ACD.	  Myopic	  patients	  are	  known	  to	  have	  an	  increased	  risk	  of	  developing	  RRD.	  Nowadays,	  they	  can	  opt	  to	  undergo	  correction	  of	   their	   refractive	   error	   by	   phakic	   intraocular	   lens	   (pIOL)	   implantation.	   After	  implantation,	   progressive	   endothelial	   cell	   loss	  can	  occur	   if	  the	  ACD	   is	   too	   shallow.	   This	  may	  form	  an	  important	  issue	  not	  only	   for	  the	  retinal	   surgeon	  in	  patients	  with	  combined	  RRD	  and	  a	  pIOL,	   but	   also	   for	   the	  refractive	   surgeon	  who	   has	   to	   consider	   the	   potential	  problems	  of	  pIOL	  implantation	  in	  an	  eye	  that	  has	  previously	  undergone	  SB	  surgery.	  
Design:	  A	  prospective	  controlled	  study.
Participants:	   Thirty-­‐eight	   eyes	   with	   primary	   RRD	   treated	   with	   SB	   surgery,	   using	   an	  encircling	  element	  and	  a	  radial	  or	  segmental	  buckle;	  31	  fellow	  eyes	  served	  as	  controls.
Methods:	   ACD	   (in	   the	   horizontal	   meridian)	   and	   axial	   length	   were	   measured	  preoperatively	  and	  at	  1	  week,	   1	  month	  and	  3,	   6,	   9	  and	  12	  months	  postoperatively	  using	  an	  anterior	  optical	  coherence	  tomography	  method	  and	  an	  IOL	  master,	  respectively.
Main	   outcome	   measures:	   In	   all	   38	   SB	   surgery	   eyes,	   ACD	   was	   signigicantly	   decreased	  compared	  to	  the	  preoperative	  levels	  up	  to	  9	  months	  after	  SB	  surgery.
Results:	  ACD	  had	  returned	  to	  normal	  at	  one	  year	  follow-­‐up.	  Axial	   length	  was	  signigicantly	  increased	  during	   the	  whole	   follow-­‐up	  period.	  No	  signigicant	   differences	   in	  ACD	  or	   axial	  length	  were	  found	  between	  the	  use	  of	  radial	  or	  segmental	  buckles.
Conclusions:	  ACD	  may	  remain	  decreased	  after	  SB	   surgery	  for	  longer	   than	  has	  previously	  been	  reported.	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IntroductionMany	   vitreoretinal	   surgeons	   consider	  SB	   surgery	   to	   be	   the	   girst	   choice	   of	  treatment	   in	  patients	  with	  uncomplicated	  RRD.1	   Previously,	   scleral	   dissection	  was	   performed,2	  while	  the	   use	   of	   an	  encircling	   element	   was	   introduced	   by	   Schepens	   et	   al	   in	   1957.3	   In	   some	  patients,	   these	   external	   techniques	   not	   only	   caused	   changes	   in	   axial	   length,	   but	   also	  decreased	   the	  ACD.2,	   4,	   5	   Earlier	   studies	   on	   ACD	   changes	   after	   RRD	   surgery	   reported	   a	  temporary	  decrease	  in	  ACD	  until	  3	  months	  follow-­‐up,	  but	  no	   further	  ACD	  measurements	  were	  performed	  beyond	  that	  point.2,	  4	  Nowadays,	   a	   phakic	   intraocular	   lens	   (pIOL)	   can	   be	   implanted	   in	   an	   eye	   to	   correct	  refractive	   errors.6,	   7	   Strict	   ACD	   criteria	  have	  been	   formulated	  by	   refractive	  surgeons	   to	  lower	   the	   risk	   of	   endothelial	   cell	   loss	   after	   pIOL	   implantation.8	   SB	   surgery	   for	   the	  treatment	   of	  RRD	   may	   also	   result	   in	  decreased	  ACD.	   Therefore,	   in	   patients	   who	   have	  previously	  undergone	  SB	  surgery,	  accurate	  preoperative	  ACD	  measurements	  are	  essential	  if	  they	  need	  pIOL	  implantation	  surgery.	  Conversely,	  when	  a	  patient	  with	  a	  pIOL	  presents	  with	  primary	  RRD	  (myopic	   patients	  are	  known	   to	   have	  an	  increased	   risk	  of	  developing	  RRD),	   the	  vitreoretinal	  surgeon	  must	  be	  aware	  that	   the	  ACD	  can	  become	  shallower	  after	  SB	  surgery,	  with	  a	  subsequent	  increase	  in	  endothelial	  cell	  loss.	  Recently,	   a	   new	   non-­‐contact	   anterior	   segment	   optical	   coherence	   tomography	   imaging	  method	  (AS-­‐OCT)	  has	  become	  available	  that	  can	  provide	  high	  resolution	  cross-­‐sectional	  images	   of	   the	   anterior	   chamber	   (Visante,	   Carl	   Zeiss,	   Meditec,	   Jena,	   Germany).	   Several	  studies	  have	  reported	  on	  its	  high	  reproducibility	  and	  repeatability,	  which	  were	  equal	   to	  other	  ACD	  measurement	  techniques,	  or	  even	  better.9	  The	  goal	  of	  this	  study	  was	  to	   evaluate	  the	  nature	  and	  time	  frame	  of	  changes	   in	  ACD	  and	  axial	  length	  after	  SB	  surgery.
Subjects and methodsThis	  prospective	  study	  included	  all	   the	  patients	  with	  primary	  RRD	  who	  had	  been	  treated	  with	  conventional	  SB	  surgery	  between	  July	  2006	  and	  January	  2007.	  Eyes	  were	  excluded	  if	  they	   developed	   recurrent	   RRD	   during	   follow-­‐up	   and	   if	   they	   had	   undergone	   previous	  glaucoma	  surgery	  in	  one	  or	  both	  eyes.	  The	  fellow	  eye	  served	  as	  a	  control	   for	  all	   the	  measurements.	  We	  excluded	  fellow	  eyes	  if	  they	   developed	   RRD	   preoperatively	   or	   during	   the	   study	   period,	   or	   if	   they	   underwent	  subsequent	  intraocular	  surgery	  during	  follow-­‐up.	  Approval	   for	  the	  study	  was	   granted	  by	  the	  institutional	  ethics	   committee.	  Patients	  were	  informed	  about	  the	  study	  procedure	  and	  provided	  informed	  consent.	  All	  procedures	  were	  conducted	  in	  accordance	  with	  the	  ethical	  standards	  laid	  down	  in	  the	  1964	  Declaration	  of	  Helsinki.The	   following	   preoperative	   patient	   characteristics	   were	   collected	   for	   analysis:	   age,	  gender,	   myopia	   (degined	  as	   spherical	   equivalent	   of	   -­‐6	  dioptres	   (D)	   or	  more),	   previous	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intraocular	  surgery	  (i.e.	   cataract	  and/or	  retinal	  detachment	  in	  the	  fellow	  eye),	  number	  of	  retinal	  quadrants	   detached,	   foveal	   involvement	  (yes/no)	  congirmed	  by	  posterior	  optical	  coherence	   tomography	   (OCT)	   (Carl	   Zeiss,	   Meditec,	   Jena,	   Germany),	   number	   of	  days	   of	  foveal	   detachment,	   the	   presence	   and	   grade	   of	   proliferative	   vitreoretinopathy	   (PVR),10	  type	  and	  localization	  of	  the	  retinal	  tear	  and	  the	  number	  of	  tears.Four	   vitreoretinal	   surgeons	   (FH,	   ELH,	   AL,	   IL)	   at	   our	   retina	  department	   performed	   the	  operations	  under	  general	  anaesthesia.	  Each	  patient	  received	  a	  silicone	  encircling	  element	  (ref.	   no.	   240,	   MIRA	   Inc.,	   Uxbridge,	   MA,	   USA)	   under	   the	   rectus	   muscles	   and	   either	   a	  segmental	   buckle	   (silicone	   grooved	   strip	   no.	   506G,	   DORC	   International,	   Zuidland,	   the	  Netherlands)	  or	  a	  radial	  buckle	  (solid	  silicone	  wedge,	  G135,	  MIRA	  Inc	  Uxbridge,	  MA,	  USA	  or	   G137,	   Labtician	   Ophthalmics	   Inc.,	   Oakville,	   Canada).	   The	   encircling	   band	   was	   gixed	  10-­‐12	  mm	   posteriorly	   to	   the	   limbus	   with	  a	  mercilene	   5.0	   suture.	   Whether	   a	   radial	   or	  segmental	   buckle	   was	   used	   depended	   on	   the	   size	   and	   location	   of	   the	   retinal	   tear.	  Subretinal	  gluid	  was	  drained	  when	  judged	  necessary	  by	  the	  surgeon.	  Cryocoagulation	  was	  performed	   in	  some	   cases,	   according	   to	   the	   preferences	   of	   the	  surgeon.	   Intravitreal	   gas	  tamponade	   was	   used	   for	   RRDs	   in	   the	   upper	   quadrants,	   located	   between	   the	   8	   and	   4	  o’clock	  positions.All	   the	   patients	   received	   routine	   postoperative	   treatment	   with	   antibiotic	   eye	   drops	  (chloramphenicol	   5	   mg/ml)	   4	   times	   daily	   for	   14	   days	   (Ratiopharm,	   Zaandam,	   the	  Netherlands	   and	  prednisolone	   eye	  drops	   (Pred	  Forte®,	   prednisolone	  acetate	  10	  mg/ml,	  Allergan	   BV,	   Nieuwegein,	   the	   Netherlands)	   3	   times	   daily	   for	   2	  months.	   Patients	   with	  phakic	   eyes	   also	   used	  mydriatic	   eye	   drops	   (atropine	   sulphate	   1%)	   2	   times	   daily	   for	   1	  week	   after	   the	   operation	   (Chauvin	   Pharmaceuticals	   Ltd	   Surrey,	   UK).	   Patients	   with	  pseudophakic	  eyes	  used	  additional	   tropicamide	  0.5%	  (Thea	  Pharma,	  Wetteren,	  Belgium)	  2	  times	  daily	  for	  1	  week.The	   following	   SB-­‐surgery-­‐related	   variables	   were	   noted:	   radial	   or	   segmental	   silicone	  buckle,	  subretinal	  gluid	  drainage	  (yes/no),	  cryocoagulation	  (yes/no),	   intravitreal	  sulphur	  hexagluoride	   (SF6)	   gas	   as	   internal	   retinal	   tamponade	   (yes/no),	   paracenthesis	   (yes/no)	  and	  postoperative	  acetazolamide	  (Diamox®,	  Goldshield	  Pharmaceuticals	  BV,	  Surry,	  UK).All	  the	  patients	  were	  examined	  by	   two	   investigators	  (FG	  and	  DC).	  One	  investigator	  (FG)	  performed	   all	   the	   measurements.	   The	   analysis	   was	   performed	   later,	   without	   prior	  knowledge	  of	  patient	  history.	  IOL	  master	  (Carl	  Zeiss,	  Meditec,	  Jena,	  Germany)	  was	  used	  to	  measure	   pre	   and	   postoperative	   axial	   length	   in	   the	   RRD	   eyes	   and	   the	   fellow	   eyes;	  postoperatively,	  only	  the	  scleral	  buckling	  surgery	  (SBS)	  eyes	  that	  had	  an	  attached	  macula	  preoperatively	  (congirmed	  with	  posterior	  OCT)	  were	  re-­‐measured.	  During	  follow-­‐up,	  we	  obtained	   the	  following	  data:	   intraocular	  pressure	   (IOP)	  (Goldman	  applanation	  tonometry),	   ACD	   in	  the	   horizontal	  meridian	   (AS-­‐OCT),	   temporal	   and	  nasal	  anterior	   chamber	   angle	   and	   pupil	   diameter	   (AS-­‐OCT)	   (Figure	   4.1).	   Anterior	   chamber	  depth	   and	   angles	   were	   calculated	   (FG)	   with	   the	   AS-­‐OCT	   software.	   Anterior	   chamber	  depth	   (ACD)	   was	   degined	   as	   the	   distance	   between	   the	   corneal	   endothelium	   and	   the	  anterior	  pole	  of	  the	  crystalline	  lens	  or	  IOL.	  The	  lens	  rise	  was	  measured	  as	  the	  horizontal	  distance	   from	   the	   angles	   to	   the	   lens	   (Figure	   4.1).	   Angle-­‐to	   angle	   distance	   (AAD)	   (also	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known	  as	  anterior	  chamber	  width	  (ACW)	  was	  degined	  as	  the	  distance	  from	  the	  temporal	  angle	   to	   the	   nasal	   angle	   along	   the	  0-­‐180°	   axis.	   Intra-­‐investigator	   and	   inter-­‐investigator	  differences	   in	  measurements	  were	  tested	   in	  a	   group	  of	  eight	   patients,	   differences	  were	  negligible.	  All	  the	  measurements	  were	  performed	  on	  both	  eyes	  preoperatively,	   and	  on	  the	  SBS	  eyes	  on	   the	   girst	   postoperative	   day,	   1	   week	   postoperatively	   and	   3,	   6,	   9	   and	   12	   months	  postoperatively.	  It	  was	  impossible	  to	  measure	  axial	  length	  on	  the	  girst	  postoperative	  day	  due	  to	  the	  presence	  of	  intravitreal	  gas	  in	  most	  of	  the	  SBS	  eyes.	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Figure	   4.1:	   Anterior	   chamber	   depth	   using	   anterior	   segment	   optical	  coherence	  tomography	  (AS-­‐OCT)	  Sectional	  plane	   is	  horizontal	  (from	  0°	  to	  180°).	   The	   white	   line	   in	   the	  middle	   shows	   that	   the	   image	   was	   obtained	  correctly.A	  and	  B	  are	  the	  same	  OCTs.A:	  anterior	  chamber	  depth	  (ACD)	  measured	  from	  the	  corneal	  endothelium	  to	  the	  anterior	  pole	  of	   the	  crystalline	   lens	  (2.68	  mm).	   The	  angle	   to	  angle	  distance	   was	   measured	   from	   the	   nasal	   angle	   to	   the	   temporal	   anterior	  chamber	  angle	  (also	  known	  as	  the	  anterior	  chamber	  width)	  (12.57	  mm).	  Lens	  rise	   is	  also	  marked	  (from	  the	  angle	  tot	  angle	  distance	  to	  the	  anterior	  pole	  of	  the	  crystalline	  lens	  (660	  μm)	  B:	  pupillary	  distance	   is	  4.67	  mm.	  Note	  that	  the	  pupil	  was	  not	  dilated	  with	  tropicamide	  and	  phenylephrine	  drops	  
Except	  for	   IOP,	  all	   the	  data	  were	  obtained	  after	   the	  instillation	  of	  tropicamide	  0.5%	  and	  phenylephrine	  2.5%	  (Thea	  Pharma,	  Wetteren,	  Belgium)	   in	   each	  eye.	  The	  effect	  of	   these	  mydriatic	   eye	  drops	  on	  the	  ACD	  was	  determined	  in	  11	  postoperative	  patients	  by	  taking	  measurements	  before	   instillation	  and	  30	  minutes	   afterwards	   (Table	  4.1).	   No	   signigicant	  differences	  in	  ACD	  and	  AAD	  were	  found	  before	  and	  after	  instillation.	  Statistical	  analysis	  was	  performed	  using	  the	  SPSS	  software	  15.0	  (SPSS	  for	  Windows,	  Rel.	  13.0	  Chicago:	   SPSS	   Inc.	  USA)	  using	  independent	   sample	  T-­‐test.	   Signigicance	  was	  degined	  as	  P	  <	  0.05.
ResultsBetween	  July	   2006	  and	  January	  2007,	   53	  patients	  with	  RRD	  underwent	  SB	  surgery.	  We	  excluded	   patients	   with	   recurrent	   retinal	   detachment	   (n=13)	   or	   additional	   intraocular	  surgery	  (n=2)	  (i.e.	  cataract	  extraction)	  from	  our	  analysis.	  No	  signigicant	  differences	  were	  found	  between	  the	  patients	   included	  in	  the	   analysis	  and	   the	  patients	  who	  we	  excluded	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Table	  4.1:	  Before	  and	  after	  effects	  of	  mydriatic	  tropicamide	  0.5%	  and	  phenylephrine	  2.5%	  eye	  drops	  on	  anterior	  chamber	  depth	  in	  11	  postoperative	  patients	  





1 4.35 4.30 12.32 12.42 2.40 7.302 4.71 4.70 12.71 12.48 3.73 6.963 3.75 3.72 12.71 12.29 3.97 7.394 2.57 2.54 12.11 12.19 3.16 7.875 1.83 1.80 10.72 10.95 2.49 6.236 2.68 2.75 11.56 11.30 3.51 5.697 2.93 2.97 11.70 11.51 3.60 6.298 3.92 3.97 12.09 11.85 2.46 5.929 3.32 3.35 12.19 12.04 5.13 7.4410 3.43 3.54 12.21 12.73 3.22 6.7011 2.63 2.79 12.23 12.71 3.72 7.33Mean	  ±	  SD 3.28	  ±0.86 3.31	  ±0.85 12.04	  ±0.56 12.04	  ±0.85 3.40	  ±0.80 6.93	  ±0.71Signigicance p=0.939 p=0.985 p<0.001before:	   before	   instillation	   of	   eyedrops;	   after:	   30	   minutes	   after	   instillation	   of	   eyedrops;	   ACD:	   Anterior	  chamber	  depth;	  AAD:	  angle	  to	  angle	  distance;	  SD:	  standard	  deviationStatistics:	  Independent	  sample	  T-­‐test
(lost	   to	   follow-­‐up),	   except	   for	   re-­‐detachment	   (which	   was	   an	   exclusion	   criterion)	   and	  gender	  (Table	  4.2).	   A	   total	  of	  69	  eyes	   in	  38	  patients	  with	  RRD	  (20	  men	  (52.6%)	  and	  18	  women	  (47.4%)	  who	   underwent	   successful	   SB	   surgery	  were	   included	  in	  this	  study.	  We	  analysed	  38	  RRD	  eyes	  and	  31	  fellow	  eyes;	   the	  fellow	  eyes	  served	  as	  controls.	  Ultimately,	  seven	   fellow	   eyes	   were	   excluded,	   because	   of	   RRD	   development	   (n=3)	   or	   intraocular	  surgery	   (n=4)	   (i.e.	   cataract	   extraction)	  during	   the	   study	   period.	   Mean	   patient	   age	  was	  58.5	  years	  (range	  36-­‐74	  years).	   The	  SB	  surgery	  group	  comprised	  23	  right	  eyes	   (60.5%)	  and	  15	  left	  eyes	  (39.1%);	  the	  control	  group	  comprised	  13	  right	  eyes	  (41.9%)	  and	  18	  left	  eyes	   (58.1%).	   Preoperatively,	   12	   eyes	   did	   not	   have	   PVR	   (31.6%),	   13	   eyes	   had	   PVR-­‐A	  (34.2%)	  and	  13	  eyes	  had	  PVR-­‐B	   (34.2%).	   Based	  on	  preoperative	  OCT	   imaging,	   16	  eyes	  (42.1%)	  had	  an	   attached	   fovea	   prior	   to	   surgery	   and	  22	  eyes	   (57.9%)	  had	   a	   detached	  fovea.	  Clinical	  characteristics	  of	  all	  69	  eyes	  are	  summarized	  in	  Table	  4.3.Up	  to	  9	  months	  after	  SB	  surgery,	  the	  mean	  postoperative	  ACD	  was	  signigicantly	  decreased	  (P	  =	  0.007)	  compared	  to	  the	  mean	  preoperative	  ACD	  (Figure	  4.2).	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Figure	   4.2:	   ACD	   measurements	   (anterior	   chamber	   depth)	   in	   SBS	   eyes	   and	  control	  eyes	  Anterior	  chamber	  depth	  decreased	  signigicantly	  in	  the	   SBS	   eyes	  up	  to	  9	  months	  after	   scleral	   buckling	   surgery	   (P	   <	   0.05)	   (*).	   Control	   eyes	   did	   not	   show	   any	  signigicant	  change	  compared	  to	  preoperative	   values.	  The	  vertical	   lines	  represent	  the	  standard	  error	  of	  the	  mean	  (S.E.M.).	  Statistics:	  Independent	  sample	  T-­‐test
Preoperatively,	  the	  mean	  ACD	  was	  3.33	  ±	  0.75	  mm.	  On	  the	  girst	  postoperative	  day,	   it	  was	  2.78	  ±	  0.71	  mm;	  at	  1	  week	   it	  was	  2.99	  ±	  0.70	  mm;	   at	  1	  month	  it	  was	  3.05	  ±	  0.67;	  at	  3	  months	   it	  was	  3.07	  ±	  0.68	  mm;	   at	  6	  months	   it	  was	  3.09	  ±	  0.71	  mm;	  at	  9	  months	   it	  was	  3.08	  ±	  0.70	  mm;	  at	  1	  year	  it	  was	  3.16	  ±	  0.81	  mm	  (P	  =	  0.144).	  Preoperatively,	  there	  was	  no	  signigicant	  difference	  in	  the	  mean	  ACD	  between	  the	  SBS	  eyes	  and	  the	  fellow	  eyes;	  (3.33	  ±	  0.75	   mm	   versus	   3.12	   ±	   0.52	   mm,	   respectively)	   (P	   =	   0.19).	   However,	   there	   was	   a	  signigicant	   difference	   in	   preoperative	   ACD	   between	   the	   phakic	   eyes	   (n=28)	   and	   the	  pseudophakic	  (n=10)	  eyes	  (3.04	  ±	  0.64	  mm	  versus	  4.13	  ±	  0.39	  mm,	  P	  <	  0.001).	  Postoperatively,	   the	   mean	  ACD	   in	   the	   phakic	   eyes	   was	   signigicantly	   decreased	  up	  to	   9	  months	   follow-­‐up	   (3.04	   ±	   0.64	   mm	   versus	   2.79	   ±	   0.37	   mm)	   (P	   =	   0.010).	   In	   the	  pseudophakic	  eyes,	   the	  mean	  ACD	  was	  signigicantly	  decreased	  even	  up	  to	  1	  year	  follow-­‐up	  (4.13	  ±	  0.39	  mm	  versus	  4.04	  ±	  0.38	  mm)	  (P	  =	  0.007).	   On	  the	   girst	  postoperative	  day,	  there	  was	  no	  signigicant	  difference	  in	  ACD	  between	  the	  eyes	  that	  received	  intraoperative	  gas	  (0.55	  ±	  0.60	  mm)	  and	  the	  eyes	  that	  did	  not	  (0.53	  ±	  0.40	  mm).	  In	  16	  out	  of	  the	  32	  eyes	  that	  had	  paracenthesis	  prior	  to	   intraocular	  gas	  injection,	  ACD	  was	  signigicantly	  decreased	  until	  1	  week	  after	  surgery,	  compared	  to	  the	  eyes	  without	  paracenthesis	  (n=22).	  The	  segmental	   buckle	  group	  (silicone	  grooved	   strip	  n=25)	   and	  the	   radial	   buckle	  group	  (n=13)	   had	  signigicantly	  decreased	  mean	   ACD	  up	   to	   9	  months	   follow-­‐up	   (difference	   of	  0.29	  ±	  0.6	  mm	  versus	  0.15	  ±	  0.8	  mm,	  P	  =	  0.028	  and	  P	  =	  0.025,	  respectively).	  However,	  no	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Figure	  4.3:	  Measurements	  of	  the	  axial	  length	  in	  the	  SBS	  eyes	  and	  the	  control	  eyes	  In	   the	   SBS	   eyes	   (n=14),	   axial	   length	   increased	   signigicantly	   during	   follow-­‐up.	  Signigicant	  differences	  were	  found	  between	  1	  week	  and	  3	  months	  postoperatively	  (P	  =	  0.024),	  between	  1	  and	  6	  months	  postoperatively	  (P	  =	  0.020)	  and	  between	  3	  months	   and	   9	   months	   postoperatively	   (P	   =	   0.027).	   No	   signigicant	   differences	  were	   found	  in	  the	  control	  eyes	  (n=31).	  The	  straight	  line	  shows	  a	  trend	  in	  the	  SBS	  eyes.Statistics:	  Independent	  sample	  T-­‐test	  
signigicant	   difference	   in	  mean	  ACD	   was	   found	   between	   the	   two	   buckle	   groups.	   All	   the	  patients	   received	  an	   encircling	   element	   of	   360°	  around	   the	   eye;	   the	   segmental	   buckle	  extended	  from	  90°	  to	  270°	  with	  a	  mean	  of	  108°.	  ACD	  was	  signigicantly	  decreased	  in	  all	  the	  SBS	  eyes,	  irrespective	  of	  whether	  they	  were	  myopic	  (>-­‐6	  D),	  or	  whether	  they	  had	  received	  cryocoagulation	   or	   scleral	   puncture.	   No	   signigicant	   decrease	   in	  ACD	  was	   found	   in	   the	  fellow	  eyes,	  even	  when	  they	  had	  received	  acetazolamide	  (n=14).Mean	   preoperative	   axial	   length	   was	   24.9	   ±	   1.5	   mm	   (n=14)	   and	   was	   not	   signigicantly	  different	   from	   the	   mean	   value	   in	   the	   fellow	   eyes	   (n=14)	   (24.8	   ±	   1.2	   mm).	   Mean	  postoperative	  axial	   length	  was	  signigicantly	  increased	  during	  the	  whole	  follow-­‐up	  period	  (Figure	   4.3).	   No	   signigicant	   differences	   between	   the	   preoperative	   and	   postoperative	  measurements	  were	  found	  in	  the	  fellow	  eyes	  during	   follow-­‐up	  (n=31).	   At	  3	  months,	   the	  mean	  difference	   in	  spherical	   equivalent	  was	  2.6	  ±	  1.2	  D	   (range	  0.75	  -­‐	  4.75).	  No	   further	  increase	  in	  myopia	  was	  observed	  after	  3	  months	  follow-­‐up.Mean	  AAD	  in	  the	  SBS	  eyes	  was	  13.1	  ±	  6.3	  mm,	  which	  was	  not	  signigicantly	  different	  from	  the	  mean	  value	   in	   the	   fellow	   eyes	   (12.0	   ±	   0.5,	   P	   =	   0.26).	   No	   signigicant	  difference	  was	  found	   between	   the	  mean	  preoperative	  AAD	   and	   the	   postoperative	  AAD	  measurements	  obtained	  during	  the	  whole	  follow-­‐up	  period.	  Lens	  rise	  was	  found	  to	  be	  signigicantly	  increased	  up	  to	  1	  year	  postoperatively	  (increase	  of	  145.8	   µm	  ±	  161.2	  µm,	   P	   <	   0.001).	   Remarkably,	   a	  signigicant	  difference	   in	  lens	   rise	  was	  found	  preoperatively	  between	  the	  phakic	  eyes	  (n=10)	  and	  the	  pseudophakic	  eyes	  (n=28,	  342.5	  µm	  versus	  -­‐830µm,	  P	  <	  0.001).	  No	  differences	   in	  lens	  rise	  were	  found	  between	  the	  eyes	  that	  received	  a	  radial	  buckle	  and	  the	  eyes	  that	  received	  a	  segmental	  buckle.
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Table	  4.2:	  Baseline	  data	  on	  patients	  lost	  to	  follow-­‐up	  compared	  to	  study	  patients
Preoperative	  characteristics Study	  eyes Lost	  to	  follow-­‐up P	  value
Number	  of	  eyes 38 15
Mean	  age	  (years) 58	  ±	  10 58	  ±	  18 P=0.435
Re-­‐detachment 0 13 P<0.001
Gender	  male	  :	  female 20	  :	  18 14	  :	  1 P=0.05
Pseudophakic	  eye	  :phakic 10	  :	  28 3	  :	  12 P=0.376
Myopia	  of	  >	  6	  Dioptres	  (Yes	  :	  No) 10	  :	  28 3	  :12 P=0.932
Macular	  involvement	  (Yes	  :	  No) 16	  :	  22 4	  :	  11 P=0.376
Type	  of	  Buckle	  (S:R) 25	  :	  13 12	  :	  3 P=0.484S	  :	  R:	  	  segmental	  buckle	  :	  radial	  buckle
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Table	  4.3:	  Patients	  characteristics	  before,	  during	  and	  after	  surgery
Clinical	  variable SBS	  eyes Fellow/control	  eye
(n=38) Percentage	  (%) (n=31) Percentage	  (%)
Gender Male 20 52.6 16 51.6Female 18 47.4 15 48.4
Eye Right 23 60.5 13 41.9Left 15 39.5 18 58.1
Pseudophakic	  eye Yes 10 26.3 4 12.9No 28 73.7 27 87.1
Myopia	  of	  >	  6	  Dioptres	   Yes 10 26.3 9 29.0No 28 73.7 22 71.0
Quadrants	  involved 1 16 42.12 19 503 2 5.34 1 2.6
PVR None 12 31.6PVR	  A 13 34.2PVR	  B 13 34.2
Macular	  involvement Yes 16 42.1No 22 57.9
Type	  of	  retinal	  tear Horseshoe 25 65.8Hole 12 31.6Tear 1 2.6
Cumulative	  size	  of	  the 1 25 65.8
retinal	  tear	  in	  Disc 2 7 18.4
Diameters 3 4 10.5>3 1 2.6Missing 1 2.6
Paracenthesis Yes 16 42.1No 22 57.9
Use	  of	  intravitreal	  gas Yes 32 84.2No 6 15.8
Type	  of	  buckle Segmental 25 65.8Radial 13 34.2
Subretinal	  !luid	  drainage Yes 33 86.8No 5 13.2
Transscleral	  cryopexy Yes 23 60.5No 15 39.5
Use	  of	  Acetazolamide None 24 63.2 17 54.8250	  mg 1 2.6 1 3.2500	  mg 5 13.2 5 16.1750	  mg 2 5.3 2 6.51000	  mg 5 13.2 5 16.11500	  mg 1 2.6 1 3.2PVR:	  proliferative	   vitreoretinopathy;	  RD:	   retinal	   detachment; 	  SBS	   eyes:	   eyes	   that	   underwent	   scleral	  buckling	  surgery
On	  the	  girst	  postoperative	  day,	  mean	  IOP	  in	  the	  SBS	  eyes	  was	  signigicantly	  higher	  than	  the	  preoperative	  value	  (n=37,	  19.4	  ±	  5.4	  mmHg	  versus	  14.2	  ±	  3.7	  mmHg,	   respectively)	  (P	  =	  0.016).	  No	  signigicant	  changes	  in	  mean	  IOP	  were	  observed	  at	  1	  week	  or	  at	  1,	  3,	  6,	  9	  and	  12	  months	   follow-­‐up	  in	  the	  SBS	   eyes.	   None	  of	  the	   eyes	   developed	  secondary	   angle	   closure	  glaucoma.	  In	  the	  eyes	  that	   received	  gas	  tamponade	  during	  SB	  surgery,	  mean	  IOP	  was	  signigicantly	  higher	   than	  the	  mean	  preoperative	  value	  only	  on	  the	  girst	  day	  after	  surgery	  (P	  <	  0.001);	  this	  situation	  did	  not	  apply	   to	   the	  eyes	  without	  gas	  tamponade	  (P	  =	  0.08).	   Furthermore,	  on	  the	  girst	  postoperative	  day,	  mean	  IOP	  was	  signigicantly	  higher	  in	  the	  eyes	  that	  did	  not	  receive	   acetazolamide	   than	   in	   the	   eyes	   that	   did	   (19.6	   ±	   4.9	  mmHg	   versus	   13.3	   ±	   3.9	  mmHg)	  (n	  =	  18;	  P	  =	  0.001).	  
DiscussionIn	  this	  study,	  we	  demonstrated	  that	  ACD	  was	  signigicantly	  decreased	  up	  to	  9	  months	  after	  SB	  surgery.	  ACD	  had	  returned	  to	  normal	  levels	  at	  one	  year	  follow-­‐up.	  Decreased	  ACD	  after	  SB	  surgery	  was	   also	  described	  by	  Fiore	  et	  al.5	   They	   found	  a	  depth	  difference	  of	  0.44	  mm	  one	  week	  after	  surgery	  (n=14),	  compared	  to	  0.34	  mm	  in	  our	  study.	  After	   2	  months,	   they	   found	  a	   mean	  ACD	   difference	   of	   0.13	  mm,	   compared	   to	   a	   mean	  difference	  of	  0.26	  mm	  after	  3	  months	   in	  our	  study.	  An	  explanation	  for	  the	  discrepancies	  between	   the	   results	  may	   lie	   in	   the	  measurement	  methods.	   Fiore	   et	   al	   used	   a	  slit-­‐lamp	  technique,	  whereas	  we	  used	  AS-­‐OCT	  in	  a	  large	  group	  of	  patients.	  Meinhardt	  et	  al11	  did	  not	  gind	  any	  signigicant	  differences	   between	  slit-­‐lamp,	   IOL-­‐Master,	   AC-­‐Master	  and	  Pentacam	  measurements,11	  but	  they	  did	  not	  include	  AS-­‐OCT,	  which	  was	  used	  in	  our	  study.	  Cetin	  et	  al4	  monitored	  ACD	  with	  Orbscan	   II	  up	   to	   3	  months	   after	  SB	   surgery.	   They	  also	   found	  a	  signigicant	  decrease	  in	  ACD	  within	  the	  same	   time	   frame.4	  However,	   their	  measurements	  did	  not	  continue	  beyond	  3	  months	  follow-­‐up.	  Burton	  et	  al2	  found	  a	  signigicant	  decrease	  in	  ACD	  up	  to	  6	  weeks	  after	  SB	  surgery	  using	  A-­‐scan	  ultrasonography.2Over	  the	  past	  40	  years,	  various	  techniques	  have	  been	  developed	  to	  measure	  ACD,	  such	  as	  A-­‐scan	   ultrasonography,	   Orbscan	   II,	   IOL-­‐Master	   and	   Pentacam	   rotating	   Scheimpglug	  camera.11-­‐20	   In	   our	   study,	   we	   used	   AS-­‐OCT,	   which	   is	   a	   non-­‐contact	   anterior	   segment	  optical	   coherence	   imaging	   method.	   This	   choice	   was	   based	   on	   evidence	   of	   the	   high	  reproducibility	   and	   repeatability	   reported	   in	   previous	   studies.9,	   21	   In	   the	   studies	   by	  Lavanya	   et	   al21	   and	   Nemeth	   et	   al,9	   it	   was	   shown	   that	   AS-­‐OCT	   measurements	   were	  signigicantly	  deeper	   than	  those	  obtained	  with	  IOL-­‐Master	  or	  US	   immersion	  A-­‐scan.	   This	  implies	   that	  the	  decrease	   in	  ACD	  in	  our	  study	  may	  be	  even	  more	  profound.	   Elbaz	  et	  al15	  reported	  that	  measurements	  obtained	  with	  three	  different	  devices,	  such	  as	  Pentacam,	  A-­‐scan	  ultrasonography	  and	  IOL	  Master,	  are	  not	  necessarily	  comparable	  or	  interchangeable.	  For	  this	  reason,	  we	  only	  used	  one	  device	   in	  the	  present	  study.	  Moreover,	   no	   signigicant	  intra-­‐investigator	  and/or	  inter-­‐investigator	  differences	  were	  found.	   Furthermore,	   all	   the	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measurements	   were	   performed	   by	   one	   investigator,	   which	   may	   have	   led	   to	   higher	  reproducibility.	  Potentially,	   discrepancies	   between	   ACD	   results	   can	   be	   explained	   by	   differences	   in	   SB	  techniques:	   in	   the	   older	   studies	   by	   Fiore	  et	   al5	   and	  Burton	  et	   al,2	   the	   majority	  of	   eyes	  received	   hard	   silicone	   explants	   or	   scleral	   implants,	   whereas	   in	  our	   study,	   only	   scleral	  explants	   were	   used,	   without	   dissection	   of	   the	   sclera.	   We	   did	   not	   gind	   any	   signigicant	  difference	  in	  postoperative	  ACD	  between	  the	  use	  of	  radial	   or	  segmental	  buckles.	  All	  our	  SBS	   eyes	  had	  an	  additional	   encircling	  band,	  which	  may	   itself	  have	  caused	  a	  decrease	  in	  ACD.	   A	   possible	   explanation	   is	   as	   follows:	   if	   encircling	   elements	   reduce	   the	   uveal	   or	  retinochoroidal	   circulation,	   ciliary	   body	   oedema	   is	   a	   likely	   consequence.22	   This	   ciliary	  body	   oedema	   with	   forward	   rotation	   of	   its	   body	   and	   forward	   shift	   of	   the	   iris-­‐lens	  diaphragm,	   in	  combination	  with	  compression	  by	  the	  encircling	   element	  on	  the	  vitreous,	  might	  signigicantly	  decrease	  the	  ACD.22	  We	  believe	  that	  this	  could	  be	  the	  major	  reason	  for	  the	  decrease	   in	  ACD	  found	   in	  our	   study.	   The	   accompanying	   increase	   in	   lens	   rise	   lends	  support	  to	  this	   idea.	  Further	  potential	  evidence	  was	  provided	  by	  Burton	  et	  al,	  who	  found	  an	  increase	  in	  lens	  thickness	  for	  at	  least	  6	  weeks	  after	  SB	  surgery.2	  Fiore	   et	   al5	   found	   a	   minimal	   change	   of	   1	   grade	   decrease	   in	   anterior	   chamber	   angle	  (according	  to	  the	  classigication	  of	  Becker	  and	  Schaffer23)	  in	  the	  quadrant	  directly	  anterior	  to	   the	  intrascleral	   implant.5	   In	  a	  histopathological	   study	  on	  rhesus	  monkeys,	   Berler	  and	  Goldstein24	  showed	  that	  the	  ciliary	  body	  rotated	  around	  the	  scleral	  spur	  after	  SB	  surgery.	  This	   might	   explain	   the	   higher	   incidence	   of	   angle	   closure	   glaucoma	   reported	   after	   SB	  procedures.	   In	   the	   present	   series	   of	  38	   eyes,	   however,	   mean	   IOP	  was	  not	   signigicantly	  higher,	   except	  at	  1	  week	  after	  SB	  surgery.	  None	  of	  our	  cases	  presented	  with	  acute	  angle	  closure	  glaucoma.We	  found	  a	  signigicant	  increase	  in	  axial	   length,	  which	  even	  continued	  to	   increase	  during	  follow-­‐up.	  It	  resulted	  in	  a	  mean	  myopic	  shift	  of	  2.6	  D	  3	  months	  after	  SB	  surgery.	  Smiddy	  et	  al25	  observed	  a	  larger	  difference	  in	  axial	  length	  than	  ours.	  Possible	  explanations	  for	  these	  differences	   are	   inter-­‐surgeon	   variance	   or	   variation	   between	   surgical	   techniques.	   Axial	  length	  may	  be	  ingluenced	  by	  the	  tension	  of	  the	  encircling	  element.	  Citirik	  et	  al,26	  however,	  did	   not	   gind	   any	   increase	   in	  axial	   length.	   Burton	   et	   al2	   even	   found	  a	   decrease	   in	   axial	  length	  after	  surgery.	  A	  plausible	  explanation	  for	  the	  decrease	  in	  axial	  length	  is	  that	  Burton	  et	   al2	   used	   a	   technique	  with	   silicone	   implants	   under	   scleral	   glaps2,	   which	   resulted	   in	  scleral	   shortening.	   Burton	  et	  al2	   only	   included	  patients	  with	  an	  attached	  macula,	   so	   the	  axial	   length	   measurements	   were	   probably	   more	   reliable,	   as	   was	   also	   the	   case	   in	   our	  study.	  In	  our	  study,	  ACD	  was	  signigicantly	  decreased	  up	  to	  9	  months	  after	  SB	  surgery.	  Saxena	  et	  al8	   reported	   a	   signigicant	   negative	   correlation	   between	  ACD	   and	   endothelial	   cell	   loss.	  They	  suggested	  stricter	  inclusion	  criteria	  for	  pIOL	  implantation	  surgery:	  ACD	  should	  be	  at	  least	  3.5	  mm,	  measured	  from	  the	  corneal	  epithelium	  to	  the	  anterior	  pole	  of	  the	  crystalline	  lens	   or	   IOL,	   in	   order	   to	   prevent	   an	   excessive	   rate	   of	   endothelial	   cell	   loss	   after	   pIOL	  implantation.	   If	  a	  patient	   presents	  with	  an	  eye	   that	   has	   a	   combination	  of	  myopic	   pIOL,	  RRD	  and	  an	  ACD	  of	  less	  than	  3.5	  mm,	  the	  vitreoretinal	  surgeon	  may	  consider	  performing	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primary	  vitrectomy	  instead	  of	  SB	  surgery.	  Marigo	  et	  al27	  showed	  that	  uncomplicated	  pars	  plana	   vitrectomy	   did	   not	   induce	   any	   long-­‐term	   changes	   in	   anterior	   segment	  morphometry.	  A	  potential	  disadvantage	  of	  performing	  vitrectomy	  in	  eyes	  with	  RRD	  and	  a	  pIOL	   is	  the	  progressive	  development	  of	  cataract,	  making	  it	  necessary	  to	  remove	  the	  pIOL.28,	   29	   On	   the	  other	  hand,	   if	  a	  patient	  with	  a	  history	   of	  SB	   surgery	  wants	   to	   have	  a	  pIOL	  implanted	  and	  the	  ACD	  is	  too	  shallow,	  dissection	  of	  the	  encircling	  element	  is	  potentially	  a	  good	  option,	  as	  was	  described	  by	  Kreissig	  et	  al.30	  A	  weakness	   of	  our	  study	  was	   that	   the	  measurements	  were	  performed	  in	  a	  non-­‐masked	  fashion,	  with	  the	  use	  of	  AS-­‐OCT	  alone.	  Therefore,	  the	  results	  may	  not	  be	  fully	  applicable	  to	  a	  clinical	  setting	  without	  this	  equipment.In	  conclusion,	  ACD	  was	  signigicantly	  decreased	  up	  to	  9	  months	  after	  SB	  surgery,	  while	  the	  axial	   length	  increased.	   AS-­‐OCT	  was	   an	  accurate	  and	  practical	  device	  for	  the	  follow-­‐up	  of	  ACD	  after	  SB	   surgery.	  In	  patients	  with	  prior	  SB	  surgery	  who	  plan	  to	  have	  a	  myopic	  pIOL	  implanted,	  dissection	  of	  the	  encircling	  element	  may	  be	  considered	  if	  the	  anterior	  chamber	  has	  become	  too	  shallow,	  with	  the	  aim	  of	  preventing	  excessive	  endothelial	  cell	  loss.
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Chapter
Diplopia was not predictable 
and not associated with 
buckle position after 
scleral buckling surgery 
for retinal detachment





Background	   or	   Purpose:	   The	   risk	   of	   postoperative	   binocular	   diplopia	   is	   seen	   as	   an	  important	   drawback	   of	  conventional	   scleral	   buckling	   (SB)	   surgery	   for	   rhegmatogenous	  retinal	   detachment	   (RRD).	   The	   goal	   of	   this	   study	   was	   to	   evaluate	   the	   incidence	   of	  binocular	  diplopia	  and	  the	  pattern	  of	  progression	  after	  SB	  surgery	  in	  patients	  with	  RRD.
Methods:	   In	  retrospect,	  postoperative	  data	  on	  the	  occurrence	  of	  binocular	  diplopia	  were	  retrieved	  from	   the	  medical	   records	  of	  1030	  patients	  with	  primary	  RRD	  who	  underwent	  SB	  surgery	  between	  January	  2001	  and	  July	  2008.
Results:	  Secondary	  strabismus	  occurred	  in	  39	  subjects	  (3.8%)	  during	  a	  mean	  follow-­‐up	  of	  6.4	  ±	  6.3	  months.	  Twenty-­‐eight	  patients	  (2.7%)	  developed	  strabismus	  due	  to	  mechanical	  restriction	  of	  one	  of	  the	  ocular	  muscles.	  No	  association	  was	  found	  between	  the	  position	  of	  the	  buckle,	   i.e.	  the	  muscle	  affected,	  and	  the	  incidence	  of	  diplopia.	  A	  moderately	  signigicant	  association	  was	  found	  between	  the	  involvement	  of	  two	  muscles	  and	  a	  higher	  incidence	  of	  diplopia.	  However,	  this	  did	  not	  apply	  to	  the	  involvement	  of	  three	  or	  more	  muscles.	  In	  28	  out	  of	  the	  39	  patients,	  binocular	  single	  vision	  was	  restored	  at	  the	  end	  of	  follow-­‐up.	  In	  the	  majority	  of	  cases,	  this	  had	  been	  accomplished	  with	  conventional	  prism	  treatment.
Conclusions:	  Strabismus	  due	  to	  restriction	  of	  the	  ocular	  muscles	  after	  SB	  surgery	  was	  not	  predictable	   on	   the	   basis	   of	   buckle	   position.	   Conventional	   prism	   treatment	   proved	  successful	  in	  patients	  with	  minimal	  restriction	  of	  the	  muscles	  after	  SB	  surgery.	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IntroductionFor	  many	  vitreoretinal	  surgeons,	  scleral	  buckling	  (SB)	  surgery	  is	   	  the	  treatment	  of	  choice	  for	  primary	  rhegmatogenous	  retinal	  detachment	  (RRD)	  with	  limited	  PVR.1,	   2	   Adversaries	  of	   SB	   surgery	   emphasize	   that	   diplopia	   is	   one	   of	   the	   most	   important	   postoperative	  complications,	  which	  can	  be	  avoided	  by	  performing	  primary	  vitrectomy	  instead.3-­‐5	  Diplopia	  was	   reported	   in	   3%	   to	   40%	   of	   the	   patients	   after	   SB	   surgery.3,	   4,	   6-­‐15	   Multiple	  causes	  have	  been	  proposed.3,	  4,	  14,	   16-­‐20	  One	  mechanism	  that	  may	  play	  an	  important	  role	  is	  ocular	  muscle	  restriction	  due	  to	  leverage	  from	  the	  buckle.	  Therefore,	  an	  association	  might	  be	  expected	  between	  the	  affected	  ocular	  muscle	  and	  the	  buckle	  that	  is	  placed	  beneath	  it.	  The	   goal	   of	   this	   study	   was	   to	   investigate	   the	   incidence	   of	   binocular	   diplopia	   and	   the	  pattern	   of	   progression	   in	   a	   large	   group	   of	   patients	   who	   had	   recently	   undergone	   SB	  surgery.	   Secondary	   aims	  were	   to	   analyse	  whether	  strabismus	  was	   predictable	   after	   SB	  surgery	   and	   to	   identify	   the	   type	  of	   treatment	   that	  had	  mostly	   been	  used	  to	   resolve	   the	  diplopia.
Materials and methodsA	  retrospective	  review	  was	  made	  of	  the	  medical	  records	  of	  all	  the	  patients	  with	  RRD	  who	  had	  undergone	  primary	  SB	  surgery	  without	  vitrectomy	  between	  January	  2001	  and	   July	  2008.	   Seven	  different	  surgeons	   had	  performed	  the	  operations	   (FH,	   ELH,	   AL,	   IL,	   VN,	  WJ	  and	  EB).	  We	  excluded	  any	  patients	  with	  a	  history	  of	  strabismus	   and/or	  thyroid	  disease.	  Medical	  records	  were	  matched	  with	  the	  data	  obtained	  during	  our	  orthoptic	  consultations.	  In	  39	  out	  of	   the	   1030	  patients,	   the	  orthoptic	   consultation	   included	  the	  measurement	  of	  visual	   acuity	   and	   the	   range	   of	   ocular	   movement.	   Patients	   had	   been	   referred	   to	   the	  orthoptist	  due	   to	   complaints	   of	  binocular	   diplopia.	   The	   orthoptist	   used	   the	   serial	   Hess	  charts	  to	  examine	  patients	  for	  muscle	  restriction	  and	  the	  prism	  cover-­‐test	  to	  measure	  the	  angle	  of	  heterotropia.	   To	   calculate	  the	  mean	  angles,	  we	  used	  mean	  horizontal	   deviations	  from	  patients	  with	  horizontal	   diplopia	  and	  mean	   vertical	  deviations	   from	   patients	  with	  vertical	   diplopia.	   Absolute	   values	   were	   used	   in	   the	   statistical	   analysis	   to	   calculate	   the	  mean	  deviation.	   The	   study	  was	  conducted	  in	  accordance	  with	  the	  ethical	   standards	   laid	  down	  in	  the	  1964	  Declaration	  of	  Helsinki.During	   SB	   surgery,	   a	   silicone	   encircling	   element	   (reference	   number	   240,	   MIRA	   Inc.	  Uxbridge,	   MA,	   USA)	   was	   placed	   beneath	   the	   rectus	   muscles,	   with	   either	   a	   segmental	  buckle	  (silicone	  grooved	  strip	  no.	   506G,	  DORC	  International,	   Zuidland,	   the	  Netherlands)	  and/or	   a	   radial	   buckle	   (solid	   silicone	   wedge,	   G135,	   MIRA	   Inc.,	   Uxbridge,	   MA,	   USA,	   or	  G137,	   Labtician	  Ophthalmics	   Inc.,	   Oakville,	   Canada).	   Data	  on	   the	  position	   of	  the	   buckle	  could	  easily	  be	  retrieved	  from	  the	  surgical	  reports,	  because	  all	  the	  surgeons	  had	  drawn	  a	  diagram	  or	  described	  in	  detail	   the	  exact	   location	  of	  the	  buckle.	  The	  encircling	  band	  was	  gixed	  10-­‐12	  mm	  posteriorly	  to	  the	  limbus	  with	  a	  mercilene	  5.0	  suture.	  Whether	  a	  radial	  or	  segmental	   buckle	   was	   selected	   depended	   on	   the	   size	   and	   location	   of	   the	   retinal	   tear.	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Subretinal	  gluid	  was	  drained	  when	  judged	  necessary	  by	  the	  surgeon.	  Cryocoagulation	  was	  performed	   in	  some	   cases,	   according	   to	   the	   preferences	   of	   the	  surgeon.	   Intravitreal	   gas	  tamponade	   was	   used	   for	   RRDs	   in	   the	   upper	   quadrants,	   located	   between	   the	   8	   and	   4	  o’clock	  positions.All	   the	   patients	   received	   routine	   postoperative	   treatment	   with	   antibiotic	   eye	   drops	  (chloramphenicol	   5	   mg/ml)	   4	   times	   daily	   for	   14	   days	   (Ratiopharm,	   Zaandam,	   the	  Netherlands)	  and	  prednisolone	  eye	  drops	  (Pred	  Forte®,	   prednisolone	  acetate	  10	  mg/ml,	  Allergan	   BV,	   Nieuwegein,	   the	   Netherlands)	   3	   times	   daily	   for	   2	  months.	   Patients	   with	  phakic	   eyes	   also	   used	  mydriatic	   eye	   drops	   (atropine	   sulphate	   1%)	   2	   times	   daily	   for	   1	  week	   after	   the	   operation	   (Chauvin	   Pharmaceuticals	   Ltd,	   Surrey,	   UK).	   Patients	   with	  pseudophakic	  eyes	  used	  additional	   tropicamide	  0.5%	  (Thea	  Pharma,	  Wetteren,	  Belgium)	  2	  times	  daily	  for	  1	  week.The	   following	   patient	   characteristics	   were	   noted:	   gender,	   age,	   right	   or	   left	   eye,	   re-­‐detachment	   (yes/no),	   RRD	   in	   the	   fellow	   eye	   (yes/no),	   removal	   of	   the	  scleral	   buckle	   or	  encircling	   element	   (yes/no).	   SB-­‐surgery-­‐related	   variables	   were	   also	   noted:	   radial	   or	  segmental	  silicone	  buckle	  and	  muscle	  or	  muscles	  involved,	  subretinal	  gluid	  drainage	  (yes/no),	   cryocoagulation	   (yes/no),	   intravitreal	   sulphur	   hexagluoride	   (SF6)	   gas	   tamponade	  (yes/no).	   Additional	   data	  were	  noted	   in	   patients	  with	  diplopia:	   macula	   involved	  in	   the	  retinal	  detachment	   (yes/no),	   duration	  of	  diplopia	  after	  surgery,	   visual	  acuity	  at	  the	  time	  of	  diplopia,	  cause	  of	  the	  diplopia	  and	  treatment	  received,	   treatment	  successful	   (yes/no).	  In	   our	   study,	   ‘diplopia’	   refers	   exclusively	   to	   binocular	   diplopia.	   Mechanical	   strabismus	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Table	  5.1:	  Patient	  characteristics	  in	  the	  groups	  with	  and	  without	  diplopia









Age	  (years) 58.1±13.5	   58.6	  ±	  10.6 P=0.861
Gender	  m	  :	  f	  (%) 644	  :	  347	  (63	  :	  37) 22	  :	  6	  (79	  :	  21) P=0.133
Re-­‐detachment	  (%) 185	  (18.7) 9	  (32.2) P=0.085
Fellow	  eye	  detachment	  (%) 148	  (14.9) 4	  (14.3) P=0.920
Buckle	  beneath	  superior	  rectus	  (%) 508	  (50.6) 13	  (46.4) P=0.663
Buckle	  beneath	  lateral	  rectus	  (%) 473	  (47.7) 13	  (46.4) P=0.888
Buckle	  beneath	  medial	  rectus	  (%) 193	  (19.5) 8	  (28.6) P=0.234
Buckle	  beneath	  inferior	  rectus	  (%) 224	  (22.6) 7	  (25.0) P=0.767
Punction 839	  (84.7) 23	  (82.1) P=0.731
Cryocoagulation 546	  (55.1) 15	  (53.6) P=0.866
Intravitreal	  gas 750	  (75.7) 19	  (67.9) P=0.345
Radial	  buckle 216	  (25.5) 10	  (35.7) P=0.179
Segmental	  buckle 716	  (72.3) 17	  (60.7) P=0.459
Mean	  no.	  of	  muscles	  involved 1.4 1.4 P=0.699
was	  degined	  as	  diplopia	  due	  to	  mechanical	  restriction.	  Functional	  diplopia	  was	  degined	  as	  diplopia	   due	   to	   decompensation	  of	   former	  heterotopia	   and	   limited	   fusional	   amplitudes	  caused	  by	  decreased	  visual	  acuity.Snellen	  visual	  acuities	  were	  converted	  into	  a	  logarithmic	  scale	  (LogMAR,	  i.e.	  the	  logarithm	  of	   the	  minimal	   angle	  of	   resolution)	  as	   described	  previously.21	   In	  this	   study,	   poor	   visual	  outcome	   was	   degined	   as	   less	   than	   0.1	   Snellen	   visual	   acuity	   at	   12	   months	   follow-­‐up.	  Statistical	  analysis	  was	  performed	  using	  the	  SPSS	  software	  15.0	  (SPSS	  for	  Windows,	  Rel.	  13.0	  Chicago:	   SPSS	   Inc.,	   USA)	  with	  independent	   sample	  T-­‐test	   and	   χ2	   test.	   Signigicance	  was	  degined	  as	  P	  <	  0.05.
ResultsBetween	   January	   2001	   and	   July	   2008,	   a	   total	   of	   1030	   patients	   with	   primary	   RRD	  underwent	  SB	  surgery.	  Mean	  age	  was	  58.1	  ±	  13.4	  years.	  In	   the	  patients	  with	  diplopia	   (n=39)	  mean	   age	  was	   59.3	   ±	  12.7	  years	   (not	  signigicantly	  different	  from	  the	  whole	  group).	  The	  diplopia	  group	  comprised	  24	  right	  eyes	  (61.5%),	  15	  left	   eyes	   (38.5%),	   28	   men	   (71.8%)	   and	   11	   women	   (28.2%);	   6	   patients	   had	   retinal	  detachment	  in	  the	  fellow	  eye;	  24	  segmental	  buckles	  had	  been	  used	  compared	  to	  14	  radial	  buckles.	  All	   the	   patients	   attended	   regular	   follow-­‐up	   visits	   after	   SB	   surgery.	   Patients	   with	   an	  uneventful	  and	  uncomplicated	  postoperative	  course	  and	  the	  patients	  without	  complaints	  of	  diplopia	   returned	   to	   their	  referring	  ophthalmologist	  after	   approximately	   three	  to	   six	  months.	   The	   patients	   who	   complained	   of	   diplopia	   (n=39)	   were	   sent	   for	   orthoptic	  evaluation	   after	   a	   mean	   follow-­‐up	   of	   6.4	   ±	   6.3	   months	   (range	   1-­‐24	   months).	   Total	  duration	  of	  follow-­‐up	  in	  this	  group	  was	  41.2	  ±	  23.3	  months	  (range	  9-­‐48	  months).	  Within	  the	  group	  of	  39	  patients	  who	   complained	  of	  diplopia,	  28	  patients	  (2.7%)	  had	  mechanical	  strabismus	  due	  to	  mechanical	   restriction	  of	   the	  ocular	   muscles.	   These	  patients	   formed	  our	   diplopia	  study	   group.	   Their	   girst	   orthoptic	   assessment	   took	  place	   4.1	  ±	  3.7	  months	  postoperatively.	   The	  macula	   was	   involved	   in	   the	   detachment	   in	   15	   patients.	   Superior	  rectus	  muscle	  restriction	  was	  present	  in	  14	  patients	  (congirmed	  by	  Hess	  chart)	  and	  in	  9	  of	  them	  (64.3%)	  the	  buckle	   lay	  beneath	  this	  muscle.	   Inferior	  rectus	  muscle	  restriction	  was	  present	  in	  13	  patients	  (congirmed	  by	  Hess	  chart)	  and	  in	  5	  of	  them	  (38.4%)	  the	  buckle	  lay	  beneath	  that	  muscle.	  Lateral	  rectus	  muscle	  restriction	  was	  present	  in	  one	  patient	  and	  the	  buckle	  lay	  beneath	  that	  muscle.	  Patient	  characteristics	  in	  the	  diplopia	  group	  and	  the	  non-­‐diplopia	  group	  are	  shown	  in	  Table	  5.1.	  Ten	  patients	  (1.0%)	  had	  functional	  diplopia	  due	  to	  decompensation	  of	  former	  heterophoria,	   low	  visual	  acuity	  and	  inefgicient	  fusion.	   Paresis	  of	  the	  trochlear	  nerve	  was	  found	  in	  one	  patient	  (0.1%).	  None	  of	  the	  patients	  with	  diplopia	  had	  thyroid	  eye	  disease.In	  the	  patients	  with	  vertical	  diplopia	  (n=25)	  mean	  vertical	  deviation	  at	  30	  cm	  was	  6.0	  ±	  5.1	  ∆	  versus	  3.7	  ±	  1.5	  ∆	  in	  the	  patients	  with	  functional	  diplopia	  (n=5)	  (P=0.06).	  At	  6	  m,	  the	  mean	  values	  were	  6.7	  ±	  5.4	  ∆	  and	  7.0	  ±	  5.4	  ∆,	  respectively	  (P=0.87).	   In	  the	  patients	  with	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horizontal	   diplopia	  (n=11)	  mean	  horizontal	  deviation	  at	  30	  cm	  was	   6.7	  ±	  5.3	  ∆	   versus	  16.4	   ±	   13.4	   ∆	   in	   the	   patients	   with	   functional	   diplopia	   (n=5);	   this	   was	   a	   signigicant	  difference	  (P=0.04).	  When	  measured	  at	  6	  m,	  the	  mean	  values	  were	  8.0	  ±	  7.3	  ∆	  and	  15.2	  ±	  12.4	  ∆,	  respectively	  (P=0.06).	  Table	  5.1	   lists	   the	  positions	  of	   the	  buckle	   in	   the	  patients	   in	   the	  diplopia	  group	  and	   the	  non-­‐diplopia	   group.	   No	   association	  was	   found	  between	   the	   buckle	   position	   or	   type	   of	  buckle	   and	   the	   incidence	   of	   diplopia.	   Similarly,	   no	   correlation	  was	   found	  between	   the	  position	   of	   the	   buckle	   and	   restriction	   of	   the	  muscle	  under	  which	   the	   buckle	   had	   been	  placed.	   In	   the	   majority	   of	   patients	   with	   mechanical	   strabismus,	   the	   buckle	   was	   not	  beneath	   the	   muscle	   that	   would	   be	   expected	   to	   be	   associated	   with	   the	   diplopia.	  Furthermore,	   in	   six	   out	   of	   the	   28	   patients	   (21%)	   in	   the	   diplopia	   group,	   the	   surgical	  reports	   revealed	   that	   no	   buckle	  had	  been	  placed	  beneath	  any	  of	   the	   rectus	   muscles.	   A	  buckle	  had	  been	  placed	  beneath	  one	  muscle	  in	  7	  patients	  (25%),	  beneath	  two	  muscles	  in	  13	  patients	  (47%)	  and	  beneath	  three	  muscles	  in	  2	  patients	   (7%).	   It	  was	  only	  when	  two	  muscles	   were	   involved	   that	   we	   found	   a	   moderately	   signigicant	   association	   with	   the	  incidence	  of	  diplopia.	  No	   signigicant	  associations	  were	  found	  when	  3	  or	  4	  muscles	  were	  affected	  (Table	  5.2).	  Visual	  acuity	  in	  LogMAR	  was	  0.41	  ±	  0.47	  (20/50)	  in	  the	  diplopia	  group	  versus	  0.27	  ±	  0.32	  (P=0.201)	  (20/40)	  in	  the	  patients	  with	  functional	  diplopia.	  In	  the	  fellow	  eye,	  visual	  acuity	  in	   LogMAR	   was	   0.00	  ±	  0.09	  (20/20)	  in	  the	   diplopia	  group	  versus	   0.18	  ±	  0.41	  (P=0.01)	  (20/30)	  in	  the	  functional	  diplopia	  group.
Treatment	  for	  diplopiaIn	   the	   diplopia	   group,	   17	  out	   of	   the	   28	   patients	   regained	  binocular	   single	   vision	   after	  prism	   treatment:	   16	   patients	   had	   prisms	   for	   vertical	   deviation	   and	   one	   patient	   had	   a	  prism	   for	   horizontal	   deviation.	   Another	   two	   patients	   regained	   binocular	   single	   vision	  after	   a	   training	   programme	   with	   fusional	   exercises.	   One	   patient	   underwent	   surgical	  strabismus	  correction,	  but	  without	  success	  and	  was	  ultimately	  advised	  to	  occlude	  the	  eye.	  In	  two	  other	  patients,	  the	  diplopia	  disappeared	  after	  adjusting	  the	  refractive	  error.	   Four	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Table	  5.2:	  Buckle	  placement	  beneath	  muscles	  in	  the	  groups	  with	  and	  without	  diplopia




Diplopia	  (n=28) P	  value
0 208 6 0.9551 314 7 0.4532 342 13 0.0373 124 2 0.3954 3 0 0.771
patients	  with	  minimal	  vertical	  deviation	  followed	  a	  “no	  treatment	  policy”	  and	  the	  diplopia	  resolved	   spontaneously	   after	   6	   months.	   Prism	   treatment	   was	   unsuccessful	   in	   two	  patients,	  who	  were	  ultimately	  advised	  to	  occlude	  the	  eye.	  In	  the	  group	  of	  patients	  with	  functional	  diplopia	  who	  were	  considered	  for	  treatment	  for	  the	  diplopia	   (n=10)	  one	  patient	   was	   treated	   successfully	   with	   a	   prism	  and	  one	  patient	  recuperated	  after	  optimal	  refractive	  correction.	   It	  was	  necessary	  to	  occlude	  the	  eye	  in	  4	  cases.	   Three	  other	  patients	  declined	  further	  treatment.	  The	  scleral	  buckle	  and	  encircling	  element	  had	  to	  be	  removed	  from	  one	  patient,	  which	  resulted	  in	  resolution	  of	  the	  diplopia.	  Trochlear	  nerve	  paresis	  (n=1)	  resolved	  spontaneously	  within	  6	  months.	  Ultimately,	   binocular	  single	  vision	  was	  restored	  in	  28	  (72%)	  out	  of	  the	  39	  patients	  at	  the	  end	  of	  follow-­‐up.
DiscussionIn	   our	   series	   of	   1030	   eyes	   that	   underwent	   SB	   surgery	   for	   RRD,	   secondary	   diplopia	  occurred	  in	  3.8%	  after	  a	  mean	  follow-­‐up	  of	  more	  than	  six	  months.	  Orthoptic	  assessment	  congirmed	  the	  presence	  of	  mechanical	  restriction	  in	  2.7%	  of	  the	  total	  series.	  No	  signigicant	  correlation	  was	   found	  between	  the	  position	  of	  the	  buckle	  or	   the	  type	  of	  buckle	  and	   the	  incidence	  of	  diplopia	  or	   the	  pattern	  of	  strabismus.	   A	  moderately	   signigicant	  association	  was	   found	  between	  the	   involvement	  of	   two	  muscles	  and	  a	  higher	   incidence	  of	  diplopia.	  However,	   this	  did	  not	  apply	   to	   the	   involvement	  of	   three	  or	  four	  muscles.	   Therefore,	  we	  did	  not	  observe	  the	  expected	  trend	  of:	  the	  more	  muscles	  affected,	  the	  higher	  the	  incidence	  of	   diplopia.	   It	   cannot	   be	   ruled	  out	   that	   this	   was	   due	   to	   small	   group	   size.	   Based	  on	  our	  calculations	   and	   statistics,	   we	   can	   conclude	   that	   in	   the	   present	   retrospective	   study,	  diplopia	   was	   not	   associated	   with	   the	   position	   of	   the	   buckle	   and	   there	   was	   only	   a	  moderate	  association	  with	  the	  number	  of	  muscles	  affected.	  Moreover,	   in	   the	  majority	  of	  patients	   in	   the	   diplopia	   group,	   the	   buckle	  was	   not	   beneath	   the	  muscle	   that	   would	  be	  expected	  to	  be	  associated	  with	  the	  diplopia.	  Therefore,	  the	  incidence	  of	  diplopia	  was	  only	  predictable	  in	  a	  minority	  of	  the	  patients.It	  has	  previously	  been	  suggested	  that	  transient	  diplopia	  after	  SB	  surgery	  can	  be	  attributed	  to	  cryocoagulation	  of	  a	  muscle.3	  In	  our	  series,	  this	  may	  explain	  the	  disappearance	  of	  the	  diplopia	   within	   6	  months	   in	   two	   patients	   who	   received	   conservative	   treatment	   with	  fusional	  exercises	  from	  an	  orthoptist.	  Another	  possible	  explanation	  for	  diplopia	  after	  SB	  surgery	  is	  scarring	  of	  the	  conjunctiva	  near	  the	  limbus,	  which	  would	  induce	  shortening,	  i.e.	  mechanical	  restriction,	  as	  was	  proposed	  in	  a	  study	  on	  pterygium	  excision.22	  Kanski	  et	  al4	  published	  a	  study	  on	  750	  SB	  surgery	  patients	  in	  1973.	  They	  reported	  that	  25	  out	   of	   the	   30	   patients	   who	   developed	   diplopia	   underwent	   a	   secondary	   procedure	   to	  mobilize	  the	  muscles,	  which	  was	  standard	  procedure	  in	  those	  days.	  In	  the	  present	  study,	  however,	  we	  did	  not	  mobilize	  any	  of	  the	  muscles	  or	  perform	  tendonectomies.	  Many	   causes	   for	   strabismus	   have	   been	   described	   in	   the	   literature	   (Table	   5.3).	   Local	  anesthetics7	   sometimes	   cause	   anaesthetic	   myotoxicity,	   with	   temporary	   restrictive	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Year N %	  Diplopia Δ	  Angle	  (horizontal)
2005 6 NN 25-­‐	  	  >90Δ2003 18 7% 36.4∆2000 36 NN 3-­‐40∆2000 Review1999 401998 68 NN 2-­‐70∆1998 37 NN Horizontal	  0-­‐36ΔVertical	  0-­‐32ΔTorsional	  3-­‐10Δ1997 21996 44 13.6%1995 5-­‐25%1995 45 15.5%1993 70 12% NN1992 31 NN NN1992 117 6%/11%/30% NN1991 20 	  NN 10-­‐60Δ1991 31 NN 18-­‐50	  Δ19911990 21 NN 5-­‐45	  Δ1990 33 30% NN1989 69 37.7%	  strabismus4.3%	  diplopia1988 18 4.5% 1-­‐16	  Δ
1987 33 4-­‐40	  Δ1987 4 NN 6-­‐40	  Δ1987 14 4.8%1986 7 15-­‐70	  Δ1986 60 80%	  strabismus	  40%	  diplopia1985 30 10%	  (at	  6	  months) 2-­‐10Δ	  (at	  6	  months)1984 8/3 3%	  muscle	  imbalance	  2.5%	  diplopia NN1974 19 14%	  muscle	  imbalance1973 30 6%	  muscle	  imbalance	  3.3%	  diplopia NN1973 90 10%	  with	  large	  comitant	  deviation,	  	  13%	  medium	  size	  motility	  imbalance	  16%	  small	  tropias,	  51%	  orthophoric Up	  to	  8Δ	  vertically	  and	  20Δ	  horizontally	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Treatment Scleral	  buckling	  technique
1.	  Reinsertion,	  2.	  Declined	  by	  patient	  3.	  Reinsertion	  and	  Δ	  4.	  Reinsertion	  and	  SC	  5.	  Reinsertion	  LR	  and	  SC	  6.	  Reinsertion 1.	  EE	  +	  SGB,	  2.	  NN	  3.	  NN,	  4.	  NN	  5.	  EE,	  SB+PPV	  6.	  260°	  EE	  and	  SB	  +PPV12	  Δ,	  5	  OK	  1	  OC EE	  alone9	  Δ,	  27	  recommended	  SC,	  17	  operated	  on NN
17.6%	  SC	  38.2%	  BT	  in	  muscle	  (2.9	  average)	  19.1%∆	  11.7%	  OC,	  13.2%	  refused	  treatment 41	  eyes	  1	  or	  more	  explants,	  27	  eyes	  EE,	  with	  or	  without	  explant100%	  SC EE	  and	  SBSBR,	  SCMostly	  expectative EE	  +RB	  or	  SGB
Prisms RB6	  prism	  1	  SBR	  +SC+BT 58	  CFE	  2	  RB	  10	  CFE+RB1.	  Bilateral	  recession	  2.	  Recession	  resection	  procedures	  3.Removal	  of	  Tenon’s	  capsule	  	  4.	  Advancement	  of	  slipped	  muscle	  5.	  Repositioning	  of	  displaces	  superior	  oblique	  6.	  Temporary	  traction	  suture	  7	  Removal	  of	  explant
NN
NN 54	  SB	  63	  EE	  +	  RB	  or	  notBT	  in	  muscle	   NNBT	  in	  muscle,	  3	  SC	   NN
BT	  in	  muscle NN4	  SC	  or	  prisms 16	  SB	  surgery	  17	  EE	  (all	  33	  PPV+	  SOI)SC	  in	  one	  and	  prisms	  in	  two	  eyes EE	  or	  SB	  CFB,	  EE	  was	  anchored	  with	  scleral	  tunnel4	  SC,	  4Δ,	  5	  was	  not	  restored,	  2	  CHP,	  3	  expectative	   NN20	  SC	   EE	  or	  360°	  explant,	  RB,	  SGBSC	  and	  SBR1st	  Δ,	  2nd	  SBR,	  3rd	  SCSC,	  OC 6	  360°	  buckle,	  5	  mm	  radial	  buckle.	  During	  surgery	  1	  slipped	  muscle	  and	  1	  inadvertent	  section30	  balloon	  buckle	  or	  	  30	  silicone	  sponge1	  Δ,	  2	  expectative EE	  with	  radial	  buckle	  or	  radial	  buckle	  alone4	  spontaneously	  recovery	  2	  Δ,	  2SC 2/8	  had	  muscle	  mobilization,	  4	  had	  	  the	  scleral	  buckle	  over	  the	  muscle	  insertion	  	  ½	  of	  patient	  received	  tendontomy	  15	  spontaneous	  and	  complete	  recovery,	  3	  control	  imbalance,	  4Δ,	  1	  occlusion,	  1	  expectative,	  1	  SC 25/30	  patients	  had	  muscle	  detached.	  11	  EE	  with	  7	  scleral	  resection	  and	  4	  buckle,	  8	  local	  procedure	  with	  2	  scleral	  resection	  and	  6	  buckleNN Light	  coagulation,	  retinopexy,	  scleral	  resection	  (with	  or	  without	  recession	  of	  lateral	  rectus)	  indentation	  methods	  and	  EE	  (n=29)N:	   number	   ,	   NN:	   not	   noted,	   EE:	   encircling	   element,	   RB:	   radiar	   buckle,	   SGB:	   segmental	   buckle,	   CFE:	  circumferential	  explants,	  SBR:	  scleral	  buckle	  removal,	  Δ:prisms,	  F-­‐U:	  follow	  up	  SC:	  strabismus	   correction,	  OC:occlusion,	  EOM:extra	  ocular	  muscle,	   SB:	   scleral	  buckling,	   PPV:	  pars	   plana	  vitrectomy,	   SOI:	  silicone	  oil	  injection,	  BT:	  botulinum	  toxin,	  CHP:	  compensatory	  head	  posture




































Success Cause	  of	  diplopia/	  major	  
All	  except	  2	  patients	  who	  declined	  treatment Mechanical
88%	  of	  SC Mechanical	  
75%	  of	  SC.	  96%	  of	  BT	  (although	  with	  repeated	  treatment)	  77%	  of	  ∆ NN9	  mild	  residual	  deviation	  1	  no	  follow-­‐up	  6	  successful 70%	  mechanical.	  30%	  NNMechanical	  Mainly	  mechanical
MechanicalMechanical	  	  Note:	  a	  second	  procedure	  is	  more	  likely	  to	  cause	  restricted	  motility30	  mechanical,	  4	  patients	  functional,	  3	  previous	  strabismusNN NN73%	  1	  or	  2	  injections NN62% NN
60% NNNNMechanical5/8	  fusion	  was	  restored NN
Specigied	  per	  group Mechanical25% 50%	  unknown,	  50%	  mechanical80%20% MechanicalMechanical	  NNMechanical	  NN96% Mechanical	  NN
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8	  -­‐120	  months NN Cause	  of	  diplopia	  found	  with	  MRILocal	  anaestheticsNN NN
SB	  surgery	  compared	  to	  PPVNN SC	  4-­‐48	  monthsBT	  2-­‐60	  months≥6	  months 6-­‐56	  months	  mean	  8 Case	  report0-­‐6	  months 6	  months Prospective	  studyReview2-­‐4	  yearsAfter	  6	  months Mean	  20.1	  months	  (9-­‐32)NN NNNN NNNN NNOne	  year NN
4	  months-­‐20	  years 5-­‐96	  monthsNN 6-­‐29	  months4-­‐20	  monthsNN NNMore	  than	  6	  months 6	  months	  to	  17	  years
Mean	  4	  years2	  months	  to	  2	  years26	  weeks Prospective	  studyAfter	  surgery	  till	  6	  months 6	  monthsNN NN
NN 1-­‐10	  years More	  vertical	  muscle	  imbalance	  3:23After	  5	  moths 5	  months	  to	  2	  yearsN:	   number	   ,	   NN:	   not	   noted,	   EE:	   encircling	   element,	   RB:	   radiar	   buckle,	   SGB:	   segmental	   buckle,	   CFE:	  circumferential	  explants,	  SBR:	  scleral	  buckle	  removal,	  Δ:prisms,	  F-­‐U:	  follow	  up	  SC:	  strabismus	   correction,	  OC:occlusion,	  EOM:extra	  ocular	  muscle,	  SB:	  scleral	  buckling,	  PPV:	  pars	  plana	  vitrectomy,	  SOI:	  silicone	  oil	  injection,	  BT:	  botulinum	  toxin,	  CHP:	  compensatory	  head	  posture
strabismus,	  as	  was	  reported	  by	  Salama	  et	  al.7	  This	  cause	  can	  be	  ruled	  out	  in	  the	  present	  series,	  because	  all	  the	  patients	  were	  operated	  on	  under	  general	  anaesthesia,	  without	  any	  additional	   locoregional	   supplementation.	   Ischaemia	   of	   the	   rectus	   muscles	   may	   also	  explain	  diplopia	  after	  SB	  surgery.	  An	  ischaemic	  muscle	  loses	  its	  function	  and/or	  strength.	  Ischaemia	   of	   the	   rectus	   muscles	   may	   develop	   due	   to	   muscle	   constraint,	   or	   arterial	  occlusion	  by	  the	  encircling	  element.23	  A	  study	  by	  Lincoff	  et	  al23	  showed	  that	  the	  encircling	  band	  signigicantly	  reduced	  the	  pulsatile	  ocular	  blood	  glow	  by	  a	  mean	  of	  43%	  compared	  to	  the	   fellow	   eye.	   Subsequent	   cutting	   of	   the	   band	   resulted	   in	   a	  mean	   recovery	   of	   up	   to	  85.6%.23	   In	   addition,	   when	   a	   muscle	   is	   constrained	   too	   aggressively,	   it	   may	   become	  seriously	  traumatized,	   resulting	  in	  haemorrhage	   and/or	  oedema	  of	   the	  muscle,	   but	  also	  ultimately	  to	  gibrosis	  and	  scarring,	  with	  restriction	  of	  its	  function.14	  Trauma	  with	  scarring	  was	   also	   held	   responsible	   for	   the	   ocular	   motility	   disturbances	   that	   occurred	   after	   the	  placement	  of	  Baerveldt	  glaucoma	  implants	  under	  or	  on	  top	  of	  the	  superior	  rectus	  muscle	  or	   lateral	  rectus	  muscle.24	   In	  some	  of	  our	  cases,	   this	  mechanism	  of	  trauma	  with	  scarring	  may	  be	  the	  explanation,	  as	  there	  was	  no	  apparent	  association	  between	  the	  position	  of	  the	  buckle	  and	  the	  pattern	  of	  diplopia.	  It	  was	  striking	  that	  none	  of	  the	  buckles	  were	  beneath	  any	  of	  the	  muscles	   in	  six	  of	  our	  patients	  with	  diplopia	  (21%).	  All	  six	  cases	  had	  a	  fusional	  problem	   as	   a	   result	   of	   de-­‐compensation	   of	   former	   heterophoria	   caused	   by	   decreased	  visual	  acuity.Magnetic	  resonance	  imaging	  (MRI)25	   identigied	  various	  pathological	  characteristics	  in	  the	  extra	  ocular	   muscles	   8-­‐120	  months	   after	   SB	   surgery.	   Deviation	   varied	  between	  25Δ	   to	  more	   than	  90Δ	   (n=6),	  whereas	   in	  the	  present	  study,	   a	  mean	  deviation	  of	  6Δ	  was	   found.	  The	  MRI	  study25	   also	   reported	  exposure	  and	  anterior	  migration	  of	  the	  scleral	   buckle	  in	  three	   cases,	   which	  was	   caused	   by	   complete	   erosion	  of	   the	   extra	   ocular	  muscle	   tendon	  (Table	   5.3).	  Therefore,	   it	   can	  be	  concluded	  that	   the	  MRI	  study	   included	  severe	  types	   of	  pathology	  and	  that	  the	  results	  cannot	  simply	  be	  extrapolated	  to	  other	  cases	  who	  undergo	  SB	  surgery.It	   is	   well-­‐known	   that	  MIRAgel	   buckles	   give	   the	   highest	   rate	   of	   complications	   after	   SB	  surgery	   (MIRAgel,	   Medical	   Instruments	   Research	   Associates,	   Waltham,	   Massachusetts,	  USA).	   Progressive	  diplopia18,	   19,	   26	  was	   reported	  up	   to	   7-­‐11	  years	   after	  the	  placement	   of	  MIRAgel	  buckles.	  In	  the	  present	  series	  of	  patients,	  no	  MIRAgel	  buckles	  were	  used.	  Binocular	  single	  vision	  was	  ultimately	  restored	  in	  72%	  of	  the	  patients	  with	  diplopia	  in	  the	  present	   study.	  Re-­‐detachment	   is	   also	  a	  risk	   factor	  for	   diplopia,	   because	   it	   diminishes	   or	  disables	   existing	   fusion	   due	   to	   further	   deterioration	   in	   visual	   acuity.	   In	   patients	   with	  prolonged	  sensory	   deprivation	  due	   to	  macular	  detachment,	   fusion	  could	  not	   always	  be	  restored.27-­‐29	   Therefore,	   the	  only	  possible	   treatment	   in	  these	  cases	  was	  occlusion	  of	  the	  eye.	  We	  found	  that	  prism	  therapy	  was	  a	  good	  treatment	  option	  in	  patients	  whose	  strabismus	  was	  caused	  by	  mechanical	  restriction.	  In	  a	  study	  by	  Sauer	  et	  al,30	  scleral	  buckle	  removal	  was	  a	  successful	  treatment	  in	  50%	  of	  the	  patients	  with	  postoperative	  strabismus;	  prisms	  restored	  binocular	  vision	  in	  an	  additional	  25%,	  while	  strabismus	  surgery	  was	  necessary	  in	  the	  remaining	  25%.	  However,	  a	  major	  disadvantage	  of	  scleral	  buckle	  removal,	  besides	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a	   second	   operation,	   is	   the	   increased	   risk	   of	   re-­‐detachment.31-­‐33	   After	   scleral	   buckle	  removal,	  re-­‐detachment	  rates	  were	  as	  high	  as	  10-­‐25%.1,	  2,	  27,	  29,	  34A	   limitation	   of	   the	   present	   study	   was	   the	   retrospective	   design.	   During	   follow-­‐up,	   the	  patients	  were	  not	   asked	   explicitly	   whether	   they	  were	   experiencing	   diplopia.	   Thus,	   we	  assumed	  that	   patients	  would	  be	   referred	  back	   to	   our	   centre	   if	   they	  developed	  diplopia	  more	  than	  six	  months	  postoperatively,	   because	  we	  are	  the	  only	  referral	   centre	  for	   these	  complicated	   strabismus	   cases.	   This	   may	   have	   resulted	   in	   missed	   cases	   and	  underestimation	  of	  the	   incidence	  of	  diplopia.	   A	   second	   limitation	  of	   this	   study	  was	   that	  we	  did	  not	  exclude	  patients	  with	  poor	  visual	  acuity.	  Therefore,	   the	  incidence	  of	  diplopia	  may	   have	   been	   further	   underestimated.	   In	   the	   literature,	   the	   various	   studies	   on	   this	  subject	  are	  difgicult	  to	  compare,	  due	  to	  differences	  in	  surgical	  techniques.	  For	  example,	  in	  the	  present	  study,	  we	  used	  an	  encircling	  element	  and	  a	  segmental	  or	  radial	  buckle	  made	  of	  the	  same	  material	  (in	  all	  the	  cases)	  and	  we	  did	  not	  mobilize	  any	  of	  the	  muscles.	  On	  the	  basis	   of	   our	   analyses,	   we	   could	   not	   establish	   an	   exact	   cause	   for	   diplopia	   after	   retinal	  detachment	  surgery,	  which	  was	  in	  line	  with	  previous	  studies	  (Table	  5.3).
Treatment	  recommendations	  for	  postoperative	  diplopiaWe	  recommend	  that	  treatment	  should	  start	  with	  a	  conservative	  approach	  using	  prisms.	  If	  this	  does	  not	  yield	  the	  desired	  results,	   the	  buckle	  can	  be	  removed,	  or	  -­‐	  but	  only	  and	  as	  a	  last	   resort	  -­‐	  the	  buckle	  and	  the	  encircling	  element.	   Strabismus	   surgery	   is	   an	  alternative	  option.30	  Although	  operating	  on	  the	  healthy	  fellow	  eye	  is	  contradictory	  to	  the	  general	  rule	  of	  only	  operating	  on	  a	  visually	  impaired	  or	  compromised	  eye,	  perhaps	  the	  best	  result	  will	  be	  obtained	  by	  performing	  strabismus	   surgery	  on	  the	  fellow	  eye.	  The	  muscles	   of	  the	  SB	  surgery	   eye	  may	  have	  such	  extensive	  scarring	  and	   gibrosis	   that	   surgery	  on	  such	  eyes	   is	  much	  more	  difgicult	  and	  far	  less	  predictable.25	  A	  further	  consideration	  is	  that	  strabismus	  surgery	   may	  not	   be	   effective	   if	  the	   problem	   is	   truly	   restrictive;	   for	   example,	   release	   of	  conjunctival	  or	  muscle	  scarring	  may	  be	  the	  most	  effective	  means	  of	  curing	  the	  strabismus.	  Another	   form	   of	   treatment	   is	   botulinum	   injection	   into	   a	   horizontal	   or	   vertical	   ocular	  muscle.	   Scott35	   reported	   a	   success	   rate	   of	   60%	   and	   only	   three	   out	   of	   the	   20	   patients	  needed	  an	  additional	  injection.35	  In	  summary,	  2.7%	  of	  our	  1030	  patients	  had	  diplopia	  due	  to	  mechanical	  restriction	  of	  one	  of	   the	  muscles	   after	  SB	   surgery.3,	   4,	   14,	   16-­‐20	  No	   signigicant	  correlation	  was	  found	  between	  the	   position	   of	   the	   buckle	   or	   the	   type	   of	   buckle	   and	   the	   incidence	   of	   diplopia	   or	   the	  pattern	   of	   strabismus.	   A	   moderately	   signigicant	   association	   was	   found	   between	   the	  involvement	   of	   two	   muscles	   and	   a	  higher	   incidence	   of	   diplopia.	   However,	   this	   did	   not	  apply	   to	   the	  involvement	  of	  three	  or	  more	  muscles.	  Patients	  with	  minimal	  restriction	  of	  the	  muscles	  after	  SB	  surgery	  can	  often	  be	  treated	  successfully	  with	  prisms.
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Chapter 
Low re-detachment rate 
after vitrectomy with an 
encircling scleral buckle 
and silicone oil for giant 
retinal tears 




Background:	  The	  goal	  of	  this	  study	  was	  to	  assess	  the	  long-­‐term	  anatomical	  and	  functional	  results	   of	   pars	   plana	   vitrectomy	   (PPV)	  with	   or	   without	   an	  encircling	   scleral	   buckle	   in	  patients	  with	  giant	  retinal	  tear	  (GRT)	  retinal	  detachment.
Subjects	  and	  Methods:	  30	  eyes	  were	  analysed	  in	  retrospect	  following	  PPV	   for	  GRT	  retinal	  detachment	  between	  March	  1998	  and	  August	  2003.	  
Results:	  Re-­‐detachment	  occurred	   in	  nine	  out	   of	  the	  30	  eyes	   (30%)	  after	  one	  vitrectomy	  procedure.	   Ultimately,	   re-­‐attachment	   was	   achieved	   in	   29	   eyes	   (96.7%).	   Multivariate	  analysis	   showed	   that	   the	   absence	   of	   an	   encircling	   scleral	   buckle	   (P=0.008)	   was	  signigicantly	  associated	  with	  re-­‐detachment.	  Visual	  acuity	  improved	  in	  54%	  of	  the	  eyes.
Conclusion:	  Placement	  of	  an	  encircling	  scleral	  buckle	  appears	  to	   be	  highly	  recommended	  in	  the	  treatment	  of	  GRT	  retinal	  detachment	  with	  PPV.
IntroductionA	  giant	  retinal	  tear	   (GRT)	  refers	   to	   a	  retinal	  tear	   that	  extends	   over	  three	  clock	  hours	   or	  more	  of	  the	  circumference.1	  Treatment	  of	  choice	   is	  pars	   plana	  vitrectomy	  (PPV)2-­‐8	  with	  repositioning	   of	   the	   inverted	   central	   retinal	   glap	   using	   pergluorocarbon	   liquids,9	  endolaser,4	   or	  cryocoagulation	  and	  silicone	  oil	   tamponade.5,	   6,	   10	   Some	  surgeons	  elect	   to	  use	   an	   additional	   encircling	   scleral	   buckle,	   or	   a	   scleral	   buckle	   over	   a	   portion	   of	   the	  circumference.	  The	  goal	  of	  this	  study	  was	  to	  identify	  risk	  factors	  related	  to	  re-­‐detachment	  and	   to	   assess	   the	   long-­‐term	   anatomical	   and	   functional	   results	   of	   PPV	   for	   GRT	   retinal	  detachment.
Material and methodsA	   retrospective	   study	  was	   performed	  on	   all	   the	  patients	  with	   GRT	   retinal	   detachment	  who	  underwent	  vitrectomy	  (surgeons:	  FH,	   ELH	  or	  AL)	  at	  our	  clinic	  between	  March	  1998	  and	  August	  2003.	  The	  following	  preoperative	  clinical	  patient	  data	  were	  collected	  for	  statistical	  analysis:	  age,	  gender,	   preoperative	   trauma,	   size	   of	   the	   GRT	   in	   clock	   hours,	   number	   of	   detached	  quadrants	   of	   the	   retina,	   central	   macular	   (foveal	   region)	   involvement	   (yes/no)	   and	  presence	   and	   grade	   of	   proliferative	   vitreoretinopathy	   (PVR).	   Preoperative	   and	  postoperative	   best	   corrected	   Snellen	   visual	   acuity	   (also	   with	   pinhole	   correction)	   was	  measured.	   The	   following	  preoperative	  slit-­‐lamp	  examination	  variables	  were	  noted:	   lens	  status	  and	  phakia,	   pseudophakia	   or	  aphakia.	   Funduscopy	  was	   performed	  using	   indirect	  binocular	   ophthalmoscopy	  with	  a	   Goldmann	   three-­‐mirror	  contact	   lens	   (without	   scleral	  depression)	   and	   a	   panfundus	   contact	   lens	   (Supersquad	   160°).	   Fundus	   drawings	   were	  made	  of	  the	  retinal	  detachment	  (RD)	  in	  clock	  hours.	  By	  carefully	  questioning	  the	  patients,	  we	  determined	  the	  approximate	  time	  of	  onset	  of	  the	  detachment	  (visual	  gield	  loss).	  During	   follow-­‐up,	   we	   noted	   whether	   re-­‐detachment	   occurred,	   the	   interval	   until	   re-­‐detachment	   and	   any	   subsequent	   surgical	   procedures.	   In	   addition,	   we	   noted	   whether	  lensectomy	  or	   phaco-­‐emulsifaction	  was	   performed.	   Anatomical	   success	  was	   degined	   as	  complete	   attachment	   of	   the	   retina.	   PVR	   was	   graded	   according	   to	   the	   Retina	   Society	  Classigication	  of	  1983.11The	   following	   data	   were	   collected	   regarding	   the	   PPV	   procedure:	   placement	   of	   an	  encircling	  scleral	  buckle	  (yes/no),	   gas	  or	  oil	  tamponade	  (yes/no),	   endolaser	  coagulation	  (yes/no)	  and	  cryocoagulation	  (yes/no).	  Our	  vitrectomy	  technique	  with	  silicone	  oil	  or	  gas	  tamponade	   comprised:	   standard	   three-­‐port	   vitrectomy	   with	   a	   trocar	   microcannular	  system	  (Grieshaber	  &	  Co,	  AG,	   Schafghausen,	  Switzerland)	  using	  a	  non-­‐contact	  wide	  angle	  panoramic	  viewing	  system	  (BIOM,	   Carl	  Zeiss,	  Meditec,	   Jena,	  Germany).	  As	  much	  vitreous	  as	  possible	  was	  removed,	  with	  shaving	  of	  the	  vitreous	  base	  as	  described	  previously.12,	  13	  All	   the	  operations	  were	  conducted	  with	  pergluorocarbon	  liquid	  (DK-­‐line,	   Chauvin	  Opsia,	  France)	   to	   cover	   the	   ora	   serrata	   and	   glatten	   the	   retina.	   Endolaser	   coagulation	   or	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cryocoagulation	  was	  performed	  around	  the	  tears	  to	   re-­‐attach	  the	  basal	  retina.	  At	  the	  end	  of	   the	   procedure,	   the	   pergluorcarbon	   liquid	   was	   exchanged	   for	   silicone	   oil	   (1000	  centistokes)	  or	  gas	  (C3F8	  gas).	  The	  decision	  to	  use	  oil	  or	  gas	  was	  made	  during	  vitrectomy,	  but	  mostly	  depended	  on	  the	  underlying	  PVR.	  If	  necessary	  and	  according	  to	  the	  surgeon’s	  preference,	   an	   encircling	   scleral	   buckle	   was	   placed	   before	   vitrectomy.	   We	   used	   an	  encircling	  narrow	  element	  (Mira	  Inc.,	   scleral	  buckle	  component,	  reference	  number	  240).	  Our	   silicone	   oil	   removal	   technique	   was	   through	   two	   pars	   plana	   sclerotomies.	   When	  additional	  procedures	  were	  necessary,	   such	  as	  endolaser	  photocoagulation,	   lensectomy,	  removal	  of	  epiretinal	  membranes,	  or	  removal	  of	  ischaemic	  edges	  of	  former	  retinectomies,	  three-­‐port	  vitrectomy	  was	  applied.	  Statistical	   analysis	  was	   performed	  using	  the	   SPSS	   software	  15.0.	   Snellen	  visual	  acuities	  were	  converted	  to	  a	  logarithmic	  scale	  (LogMAR,	  i.e.	  the	  logarithm	  of	  the	  minimal	  angle	  of	  resolution).14	   Comparisons	   were	   made	  between	  preoperative	   and	  postoperative	   visual	  acuities	   using	   the	   paired	   sample	   T-­‐test.	   Univariate	   analysis	   was	   performed	   with	   the	  Pearson	  Chi-­‐square	  exact	   test	   to	   determine	  whether	   the	  preoperative	  clinical	   variables	  were	   associated	   with	   postoperative	   re-­‐detachment.	   Stepwise	   forward	   conditional	  multiple	   logistic	   regression	   analysis	   was	   used	  on	   the	   preoperative	   and	   intraoperative	  variables	   to	   identify	   the	   strongest	   predictors	   of	   re-­‐detachment.	   Kaplan	  Meyer	   survival	  analysis	  was	  also	  included.	  
Results A	  total	  of	  30	  eyes	  (19	  right	  eyes	  (63.3%)	  and	  11	  left	  eyes	  (36.7%);	  26	  men	  and	  4	  women,	  86.7%	  vs	   13.3%)	  in	  28	  patients	  were	   included	  in	  this	   study	  (Table	  6.1).	   Mean	  age	  was	  53.2	  years	  (range	  30-­‐70	  years).	  Mean	  follow-­‐up	  was	  49	  months	  (range	  13-­‐101	  months)	  (Table	   6.2).	  There	  were	  23	  phakic	  eyes	  (76.7%),	   six	  pseudophakic	   eyes	   (20%)	  and	  one	  aphakic	  eye	  (3.3%).	   In	  19	  out	  of	  the	  30	  eyes	  (63.3%)	  the	  macula	  was	  detached,	  while	  in	  11	  eyes	  (36.7%)	  the	  macula	  was	  attached.	   Preoperative	  PVR	  grade	  A	  was	   present	  in	  19	  out	   of	   the	   30	   eyes	   (63.3%)	   versus	   grade	   B	   in	   11	   eyes	   (36.7%).	   Dense	   vitreous	  haemorrhage	  was	  found	  in	  six	  eyes	  (20%);	  four	  eyes	  (13.3%)	  had	  suffered	  preoperative	  trauma.	  Mean	  size	  of	  the	  GRTs	  was	  3.75	  clock	  hours	  (range	  3-­‐6	  clock	  hours).	   In	  20	  out	  of	  the	  29	  eyes	  (69%)	  visual	  gield	  scotoma	  was	  present	  for	  10	  days	  or	  less,	  while	  in	  nine	  eyes	  (31%)	   visual	   gield	   scotoma	   existed	   for	   longer	   than	   11	   days.	   During	   vitrectomy,	   an	  encircling	  scleral	  buckle	  was	  placed	  in	  21	  eyes	  (70%);	  29	  eyes	  (96.6%)	  received	  silicone	  oil	   tamponade	   and	   one	   eye	   (3.4%)	   received	   C3F8	   gas	   tamponade.	   Lensectomy	   was	  performed	  on	  two	  eyes	  during	  primary	  vitrectomy.	  All	  the	  retinas	  were	  attached	  after	  the	  girst	  operation.	  Anatomical	  success	  was	  achieved	  in	  21	  out	  of	  the	  30	  eyes	  (70%)	  after	  one	  vitrectomy	  procedure.	  Ultimately,	  the	  retina	  was	  attached	  in	  29	  (96.7%)	  eyes.	  At	  the	  end	  of	   follow-­‐up,	   silicone	  oil	   had	  been	  removed	   from	  all	   the	  eyes	   except	  one	   (follow-­‐up:	   80	  months)	   (Table	   6.1).	   Although	   the	   retina	   was	   attached	   in	   this	   case,	   corneal	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decompensation	  was	  present.	  Therefore,	  the	  patient	  and	  surgeon	  agreed	  not	  to	  undertake	  any	  further	  operations	  because	  of	  the	  poor	  prognosis.Re-­‐detachment	   occurred	   in	   nine	   eyes	   after	   PPV.	   All	   nine	   eyes	   underwent	   subsequent	  vitreoretinal	   procedures	   to	   re-­‐attach	  the	   retina.	   Mean	   interval	   until	   re-­‐detachment	  was	  24.7	  weeks	   (range	  4-­‐64	  weeks,	  median	  11	  weeks).	   In	  give	  eyes,	   re-­‐detachment	  occurred	  within	  three	  months;	   another	  eye	  re-­‐detached	  in	  the	   following	   three	  months	  and	   three	  more	  eyes	  re-­‐detached	  one	  year	  after	  PPV.Univariate	  analysis	  showed	  that	  an	  age	  of	  older	  than	  60	  years	  (P=0.030),	  the	  absence	  of	  an	   encircling	   scleral	   buckle	   (P=0.008)	   and	   pseudophakia	   (P=0.049)	   were	   signigicantly	  associated	   with	   re-­‐detachment	   (Table	   6.3).	   Multivariate	   analysis	   revealed	   that	   the	  absence	   of	   an	   encircling	   scleral	   buckle	   (P=0.008)	  was	   signigicantly	   associated	   with	   re-­‐detachment.	   Figure	  6.1	   shows	   a	   Kaplan	  Meyer	   survival	  plot	   of	   retinal	   attachment	   after	  PPV	  with	  and	  without	  an	  encircling	  scleral	  buckle	  (P=0.004).	  Six	  out	  of	  the	  nine	  eyes	  that	  re-­‐detached	  did	  not	  have	  an	  encircling	  scleral	  buckle,	  versus	  three	  out	  of	  the	  21	  eyes	  that	  did	  have	  an	  encircling	  scleral	  buckle.
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Figure	  6.1:	  Kaplan	  Meyer	  cumulative	   survival	  curve	   of	   retinal	  attachment	  in	  patients	  with	  or	  without	  an	  encircling	  scleral	  buckleDifference	  between	  groups	  was	  signigicant	  (P=0.004)	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Table	  6.1:	  Patient	  characteristics























1 male 64 OD phakic 3 off A yes yes yes no 47 yes no psphakic
2 male 67 OD phakic 3 off A no no no yes 101 yes no psphakic
3 male 53 OS phakic 6 on A no no yes no 96 yes no psphakic
4 female 62 OD psphakic 3 off B no no no yes 80 yes yes aphakic
5 male 50 OS phakic 5 off A yes no no yes 24 yes no aphakic
6 male 65 OD psphakic 3 on A no no yes yes 50 yes no psphakic
7 male 70 OS psphakic 3 off B yes no yes yes 18 yes no psphakic
8 male 56 OD phakic 3 on B no no yes no 80 yes no psphakic
9 male 47 OS psphakic 4 on B no no yes no 90 yes no psphakic
10 male 41 OD phakic 3 off A no no yes no 19 yes no psphakic
11 male 33 OS phakic 5 off A no yes yes no 25 yes no psphakic
12 male 52 OD psphakic 4 off B no no yes no 72 yes no psphakic
13 male 47 OD aphakic 3 off B no no yes no 82 yes no psphakic
14 male 49 OS phakic 4 off A no no yes no 48 yes no psphakic
15 male 59 OD phakic 4.5 off A yes no no yes 62 yes no psphakic
16 male 46 OS phakic 3 on A no yes yes no 13 yes no psphakic
17 male 47 OD phakic 6 on A no no yes no 70 yes no psphakic
18 male 42 OD psphakic 3 on A no no yes yes 76 no no psphakic
19 male 46 OS phakic 3 off A yes yes yes no 59 yes no psphakic
20 female 30 OS phakic 6 off b no no no no 63 yes no psphakic
21 male 66 OD phakic 3 off A no no no yes 24 yes no psphakic
22 male 68 OD phakic 3 on A no no no no 24 yes no psphakic
23 male 42 OD phakic 4 off B no no yes no 57 yes no psphakic
24 female 63 OD phakic 3 off B no no no yes 24 yes no psphakic
25 male 70 OD phakic 3 off B no no yes no 16 yes no psphakic
26 male 67 OS phakic 3 off A no no yes no 36 yes no psphakic
27 male 49 OS phakic 6 on A no no yes no 40 yes no psphakic
28 female 53 OD phakic 3 on A yes no yes no 29 yes no psphakic
29 male 51 OD phakic 4 on B no no yes no 26 yes no psphakic
30 male 42 OD phakic 3 off A no no no no 20 yes no psphakicPt:	  patient,	   PVR:	  proliferative	  vitreoretinopathy,	  CVH:	  corpus	   vitreous	  haemorrhage,	  GRT:	  giant	   retinal	  tear,	  PPV:	  pars	  plana	  vitrectomy,	  F-­‐U:	  follow-­‐up,	  EF-­‐U:	  end	  follow-­‐up,	  mnths:	  months,	  SO:	  silicone	  oil,	  psphakic:	  pseudophakic
Postoperative	   visual	   acuity	   (VA)	   was	  signigicantly	   better	   than	   preoperative	   VA	  (paired	  sample	  T-­‐test:	   P=0.028).	   At	  the	  end	  of	   follow-­‐up,	   13	  eyes	   (43.3%)	   had	   a	   VA	   of	  0.1	   or	   less	   (Figure	   6.2).	   Multivariate	  analysis	  did	  not	  identify	  any	  risk	  factors	  for	  poor	   visual	   outcome.	   Improvement	   of	   at	  least	   two	   Snellen	  lines	  was	  seen	  in	  11	  eyes	  (36.7%),	  while	  improvement	  of	  at	  least	  one	  Snellen	   line	   was	   seen	   in	   16	   eyes	   (53.4%).	  VA	   did	   not	   change	   in	   two	   eyes	   (6.7%).	  Deterioration	  of	   two	   Snellen	   lines	   or	  more	  was	   seen	   in	   nine	   eyes	   (30%).	   This	  deterioration	  was	   due	   to	   an	   epiretinal	   membrane	   of	   the	  macula	   with	  cystoid	  macular	  oedema	   in	   three	   eyes	   (33.3%).	   One	   patient	   developed	   postoperative	   endophthalmitis	  after	  PPV	  and	  silicone	  oil	   injection;	  visual	  acuity	  was	  0.1	  after	  silicone	  oil	  removal	  (SOR).	  Another	   patient	   with	   uncontrollably	   high	   intraocular	   pressure	   received	   a	   Baerveldt	  implant;	   one	   patient	   had	   corneal	   decompensation	   and	   three	   other	   patients	   showed	  deterioration	  of	  more	  than	  two	  lines	  without	  any	  obvious	  clinical	  cause.At	   the	   end	   of	   follow-­‐up,	   28	   (93.3%)	   eyes	   were	   pseudophakic	   and	   two	   (6.7%)	   were	  aphakic.	   Seven	   (23.3%)	   eyes	   had	   combined	   SOR	   and	   phaco-­‐emulsigication	   with	  intraocular	  lens	  (IOL)	  implantation;	  14	  eyes	  (46.7%)	  underwent	  phaco-­‐emulsifation	  with	  IOL	  implantation	  after	  SOR.	  Another	  two	   eyes	  (6.7%)	  were	  aphakic	  at	  the	  end	  of	  follow-­‐up:	  one	  due	  to	  lensectomy	  during	  primary	  PPV	  and	  one	  due	  to	  removal	  of	  the	  IOL	  during	  a	  second	  PPV	  procedure.	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Table	  6.2:	  Follow-­‐up	  of	  30	  eyes	  with	  giant	  retinal	  tear	  retinal	  detachment	  
	   	   Eyes















VA	  in	  Snellen	  lines
preoperativeultimate
Figure	  6.2:	  Preoperative	  and	  ultimate	  visual	  acuity	  (VA)	  in	  Snellen	  lines
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Table	  6.3:	  Univariate	  and	  multivariate	  analysis	  on	  clinical	  variables






n=30 n=9 30.0% P	  value P	  value
Gender
Male 26 7 26.9% NS NS
Female 4 2 50%
Age	  (yrs)
<	  60 20 3 15%
≥	  60 10 6 60% P=0.030 NS
Duration	  of	  visual	  !ield	  loss
0-­‐10	  days 20 6 30% NS NS
>	  11	  days 9 3 30%
Preoperative	  visual	  acuity	  
(Snellen)
≤	  0.1 15 6 40% NS NS
>	  0.1 15 3 20%
Macular	  status
Macular	  involvement 19 7 36.8% NS NS
Macula	  not	  involved 11 2 18.2%
Size	  of	  GRT	  in	  clock	  hours
   3	  clock	  hours 18 7 38.9% NS NS
>	  3	  clock	  hours 12 2 16.7%
Pseudophakic	  eye
yes 6 4 66.7% P=0.049 NS
no 24 5 20.8%
PVR
A 19 6 31.6% NS NS
B 11 3 27.3%
Vitreous	  haemorrhage
Yes 6 3 50% NS NS
No 24 6 25%
Trauma
Yes 4 0 0% NS NS
No 26 9 34.6%
Encircling	  scleral	  buckle
present
Yes 21 3 14.3%
No 9 6 66.7% P=0.008 P=0.008
Primary	  lensectomy
Yes 2 1 50% NS NS
No 28 8 28.6%NS:	  not	  signigicant,	  GRT:	  giant	  retinal	  tear,	  PVR:	  proliferative	  vitreoretinopathy,	  yrs:	  years
Discussion Many	   techniques	   have	   been	  described	   for	   the	   management	   of	  a	  GRT.1-­‐10,	   12,	   15-­‐36	   In	   the	  present	  study,	  we	  found	  that	  the	  absence	  of	  an	  encircling	  scleral	  buckle	  was	  signigicantly	  associated	   with	   re-­‐detachment,	   which	   supported	   the	   results	   of	   the	   study	   (n=34)	   by	  Verstraeten	  et	  al.34	   In	  the	  latter	  study,	   the	  re-­‐detachment	  rate	  in	  the	  eyes	  that	  received	  a	  scleral	   buckle	  was	  14%	  versus	  45%	  in	  the	  eyes	  without	  a	  scleral	   buckle.34	   In	  our	  series,	  the	   re-­‐detachment	   rate	   in	   the	   encircling	   scleral	   buckle	   group	   was	   comparable	   with	  Verstraeten	  et	  al34	  (Figure	  6.1)	  and	  also	  comparable	  with	  other	  studies	  in	  which	  a	  scleral	  buckle	   was	   used	   (Table	   6.4).27,	   31,	   34	   However,	   we	   did	   not	   exclude	   patients	   with	  proliferative	   vitreoretinopathy	   (PVR)	   or	   traumatic	   GRT,	   which	   contrasts	   with	   various	  other	  studies	  and	  makes	  comparison	  difgicult.	  In	  agreement	  with	  the	  literature,	   the	  present	   study	  strongly	  indicated	  that	   the	  use	  of	  an	  encircling	  scleral	  buckle	  combined	  with	  PPV	   and	  gas	  or	  silicone	  oil	  tamponade,	   reduced	  the	  rate	  of	  re-­‐detachment.	  In	  their	  GRT	  patients	  who	  did	  not	  receive	  an	  encircling	  scleral	  buckle,	  Rofail	   et	  al15	   found	  a	  low	  percentage	  of	  re-­‐detachment	  after	  PPV,	  possibly	  due	  to	  the	   small	   number	   of	   patients	   with	   (only	  mild)	   PVR	   in	   their	   series.	   It	   is	   likely	   that	   the	  presence	  of	  some	  degree	  of	  PVR	  in	  most	  of	  our	  cases	  skewed	  the	  results	  towards	  greater	  success	  by	  adding	  an	  encircling	  scleral	  buckle.Other	   authors	   have	   suggested	   that	   an	   encircling	   scleral	   buckle	   reduces	   traction	   on	   the	  remaining	  vitreous	  and	  exerts	  more	  pressure	  on	  the	  retina	  when	  silicone	  oil	  tamponade	  is	   used.37,	   38	   An	  argument	   in	  favour	  of	  using	  an	  encircling	  narrow	   tyre	  is	   that	   if	  local	  re-­‐detachment	   occurs	   in	   the	   “intact”	   retina,	   which	  is	   often	   the	   case,	   the	   360 	˚   buckle	  may	  prevent	  any	  further	  detachment.	  If	  a	  wider	  tyre	  is	  used	  for	  a	  portion	  of	  the	  circumference,	  it	   can	  be	  placed	  over	  the	  GRT,	   or	  alternatively,	   over	  the	   “intact”	  retina,	   as	  was	   done	  by	  Aylward	  et	  al36	  in	  more	  than	  half	  of	  their	  patients.	  In	  the	  present	   series,	   the	  re-­‐detachment	   rate	   after	  one	  vitrectomy	   procedure	  was	  30%.	  Ultimately,	   the	   retina	  was	  attached	   in	  98%	  of	  the	  eyes.	  Over	  the	  past	  10	  years,	   primary	  anatomical	  success	  rates	  in	  eyes	  treated	  for	  GRT	  varied	  between	  50%	  and	  94%.1,	   3-­‐5,	  15,	   24,	  32,	   34	   Ultimate	   success	   rates	   were	   approximately	   95%	   in	   most	   studies.1,	   3,	   4,	   15,	   24,	   32	  Anatomical	  success	  rates	  depended	  on	  the	  surgical	  technique,	  the	   inclusion	  or	  exclusion	  of	  eyes	  with	  traumatic	  GRT	  or	  PVR,	  the	  duration	  of	  follow-­‐up	  and	  whether	  the	  silicone	  oil	  was	  removed	  from	  the	  eye	  at	  the	  end	  of	  follow-­‐up.	  Although	  most	  authors	  reported	  their	  results	   after	   a	   maximum	   of	   six	   months	   follow-­‐up	   (Table	   6.4),	   mean	   follow-­‐up	   in	   the	  present	  series	  was	  four	  years	  and	  all	   of	  our	  patients	  had	  a	  follow-­‐up	  of	  at	   least	  one	  year	  (Table	  6.2).	  We	  found	  that	  after	  one	  year,	   another	  three	  re-­‐detachments	  occurred,	  which	  was	  almost	  one	  third	  of	  the	  total	  number	  of	  recurrences.	  At	  the	  end	  of	  follow-­‐up,	  the	  silicone	  oil	  had	  been	  removed	  from	  all	  the	  eyes	  except	  one.	  In	  other	  studies,	  the	  percentage	  of	  eyes	  that	  still	  held	  the	  silicone	  oil	  at	  the	  end	  of	  follow-­‐up	  was	  much	  higher	   (Table	  6.4).5,	   24,	   32	   For	   example,	   Scott	  et	  al32	  performed	  a	   larger	  study	  (n=212)	  and	  reported	  that	  the	  silicone	  oil	  tamponade	  was	  present	  in	  41%	  of	  their	  series	  at	   the	   end	   of	   follow-­‐up	   (Table	   6.4).	   They	   also	   mentioned	   many	   risk	   factors	   for	   re-­‐
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detachment,	  including	  female	  gender,	  younger	  age,	  PVR,	  prior	  PPV,	  larger	  size	  of	  the	  giant	  retinal	  tear,	  absence	  of	  an	  encircling	  scleral	  buckle	  and	  relaxing	  retinotomy.32	  Our	  series	  only	  congirmed	  the	  association	  with	  an	  encircling	  scleral	  buckle.	  However,	  it	  is	  difgicult	  to	  compare	   the	   results,	   because	   although	   Scott	   et	   al	   studied	   a	   larger	   series	   of	  eyes,	   their	  follow-­‐up	  period	  was	   short	   and	   a	   high	  percentage	  of	  the	   eyes	   retained	  the	   silicone	   oil	  (Table	  6.4).	  In	  the	  present	  study,	  43%	  of	  the	  eyes	  had	  postoperative	  VA	  of	  ≤	  0.1.	  Karel	  et	  al24	  followed	  the	   patients	   for	   a	   longer	   period	   and	   found	   that	   VA	   was	   ≤	   0.1	   in	   70%	   (Table	   6.4).	  Postoperative	  VA	   was	   better	   than	  0.1	   in	   57%	  of	   our	   patients,	   while	  60%	  had	  equal	   or	  better	   postoperative	   VA	   than	   preoperatively,	   which	   was	   comparable	   with	   the	   results	  reported	  previously	  by	  other	  authors.32	  PPV	   in	   combination	  with	   primary	   lensectomy,	   as	   described	   by	   Kreiger	   &	   Lewis25	   and	  Aylward	   et	   al,36	   is	   advocated	   to	   provide	   better	   access	   to	   the	   vitreous	   base	   and	   the	  extreme	  periphery	   of	   the	   retina.25,	   36	   Without	   lensectomy,	   it	   can	  be	   fairly	   awkward	   to	  reach	   the	  vitreous	   base,25,	   36	   but	   an	  encircling	  scleral	   buckle	  or	   indentation	  makes	   this	  less	   difgicult.	   Primary	  lensectomy	  may	  be	  a	   traumatic	   event	  associated	  with	  endothelial	  cell	   loss.	   Earlier	  studies	  have	  shown	  that	  visual	  outcome	  was	  poor	  in	  aphakic	  eyes	   after	  surgery	   for	  complicated	  RD.39,	  40	  We	  performed	  primary	  lensectomy	   in	  a	  minority	  of	  the	  eyes.	  In	   conclusion,	   recurrent	   retinal	   detachment	   occurred	   in	   30%	   of	   our	   cases.	   Further	  surgical	  interventions	  led	  to	  an	  ultimate	  attachment	  rate	  of	  97%.	  The	  use	  of	  an	  encircling	  scleral	   buckle	  during	  vitrectomy	  with	  silicone	  oil	   tamponade	  was	   associated	  with	  a	  low	  re-­‐detachment	  rate	  in	  patients	  treated	  for	  GRT	  retinal	  detachment.
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Table	  6.4:	  Summary	  of	  the	  literature	  on	  patients	  treated	  for	  giant	  retinal	  tear


















Sirimaharaj	  et	  al3 2005 62 77.4% 93.5% 54.8%	  improvement 6.5%BSS67.7%SF617.4	  C3F88.1%	  SO
29%	  B	  &	  C 25.9% 21.3% 27.4% 24.5 8-­‐69 NN
Rofail	  et	  al	  15 2005 16 93.7% NN 68.8%	  improvement 100%	  PFO 18.8%	  mild 31.3%	  Mild 0% 0% 12 3-­‐40 6.3%Ambresin	  et	  al4 2003 18 88.8% 94.4% 50%	  improvement 94.4%SO5.6%	  gas 38.9%	  A44.4%B16.7%C 11.1% 27.2% 0% 28.6 4.5-­‐73 5.6%Scott	  et	  al32 2002 212 70% 79% 59%	  improvement 1%air7%	  SF657%	  C3F834%SO
NN 0% 34% 62% 3.8 NN 41%
Batman	  et	  al5 1999 47 NN 89.4% 48.9%	  ≥5/200 46.8%	  C3F853.2%	  SO 44.7%C55.3	  D 23.4% NN 0% NN 48-­‐60 36%Kertes	  et	  al1 1997 162 49.4% 90.7% 48.8% 9.9%	  vitr48.8%	  gas35.2%	  SO6.2%	  air
40.7%	  any	  PVR	  (32.1%	  C	  or	  D)
25.3% 37.8% 51.9%	  or	  62.5% 13.7 6-­‐48 NN
Karel	  et	  al24 1996 50 70% 78% 74%	  >0.02 96%	  SO4%	  gas 14%	  C3-­‐D3 38% 56% 98% 33 12-­‐96 56%Verstraeten	  et	  al34 1995 34 67% 88.3% 74%	  >20/80 100%	  gas 0%	  PVR 0% NN 41.2%	  SB NN 6-­‐60 NNBottoni	  et	  al7 1994 11 81.8% 100% 64%	  >	  20/40 100%PFD 100%	  PVR	  B 9% NN 100% 17.3 12-­‐21 9%Ie	  et	  al20 1994 25 88% 100% 72%	  >20/80 100%	  gas 0%	  PVR NN 69% 92% 12 6-­‐24 0%Millsap	  et	  al	  30 1993 50 74% 88% 52%	  >	  20/400	  48%	  improvement 16%	  Vitr52%	  SO	  43%	  gas 14%	  B4%	  C	  22%	  D 26% NN 40% 8.6 6 NNLeaver	  et	  al10 1993 39 NN 77% 51%>	  6/60 100%SO NN NN NN NN 120 120 28%Aylward	  et	  al36 1993 38 84.2% 89% Mean	  6/36	  65.7%>	  6/60 84%	  SO13%	  gas NN 100% 61% 58%	  ee	  61%	  se 12 12 29%Kreiger	  et	  al25 1992 11 91% 100% 73%	  improvement 45%	  SO	  55%	  gas 0%	  PVR 27% 83% 0% 13 7-­‐29 9%Mathis	  et	  al28 1992 24 96% 96% 37.5%	  >	  20/200 100%	  SO 16.6%	  C-­‐D 25% 71% 75% 11 6-­‐23 4%Glaser	  et	  al17 1991 10 90% 90% 80%	  improvement 100%	  gas 100%	  D 25% 100% 100% 8.7 6-­‐12 0%Chang	  et	  al9 1989 17 71% 94% 53%	  ≥20/60 94%	  gas6%	  SO 18%	  C-­‐D 18% NN NN 12 6-­‐20 6%PPV:	  pars	  plana	  vitrectomy,	  PVR:	  proliferative	  vitreoretinopathy,	  F-­‐UP:	  follow-­‐up,	  SO:	  silicone	  oil,	  EF-­‐UP:	  end	  follow-­‐up,	  BSS:balanced	  salt	  solution;	  SF6	  sulphurhexagluoride;	  C3F8:	  pergluoropropane,	  NN:not	  noted,	  PFO:	  pergluoro-­‐n-­‐octane,	  vitr:	  vitreon,	  SB:	  scleral	  buckling	  procedure,	  PFD:	  pergluorodecaline,	  ee:	  encircling	  element,	  se:	  segmental	  explant
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Chapter
Risk factors for 
re-detachment and 
deterioration in visual 
outcome after silicone oil 
removal from eyes treated 
for complicated retinal 
detachment 




Background:	  The	  goal	  of	  this	  study	  was	  to	  identify	  risk	   factors	  for	  re-­‐detachment	  and/or	  deterioration	   in	   visual	   outcome	   after	   silicone	   oil	   removal	   from	   eyes	   treated	   for	  complicated	  retinal	  detachment.	  
Subjects	   and	   Methods:	   An	   unselected	   series	   of	   287	   consecutive	   eyes	   that	   underwent	  silicone	  oil	  removal	  (SOR)	  between	  January	  1999	  and	  December	  2003	  were	  analysed	  in	  retrospect.	  
Results:	   Anatomical	   success	   after	   SOR	   was	   achieved	   in	   81%	   of	   the	   eyes.	   Overall	  anatomical	  success	  at	  the	  end	  of	  follow-­‐up	  was	  94%.	  Postoperatively,	  8%	  of	  the	  eyes	  had	  ocular	  hypertension,	  6%	  had	  hypotony	  and	  29%	  had	  keratopathy.	  After	  SOR,	  visual	  acuity	  improved	  by	  at	  least	   two	  Snellen	  lines	  in	  43%	  of	  the	  eyes.	  Multivariate	  analysis	  showed	  that	   male	   gender,	   preoperative	   rubeosis	   and	   proliferative	   diabetic	   retinopathy	   (PDR)	  were	   risk	   factors	   for	   re-­‐detachment.	   Furthermore,	   male	   gender,	   preoperative	   visual	  acuity	  of	  <0.1	  Snellen	  lines,	  PDR,	  three	  additional	  operations,	  retinectomy	  (irrespective	  of	  size)	  and	  hypotony	  were	  found	  to	  be	  associated	  with	  poor	  visual	  outcome	  (<0.1	  Snellen	  lines).
Conclusions:	  Retinal	  detachment	  after	  SOR	  occurred	  in	  approximately	  20%	  of	  the	  eyes	  in	  this	  unselected	  series,	  which	  was	  comparable	  with	  the	  rates	  in	  the	  Silicone	  Study	  Reports	  published	   approximately	   20	   years	   ago.	   However,	   in	   the	   previous	   studies,	   preoperative	  patient	   selection	  was	  made	  and	  SOR	  was	  performed	  on	   less	   than	  50%	  of	  the	   eyes	  with	  silicone	   oil	   tamponade.	   Our	   higher	   overall	   anatomical	   success	   may	   have	   been	   due	   to	  improved	  vitreoretinal	  surgical	  techniques.	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IntroductionSilicone	   oil	   is	   a	   commonly	   used	   tamponade	   agent	   in	   the	   surgical	   management	   of	  complicated	  retinal	  detachment	   (RD).	   The	   tamponade	   is	   often	   temporary,	   owing	   to	   the	  risk	   of	   complications.	   These	   include	   cataract,	   glaucoma,	   keratopathy	   and	   oil	  emulsigication.1-­‐9	   In	   the	   literature,	   visual	   outcome,	   recurrent	   RD	   and	   the	   incidence	   of	  these	  complications	  varies	  considerably.1-­‐3,	   6-­‐8,	   10-­‐13	  One	  of	  the	  complications	  of	  silicone	  oil	  removal	   (SOR)	   is	   hypotony.4	   Furthermore,	   various	   preoperative	   and	   intraoperative	  factors	  have	  been	  reported	  as	  risk	  factors	  for	  recurrent	  RD,	  poor	  visual	  outcome	  and	  the	  development	   of	   complications.6,	   10-­‐12,	   14	   To	   identify	   which	   patients	   have	   the	   best	  anatomical	   and	   visual	   results	   after	   SOR,	   it	   is	   important	   to	   analyse	   preoperative,	  intraoperative	  and	  postoperative	  clinical	   variables.	  Therefore,	   the	  goal	  of	  this	   study	  was	  to	  analyse	  the	  data	  on	  a	  consecutive	  series	  of	  eyes	   that	  underwent	  SOR	  after	  surgery	  for	  complicated	   RD	   and	   to	   identify	   which	   clinical	   variables	   were	   associated	   with	   re-­‐detachment	  and/or	  deterioration	  in	  visual	  outcome.	  We	  also	  investigated	  which	  variables	  were	  associated	  with	  an	  increased	  risk	  of	  glaucoma,	  keratopathy	  and	  hypotony.
Subjects and methods The	   medical	   giles	   of	   all	   the	   patients	   who	   underwent	   SOR	   (n=287)	   at	   the	   University	  Medical	  Centre	  Maastricht	  between	  January	  1999	  and	  December	  2003	  were	  reviewed	  in	  retrospect.	  A	  total	  of	  287	  eyes	  were	  identigied	  in	  280	  patients:	  210	  eyes	  had	  proliferative	  vitreoretinopathy	   (PVR),	   27	  eyes	   had	   suffered	  trauma,	   26	  eyes	   had	  a	   giant	   retinal	   tear	  and	  13	   eyes	   had	   traction	   retinal	   detachment	   due	   to	   proliferative	   diabetic	   retinopathy	  (PDR).	  We	  excluded	  eyes	  with	  retinopathy	  due	  to	  prematurity	  and	  eyes	  with	  a	  follow-­‐up	  of	  less	  than	  3	  months.The	  following	  data	  were	  gathered	  from	  the	  medical	  giles:	  age,	  gender,	  duration	  of	  silicone	  oil	   tamponade,	   follow-­‐up	   duration,	   diagnosis	   and	   original	   indication	   for	   silicone	   oil	  injection,	   ocular	   history	   including	   all	   previous	   surgery,	   intraocular	   pressure,	   trauma	  (yes/no)	  and	  a	  history	  of	  systemic	  disease	  (yes/no).	  We	  also	  noted	  the	  preoperative	  and	  postoperative	   best	   corrected	   Snellen	   visual	   acuity	   and	  preoperative	   and	  postoperative	  Goldmann	  applanation	  tonometry.	  An	  inventory	  was	  made	  of	  all	  possible	  causes	  for	  poor	  postoperative	   visual	   acuity:	   macular	   degeneration,	   macular	   hole,	   cystoid	   macular	  oedema,	  abnormal	  intraocular	  pressure	  or	  optic	  atrophy.	  Slit-­‐lamp	  examination	  was	  used	  to	   record	  the	   following:	  keratopathy	   (yes/no),	   silicone	  oil	   in	  the	  anterior	  chamber	  (yes/no)	  and	  the	   amount	   of	  remaining	   oil,	   strong	   emulsigication	  of	   the	  silicone	   oil	   (yes/no),	  neovascularization	   of	   the	   iris	   (yes/no)	   and	   the	   status	   of	   the	   lens.	   Funduscopy	   was	  performed	   using	   indirect	   binocular	   ophthalmoscopy	   with	   a	   Goldmann	   three-­‐mirror	  contact	   lens	   and	   a	   panfundus	   contact	   lens	   (Supersquad	   160°).	   The	   following	  postoperative	  data	  were	  collected:	  the	  presence	  of	  an	  encircling	  band,	  the	  cumulative	  size	  of	   all	   retinectomies	   performed	   on	   that	   eye	   and	  whether	   or	   not	   there	  was	   stable,	   but	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persistent	   peripheral	   RD	   at	   the	   time	  of	   oil	   removal.	   PVR	   was	   graded	   according	   to	   the	  Retina	  Society	  Classigication	  of	  1983.15At	  our	  clinic,	  eyes	  with	  up	  to	  PVR	  grade	  C1	  were	  operated	  on	  using	  a	  conventional	  scleral	  buckling	  technique.6,	   16	   In	   the	  case	  of	  eyes	  with	  poor	   funduscopic	   view	  (e.g.	  with	  miosis	  and/or	  extensive	  vitreous	  haemorrhage),	  central	   and	  complex	  tears	  at	  various	  distances	  from	   the	   vitreous	   base,	   PVR	   grade	   C2	   and	   higher	   and	   trauma	   with	   PVR,	   we	   applied	  primary	  vitrectomy.	  All	   the	  operations	  were	  performed	  by	  one	  of	  three	   surgeons	  (ELH,	  FH	   or	   AL).	   Our	   vitrectomy	   technique	   with	   silicone	   oil	   tamponade	   comprised	   the	  following:	   standard	   three-­‐port	   vitrectomy	   with	   a	   trocar	   microcannular	   system	  (Grieshaber	   &	   Co,	   AG,	   Schafghausen,	   Switzerland)	   with	   a	   non-­‐contact	   wide-­‐angle	  panoramic	  viewing	  system	  (BIOM,	  Carl	  Zeiss,	  Meditec,	   Jena,	  Germany).	  The	  scleral	  buckle	  was	  always	   left	   in	  situ,	  whereas	  the	  silicone	  oil	  was	  removed	  as	   completely	  as	  possible,	  including	   shaving	   of	   the	   vitreous	   base.	   The	   retina	   was	   mobilized	   by	   excising	   all	   the	  epiretinal	  and	  subretinal	  membranes	  and	  strings,	  or	  by	  performing	  relaxing	  retinectomy	  as	  a	  last	  resort	  if	  the	  retina	  remained	  rigid.	  Lensectomy	  was	  only	  carried	  out	  in	  eyes	  with	  anterior	   PVR,	   as	   described	   in	   Silicone	   Study	   Report	   10,17	   to	   completely	   clean	   the	  peripheral	   retina	  and	  vitreous	  base.	  All	   the	  eyes	   in	  our	  series	   received	  pergluorocarbon	  liquid	  (DK-­‐line,	  Chauvin	  Opsia,	  France)	  which	  was	  later	  exchanged	  for	  silicone	  oil	   (1000	  centistokes).	   Re-­‐operations	   were	   performed	   until	   stable	   attachment	   of	   the	   retina	   was	  achieved,	   centrally	   to	   the	   encircling	   element.	   Partial	   peripheral	   retinal	   detachment,	   i.e.	  anterior	  to	  the	  encircling	  scleral	  buckle,	  was	  treated	  locally	  with	  argon	  laser	  conginement,	  as	   described	   previously,18	   until	   the	   situation	  was	   stable	   enough	   to	   enable	   silicone	   oil	  removal	  (SOR).SOR	  was	   indicated	  when	  a	  stable	  situation	  had	  been	  achieved	  with	  the	   retina	   attached	  posteriorly	   to	   the	   encircling	   scleral	   buckle,	   or	   if	   complications	   arose,	   such	   as	   ocular	  hypertension,	   keratopathy,	   or	   oil-­‐corneal	   touch,	   as	   described	   previously.6	   Our	   SOR	  technique	   took	   place	   through	   two	   corneoscleral	   incisions	   in	   the	   case	   of	   aphakia,	   or	  through	  two	  pars	  plana	  sclerotomies.	  When	  additional	  procedures	  were	  necessary,	  such	  as	   endolaser	   photocoagulation,	   lensectomy	   by	   phacofragmentation	   or	   phaco-­‐emulsigication,	  removal	  of	  epiretinal	  membranes	  or	  removal	  of	  ischaemic	  edges	  of	  former	  retinectomies,	  three-­‐port	  vitrectomy	  was	  performed.	  The	  deginition	  used	  for	  recurrent	  RD	  after	  SOR	   in	  the	  present	  study	  was	  either	  complete	  retinal	   re-­‐detachment,	   or	   local	   detachment.	   Anatomical	   success	   was	   degined	   as	  attachment	   of	  the	   retina	  between	  the	  photocoagulation	  barrier	   at	   the	  end	  of	  follow-­‐up.	  During	  follow-­‐up,	  all	  the	  patients	  were	  seen	  at	  regular	  intervals	  of	  three	  to	  four	  weeks.	  A	  clinically	  signigicant	   change	   in	  visual	  acuity	  was	   degined	  as	   at	   least	  two	   lines	  of	  Snellen	  acuity	  (e.g.	  a	  change	  from	  light	  perception	  to	  hand	  movements,	  or	  from	  ginger	  counting	  to	  0.1,	  or	  vice	  versa)	  since	  the	  previous	  follow-­‐up	  visit.	  We	   used	   the	   same	   deginitions	   for	   outcome	   and	   complications	   as	   those	   described	  previously.6	  However,	  in	  the	  case	  of	  glaucoma,	  we	  employed	  the	  following	  deginition	  from	  Silicone	  Study	  Report	  6:19	  an	  intraocular	  pressure	  of	  more	  than	  25	  mm	  Hg,	   or	  more	  than	  20	  mm	  Hg	  with	  antiglaucoma	  medication,19	  measured	  at	  any	  time	  during	  follow-­‐up.19	  This	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was	   because,	   in	   this	   retrospective	   study,	   incomplete	  data	  were	   available	   on	  visual	   gield	  defects	  and	  the	  presence	  of	  optic	  disc	   cupping.	  Owing	  to	  the	  fact	   that	  this	  deginition	  was	  more	  applicable	  to	  “ocular	  hypertension”	  (i.e.	  it	  does	  not	  take	  into	  account	  whether	  there	  are	  any	  related	  morphofunctional	  optic	  nerve	  changes),	  we	  replaced	  the	  word	  ”glaucoma”	  with	   “ocular	   hypertension”,	   but	   adhered	   to	   the	   original	   deginition	   in	   the	   previously	  mentioned	  Silicone	  Study	  Report	  6.19	  Hypotony	  was	  degined	  as	  an	  intraocular	  pressure	  of	  less	   than	  5	  mm	  Hg.19	   Keratopathy	  was	  degined	  as	  bullous	  or	   band-­‐shaped	  keratopathy,	  epithelial	   or	   stromal	   oedema,	   or	   localized	   opacities,	   in	   conformity	   with	   Silicone	   Study	  Report	  6.19Statistical	  analyses	  were	  performed	  with	  SPSS	  version	  12.0.	   Snellen	  visual	   acuities	  were	  converted	   to	   a	   logarithmic	   scale	   (LogMAR,	   i.e.	   the	   logarithm	   of	   the	   minimal	   angle	   of	  resolution),	   as	   described	   previously.20	   Comparisons	   between	   preoperative	   and	  postoperative	  visual	  acuities	  were	  made	  using	  the	  Wilcoxon	  signed	  rank	  test.	  Univariate	  analysis	   was	   performed	   with	   the	   Pearson	   Chi-­‐square	   exact	   test	   to	   determine	   which	  preoperative	   clinical	   variables	   were	   associated	   with	   postoperative	   re-­‐detachment,	  complications	   (such	   as	   ocular	   hypertension,	   or	   hypotony)	   and	   the	   visual	   outcome.	  Stepwise	   forward	   conditional	   multiple	   logistic	   regression	   analysis	   was	   used	   on	   the	  following	  preoperative	  variables	   to	   determine	  the	  strongest	  predictors	   of	  postoperative	  re-­‐detachment,	  complications	  and	  visual	  outcome:	  the	  probability	  of	  PDR,	  three	  or	  more	  operations	  on	  the	  same	  eye,	  PVR,	   trauma,	   previous	  retinectomy,	   giant	  retinal	   tear	  (GRT)	  and	  the	  presence	  of	  rubeosis.
Results
Whole	  study	  groupThe	   study	   included	   287	  eyes	   in	   280	  patients	   (199	  men	   (69%)	   and	   88	  women	   (31%);	  mean	  age	  56.6	  years	  (SD	  ±	  14.8)).	  Mean	  follow-­‐up	  in	  the	  287	  eyes	  was	  21.2	  months	  (SD	  ±	  16.6).	   Mean	  duration	  of	   silicone	   tamponade	  was	  10.0	  months	  (SD	   ±	  6.9)	  and	   the	  mean	  number	  of	  surgical	  procedures	  before	  SOR	  was	  1.2	  (SD	  ±	  0.5).The	  causes	  of	  complicated	  retinal	  detachment	  were	  PVR	  in	  210/287	  eyes	  (73%),	   trauma	  in	  27/287	  eyes	  (9%),	  giant	  tear	  in	  26/287	  eyes	  (9%)	  and	  traction	  retinal	  detachment	  due	  to	   PDR	   in	  13/287	   eyes	   (5%).	   Eleven	   eyes	   (4%)	   had	  complicated	  RD	   associated	  with	  a	  previous	   intraocular	   surgical	   procedure,	   such	  as	   vitrectomy	   for	   retained	  lens	   fragments	  or	  macular	  hole	  surgery.
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Anatomical	  successAnatomical	  success	  was	   achieved	  in	  233/287	  eyes	   (81%).	   After	  silicone	  oil	   removal,	   re-­‐detachment	   occurred	   in	   54/287	   eyes	   (19%).	   Data	   on	   the	   timing	   and	   cause	   of	   re-­‐detachment	  were	  available	  in	  38/54	  eyes.	  Re-­‐detachment	  occurred	  0	  to	  108	  weeks	  after	  SOR	  (Figure	  7.1),	  with	  a	  mean	  of	  14.3	  weeks	  (SD	  ±	  20.6).	  Within	  the	  girst	  3	  months	  after	  SOR,	   re-­‐detachment	  occurred	  in	  26/38	  eyes	  (68%);	   in	  21	  cases,	   re-­‐detachment	  was	   due	  to	   the	   re-­‐opening	   of	   old	   retinal	   tears,	   or	   the	   development	   of	   a	   new	   tear,	   because	   of	  membrane	   proliferation	   attributable	   to	   PVR.	  Within	   the	   girst	   6	   months,	   re-­‐detachment	  occurred	  in	  33/38	  eyes	   (87%).	   After	  one	  year,	   re-­‐detachment	  occurred	  in	  another	  3/38	  eyes	   (8%).	   At	   the	   end	   of	   follow-­‐up,	   give	   other	   eyes	   had	   re-­‐detachment	   due	   to	   the	   re-­‐opening	  of	  old	  retinal	  tears,	  or	  the	  development	  of	  new	  tears.	  After	  re-­‐detachment,	  21/38	  eyes	  (55%)	  underwent	  vitrectomy,	   once	  again	  with	  silicone	  oil	  tamponade.	  The	  silicone	  oil	  was	   subsequently	   removed	  from	  8/21	  eyes	   (38%),	   whereas	  13/21	  eyes	   (62%)	  still	  had	  oil	  tamponade	  in	  situ	  at	  the	  end	  of	  follow-­‐up.	   In	  17/38	  eyes	  (45%),	  the	  patient	  and/or	   the	  surgeon	  decided	  not	  to	   proceed	  with	  any	  further	  operations,	   because	  of	   the	  poor	  prognosis	   for	  the	   eye,	   or	   the	  poor	   physical	   condition	  of	  the	   patient.	   Three	  eyes	  needed	  enuclation	  because	  of	  intractable	  pain	  and	  function	  loss.	  Ultimate	  anatomical	  success	  was	  achieved	  in	  265/282	  eyes	  (94%)	  at	  the	  end	  of	  follow-­‐up.	  Table	   7.1	   shows	   the	   results	   of	   our	   univariate	   analysis	   on	   the	   association	   between	   re-­‐detachment	  and	  all	  the	  preoperative	  and	  postoperative	  variables	  at	  the	  end	  of	  follow	  up.	  Multivariate	   analysis	   revealed	   that	   only	   the	   variables	   male	   gender,	   the	   presence	   of	  rubeosis	   and	   PDR	   were	   signigicantly	   associated	   with	   recurrent	   retinal	   detachment	  (P=0.034,	  P=0.007	  and	  P=0.001,	  respectively).	  
Visual	  acuityPreoperative	  and	  postoperative	  visual	  acuity	  measurements	  in	  the	  whole	  group	  are	  listed	  in	  Table	  7.2.	  At	  3	  months	  and	  12	  months	  postoperatively,	   visual	   acuity	  was	  signigicantly	  better	  than	  preoperatively	  (P=0.022	  and	  P=0.005,	  respectively)	  (Figure	  7.2,	  Table	  7.2).	  An	   improvement	  of	  at	   least	  two	  Snellen	  lines	  was	  seen	  in	  128/277	  cases	  (45%)	  (Figure	  7.3).	   Deterioration	   of	   two	   Snellen	   lines	   or	   more	   was	   seen	   in	   19/277	   cases	   (7%).	   This	  deterioration	   was	   due	   to	   retinal	   detachment	   in	   15/18	   eyes	   (83%),	   corneal	  decompensation	   in	   6/19	  eyes	   (32%),	   keratopathy	   in	  9/19	  eyes	   (47%),	  maculopathy	   in	  4/19	  eyes	  (21%)	  and	  a	  pale	  optic	   disc	   or	  optic	   atrophy	   in	  5/19	  eyes	   (26%).	   Other	   less	  frequent	  causes	  of	  visual	  loss	  were	  cataract	  and	  gloaters.	  Although	  we	  performed	  cataract	  extraction	  in	  48	  eyes	  after	  SOR,	   four	  out	  of	  the	  48	  eyes	  still	  showed	  deterioration	  of	  two	  Snellen	  lines	  or	  more.	   In	  one	  of	  the	  give	  above-­‐mentioned	  patients	  with	  a	  pale	  optic	  disc,	  this	   may	   have	   been	   caused	   by	   glaucoma,	   because	   high	  ocular	   pressures	   were	  present	  preoperatively	   and	   postoperatively.	   However,	   in	   the	   remaining	   four	   cases,	   we	   did	   not	  encounter	  any	  documented	  intraocular	  pressure	  increase	  during	  follow-­‐up.
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Postoperative	   visual	   acuity	   data	   were	   available	   in	   158	   eyes	   at	   12	   months	   follow-­‐up.	  Almost	   60%	  of	   them	   had	  a	  visual	   acuity	  of	  ≥	  0.1	  Snellen	  lines	   (Table	   7.2).	  Multivariate	  analysis	   showed	   	   that	   the	   following	   variables	  were	  statistically	  signigicantly	   associated	  with	  poorer	   visual	   outcome	   (<0.1	  Snellen	   lines)	  at	   12	  months	   follow-­‐up:	   male	   gender	  (P=0.028),	   preoperative	   visual	   acuity	   of	   <0.1	   Snellen	   lines	   (P<0.001),	   PDR	   (P=0.001),	  three	   or	   more	   operations	   (P=0.018),	   retinectomy	   (irrespective	   of	   size)	   (P=0.006)	   and	  hypotony	  (P=0.023)	  (Table	  7.3).
Complications	  Postoperative	  keratopathy	  developed	   in	  82/287	  eyes	  (29%).	   In	  33	  of	   these	  eyes	   (40%)	  the	  ultimate	  outcome	  was	  corneal	  decompensation.	  A	  history	  of	  three	  or	  more	  operations	  on	  the	  same	  eye	  (P<0.001)	  and	  aphakia	  (P=0.001)	  were	  signigicantly	  associated	  with	  the	  development	  of	  keratopathy.Preoperative	  ocular	  hypertension	  was	  found	  in	  46/271	  eyes	  (17%).	  Postoperative	  ocular	  hypertension	  was	  present	  in	  23/271	  eyes	  (8.5%)	  (P<0.001);	  12	  of	  these	  23	  eyes	  had	  new	  onset	  ocular	  hypertension	  after	  SOR.	  Mean	  preoperative	  ocular	  pressure	  was	  17.5	  mmHg	  (SD	   ±	   8.4);	   mean	   postoperative	   ocular	   pressure	   was	   13.4	   mmHg	   (SD	   ±	   6.9).	   This	  difference	  was	   statistically	  signigicant	  (P<0.001).	   In	  31/271	  eyes	  (11%)	  we	  found	  a	  pale	  optic	   disc	   postoperatively,	   which	   was	   signigicantly	   associated	   with	   the	   presence	   of	  preoperative	   ocular	   hypertension	   (P<0.001)	   and	   the	   use	   of	   antiglaucoma	   medication	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Figure	   7.1:	   Cumulative	   percentage	   of	   patients	   (n=38)	   with	   retinal	   re-­‐detachment	  after	  silicone	  oil	  removal	  (SOR).
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Figure	  7.3:	   Visual	   acuity	   improvement	  noted	   in	  number	  of	   Snellen	  lines.	   Improvement	  of	   at	   least	  2	   lines	   (n=128),	   improvement	  of	   less	  than	   2	   lines	  (n=	   30),	   equal	   visual	   acuity	  (n=72),	   deterioration	   less	  than	  2	  lines	  (n=28),	  deterioration	  of	  at	  least	  2	  lines	  (n=19).
(P<0.001).	  There	  were	  no	  signigicant	  differences	  in	  the	  rates	  of	  all	  three	  above-­‐mentioned	  complications	  and	  the	  presence	  of	  PVR,	  PDR,	   trauma,	  or	   a	  GRT.	   In	  the	  patients	  who	  did	  not	   undergo	   retinectomy	   in	   the	  present	   study,	   we	   found	  a	   signigicant	   association	  with	  postoperative	  ocular	  hypertension	  (P=0.049).	  Hypotony	  was	  found	  in	  17/287	  eyes	  (6%).	  Univariate	  analysis	  showed	  that	  three	  or	  more	  operations	   on	   the	   same	   eye	   (P=0.020),	   RD	   at	   the	   end	   of	   follow-­‐up	   (P=0.011)	   and	  retinectomy	  (irrespective	  of	  size)	  (P=0.003)	  were	  signigicantly	  associated	  with	  hypotony.	  Only	   two	   out	   of	   the	   14	   patients	   with	   preoperative	   hypotony	   also	   had	   postoperative	  hypotony.	  According	  to	  our	  univariate	  and	  multivariate	  analysis,	   this	  was	  not	  statistically	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Table	  7.1:	  Univariate	  and	  multivariate	  analysis	  on	  clinical	  variables	  associated	  with	  re-­‐detachment




n=287 n=54 8.8% P	  value P	  value
Age
≤	  70	  years 234 43 18.4% NS NS
>	  70	  years	   53 11 20.8%
Gender
Male 199 31 15.6% P=0.048 P=0.034
Female	   88 23 26.1%
Preoperative	  visual	  acuity	  
(Snellen)
<	  0.1 187 40 21.5% P=0.054 NS
≥	  0.1 100 12 12.1%
Preoperative	  rubeosis
Yes 21 8 38.1% P=0.026 P=0.007
No	   266 46 17.3%
PDR	  pre	  SOR
Yes 13 7 53.8% P=0.004 P=0.001
No 274 47 17.2%
Operations
<	  3	   180 29 16.1% NS NS
≥	  3	   107 25 23.4%
No.	  of	  SOR
<	  3	   278 53 19.1% NS NS
≥	  3 9 1 11.1%
Tamponade
<	  6	  months 79 15 19.0% NS NS
≥	  6	  months 208 39 18.8%
SOR	  procedure
Pars	  plana 182 37 20.3% NS NS
Anterior	  chamber 105 17 16.2%
Encirling	  band	  present
Yes 214 36 16.8% NS NS
No 69 17 24.6%
Retinectomy
Yes 118 26 22.0% NS NS
No 169 28 16.6%SOR:	  silicone	  oil	  removal,	  PDR:	  proliferative	  diabetic	  retinopathy,	  NS:	  not	  significant
signigicant.	   Multivariate	  analysis	   showed	  that	   RD	  at	  the	  end	  of	  follow-­‐up	  (P=0.013)	  and	  retinectomy	  (irrespective	  of	  size)	  (P=0.012)	  were	  associated	  with	  hypotony.	  SOR	  was	   performed	  on	   18	   eyes	   (6%)	   because	  of	  elevated	   intraocular	   pressure	  and/or	  keratopathy.	   After	   SOR,	   six	   eyes	   (33%)	   had	   corneal	   decompensation,	   while	   two	   eyes	  (11%)	   had	   persistent	   ocular	   hypertension.	   In	   one	   of	   these	   two	   eyes,	   Baerveldt	  implantation	   was	   necessary	   to	   successfully	   lower	   the	   intraocular	   pressure.	   One	   eye	  developed	  phthisis	  bulbi	  and	  was	  enucleated.	  
DiscussionIn	  this	  study,	  retinal	  re-­‐detachment	  occurred	  in	  19%	  of	  the	  eyes	  after	  silicone	  oil	  removal	  (SOR).	   We	   did	  not	  make	   any	   prior	   selection	  in	   relation	   to	   SOR,	   which	  was	   contrary	   to	  Silicone	   Study	   Report	   6,19	   in	   which	   only	   45%	  of	   the	   eyes	   had	   SOR.	   They	   selected	   the	  better	   eyes,	   with	  better	   visual	   acuity,	   fewer	   previous	   surgical	   interventions	   and	   fewer	  complications.19	   Nowadays,	   we	   have	   more	   sophisticated	   equipment	   with	   improved	  surgical	   techniques,21	  such	  as	  wide-­‐angle	  viewing	  systems22	  and	  pergluorocarbon	  liquids	  (DK-­‐line).18,	   23-­‐25	   These	   developments	   have	   contributed	   to	   the	   overall	   improvement	   in	  vitreoretinal	   surgery	   outcome	   compared	   to	   20	   years	   ago	   when	   the	   Silicone	   Study	  Reports19	  were	  published.	  This	  was	  congirmed	  by	  the	  results	  of	  the	  present	  study.	  Overall	  anatomical	  success	  in	  our	  study	  was	  higher	  (94%)	  than	  that	  reported	  in	  Silicone	  Study	   Report	   6:	   81%.19	   Although	  we	   did	  not	  make	   any	   preoperative	   selection	  and	   our	  postoperative	   follow-­‐up	  was	   longer	   (mean	  follow-­‐up	  21.2	  months	   (SD	  ±	  16.6)	  versus	  6	  months	  total)	  our	  results	  in	  terms	  of	  re-­‐detachment	  (19%	  versus	  20%)	  and	  deterioration	  in	   visual	   acuity	   (16.4%	   versus	   15.5%)	  were	   comparable	   with	   those	   in	   Silicone	   Study	  Report	  6.19
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Snellen	  VA	  <0.1	  
n	  	  	  	  	  (	  %)
Snellen	  VA	  ≥0.1	  
n	  	  	  	  	  (	  %)




Preoperative	   n=285 186	  (65%) 99	  (35%) 0.040	  ±	  0.73
Postoperative:3	  mnths	  F-­‐U n=262 133	  (51%) 129	  (49%) 0.05	  ±	  0.85 P=0.0226	  mnths	  F-­‐U	   n=199 97	  (49%) 102	  (51%) 0.05	  ±	  0.94 NS12	  mnths	  F-­‐U n=158 65	  (41%) 93	  (59%) 0.06	  ±	  0.95 P=0.005VA:visual	  acuity,	  Sn:Snellen,	  F-­‐U:follow-­‐up,	  mnths:months,	  NS:not	  signigicant
In	  the	  present	  study,	  the	  mean	  duration	  until	  re-­‐detachment	  was	  14.3.	  weeks	  (SD	  ±	  20.6).	  Within	  the	  girst	  3	  months	  after	  SOR,	  26	  eyes	  (68%)	  had	  re-­‐detachment,	  which	  was	  mostly	  due	  to	  PVR.	  Within	  the	  girst	  six	  months,	  87%	  had	  re-­‐detachment.	  In	  8%	  of	  the	  eyes	  with	  recurrent	   RD,	   re-­‐detachment	   occurred	  more	  than	   one	   year	   after	  SOR.	   Our	   results	  were	  comparable	  with	  previous	   studies,	   which	   reported	  re-­‐detachment	   rates	   of	  between	  9%	  and	  25%	  after	  SOR.6-­‐8,	   10-­‐14,	  26-­‐28	  It	   is	   likely	  that	  the	  variation	  between	  studies	  can	  mainly	  be	   attributed	   to	   differences	   in	   the	   duration	   of	   follow-­‐up	   and	   preoperative	   patient	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Table	  7.3:	  Univariate	  and	  multivariate	  analysis	  on	  clinical	  variables	  associated	  with	  poorer	  visual	  acuity	  after	  SOR	  at	  12	  months	  follow-­‐up




n=158 n=93 58.9% P	  value P	  value
Preoperative
Age
≤	  70	  years 137 81 59.1% NS NS
>	  70	  years	   21 12 57.1%
Gender
Male 117 76 65.0% P=0.010 P=0.028
Female	   41 17 41.5%
Preoperative	  visual	  acuity	  
(snellen)
<	  0.1 101 46 45.6% P<0.001 P<0.001
≥	  0.1 57 47 82.5%
Preoperative	  rubeosis
Yes 144 98 68.1% P=0.022 NS
No	   14 4 28.6%
PDR	  pre	  SOR
Yes 9 1 11.1% P=0.004 P=0.001
No 149 92 61.7%
Operations
<	  3	   95 68 71.6% P<0.001 P=0.018
≥	  3	   63 25 39.7%
No.	  of	  SOR
<	  3	   156 91 58.3% P=0.028 NS
≥	  3 2 2 100%
SOR	  procedure
Pars	  plana 96 59 61.5% NS NS
Anterior	  segment 62 34 54.8%
Retinectomy
Yes 68 27 39.7% P<0.001 P=0.006
No 90 66 73.3%
Keratopathy
Yes 50 20 40.0% P=0.002 NS
No	   108 73 67.6%
Hypotony
Yes 10 1 10.0% P=0.002 P=0.023
No 148 92 62.2%
Re-­‐detachment
Yes 32 12 37.5% P=0.008 NS
No	   126 81 64.3%SOR:silicone	  oil	  removal,	  PDR:proliferative	  diabetic	  retinopathy,	  NS:not	  signigicant
selection.	   Most	   authors	   reported	   their	   results	   after	  a	  maximum	   follow-­‐up	  of	  6	  months,	  whereas	  in	  the	  present	  study,	  eyes	  were	  included	  with	  longer	  follow-­‐up.	  Independent	   predictors	   of	   recurrent	   RD	   were	  male	   gender,	   PDR	   and	   the	   presence	   of	  rubeosis.	  Other	  studies,	  such	  as	  Jiang	  et	  al,14	  did	  not	  mention	  preoperative	  rubeosis	  as	  a	  risk	   factor	  for	  re-­‐detachment,	  which	  may	  have	  been	  due	  to	   their	  smaller	  number	  of	  eyes	  (n=94).14	  Jonas	  et	  al10	  studied	  a	  larger	  series	  (n=221)	  and	  found	  the	  following	  risk	  factors	  for	  re-­‐detachment:	  several	  previously	  unsuccessful	  operations	  for	  RD,	  the	  surgeon,	  visual	  acuity	  before	  SOR,	   incomplete	  removal	  of	  the	  vitreous	  base,	   the	  absence	  of	  an	  encircling	  scleral	  band	  in	  eyes	  with	  PVR	  and	  the	  duration	  of	  silicone	  oil	  tamponade.10	  Other	  studies	  reported	  that	  a	  GRT	  (n=92,	  n=58)6,	  14	  age	  above	  70	  years	  (n=58)6	  and	  retinectomy	  of	  180°	  or	  more	  (n=58)6	  were	  signigicant	   for	  risk	  factors	   for	  recurrent	  RD.	  Our	  analyses	  (n=287)	  did	  not	  congirm	  these	  gindings.	  In	   the	   present	   study,	   visual	   acuity	   improved	   signigicantly	   after	   SOR:	   45%	   of	   the	   eyes	  improved	  by	   two	   or	  more	  Snellen	  lines,	  while	  36%	  had	  equal	  visual	  acuity	  or	  improved	  by	   one	   or	   more	   Snellen	   lines,	   which	   congirms	   previous	   studies.6,	   8,	   10,	   11,	   27,	   29	   Delayed	  natural	   recovery	  of	  the	   retina	  and	  additional	  procedures	   performed	  at	   the	  time	  of	  SOR,	  such	  as	  cataract	  extraction,	  may	  have	  contributed	  to	   the	  improvements	  in	  postoperative	  visual	   outcome.	   It	  also	   has	   to	   be	  kept	   in	  mind	   that	  preoperative	  and	  postoperative	  full	  refraction	   measurements	   were	   not	   performed	   or	   documented	   in	   all	   cases.	   Thus,	   the	  apparent	  improvements	  in	  visual	  acuity	  may	  be	  partly	  due	  to	  different	  standards	  of	  acuity	  measurement.An	   independent	   predicator	   of	   poor	   postoperative	   visual	   acuity	   (degined	   as	   <0.1	   at	   12	  months	  in	  our	  study)	  was	  poor	  preoperative	  visual	  acuity,	  which	  was	  also	  found	  by	  Jiang	  et	  al.14	  Another	  signigicant	  risk	  factor	  was	  PDR,	   as	  has	  been	  described	  by	  others.30	   In	  the	  present	  study,	  we	  found	  that	  a	  history	  of	  three	  or	  more	  operations	  on	  the	  same	  eye	  before	  SOR,	   retinectomy	   (irrespective	  of	   size)	  and	  hypotony	  were	   also	   signigicantly	  associated	  with	   poor	   visual	   outcome.	   Eckardt	   et	   al,28	   in	   contrast,	   did	   not	   gind	   any	   association	  between	  retinectomy	  size	  and	  visual	   outcome,28	  whereas	  Federman	  &	  Eagle8	  reported	  a	  signigicant	  association	  between	  extensive	  retinectomy	  of	  360°	  and	  poorer	  visual	  outcome.	  It	  might	  be	   argued	  that	   the	  poor	  visual	  outcome	  in	  these	   eyes	  was	   related	   to	   advanced	  underlying	  pathology,	  which	  often	  necessitated	  large-­‐scale	  retinectomy.In	  our	   study,	  19	  patients	  (7%)	  experienced	  unexpected	  deterioration	  in	  visual	   acuity	  of	  two	   or	   more	   Snellen	   lines	   after	   SOR.	   Newsom	   et	   al31	   described	   seven	   patients	   with	  unexplained	  visual	  loss	  after	  SOR.	  Visual	  loss	  in	  these	  patients	  was	  not	  associated	  with	  re-­‐detachment,	  macular	  oedema	  or	  epiretinal	  membrane	  formation,	  while	  optical	  coherence	  tomography	   (OCT)	   showed	   normal	   foveal	   anatomy.31	   Such	   unexplained	   sudden	   visual	  loss	  has	  also	  been	  reported	  by	  others.32,	  33	  One	  possible	  explanation	  is	  retinotoxity	  of	  the	  silicone	  oil.34	  Toxicity	  may	  also	  be	  the	  explanation	  for	  the	  optic	   atrophy	  found	  in	  four	  of	  our	  eyes	  with	  a	  pale	  optic	  disc	  without	  any	  documented	  intraocular	  pressure	  rise	  during	  follow-­‐up.	   Damage	   to	   the	   outer	   segment	   photoreceptors	   forms	   another	   feasible	  explanation,35,	   36	   because	   this	   has	   recently	   been	   observed	   with	   ultra-­‐high	   resolution	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(UHR)	  OCT	   after	   successful	   anatomical	   repair.	   Similar	   microstructural	   alterations	   have	  also	  been	  discovered	  in	  eyes	  without	  macular	  detachment.35,	  36	  Different	  criteria	  and	  deginitions	  have	  been	  used	  in	  the	  literature,	  which	  makes	  it	  difgicult	  to	   compare	  studies.	   Therefore,	  we	   used	  the	  same	  deginitions	   for	  complications	   as	   those	  formulated	  in	  Silicone	  Study	  Report	  6.19	  Keratopathy	  was	  found	  in	  29%	  of	  our	  cases.	   In	  other	  studies,	  this	  percentage	  varied	  between	  4.5%	  and	  100%,1,	   2,	  11,	  27,	  37	  which	  may	  have	  been	   due	   to	   contrasting	   deginitions.	   In	   the	   present	   study,	   a	   history	   of	   three	   or	   more	  operations	  on	  the	  same	  eye	  and	  aphakia	  were	  identigied	  as	  signigicant	  risk	  factors	  for	  the	  development	  of	  keratopathy,	  which	  congirms	  previous	  gindings.3,	  13	  We	  found	  signigicantly	  more	   keratopathy	   in	   association	   with	   aphakia	   and/or	   repeated	   surgery,	   including	  anterior	  segment	   procedures,	   in	  conformity	  with	  other	   studies.38-­‐41	   These	   two	   variables	  are	  known	  to	  be	  related	  to	  (cumulative)	  damage	  to	  corneal	  endothelial	  cells,41	  which	  may	  lead	  to	  the	  keratopathy.Hypotony	   is	   another	   frequent	  major	   complication.	   In	   our	   series,	   we	   found	  hypotony	   in	  6%	  of	  the	  cases,	  which	  was	   in	  agreement	  with	  other	  research.5,	   11,	   13,	   26	  Theories	  suggest	  that	  anterior	  PVR,	   traction	  and	  detachment	  of	  the	  ciliary	  body	  may	  result	   in	  diminished	  aqueous	  humor	  production.4,	  42-­‐44	  In	  a	  previous	  smaller	  study,	  we	  found	  that	  retinectomy	  of	  180°	  or	  more	  was	  a	  signigicant	  risk	  factor	  for	  hypotony.6	  However,	  in	  the	  present	  larger	  series,	   we	   found	   a	   signigicant	   association	   between	   hypotony	   and	   retinectomy,	  irrespective	  of	  the	  size.	  In	  contrast,	  Eckhard	  et	  al28	   found	  no	  relation	  between	  intraocular	  pressure	  and	  retinectomy	  size.The	  incidence	  of	  glaucoma	  varied	  depending	  on	  the	  deginition	  used	  in	  each	  study.	  Owing	  to	   our	   retrospective	   design,	   data	  on	   visual	   gield	   defects	   and	   the	   presence	   of	  optic	   disc	  cupping	  were	  incomplete.	   Therefore,	  we	  used	   the	  same	  deginition	   for	   glaucoma	  as	   that	  employed	   in	   Silicone	   Study	   Report	   6.19	   However,	   this	   deginition	   does	   not	   distinguish	  between	  ocular	  hypertension	  and	  true	  glaucoma,	  because	  it	  disregards	  morphofunctional	  optic	  nerve	  changes.	  On	  the	  basis	  of	  this	  deginition,	  we	  found	  prepolymegathismive	  ocular	  hypertension	  in	  17%	  of	  the	  eyes	  and	  postoperative	  ocular	  hypertension	  in	  8.5%.	   In	  most	  other	  studies,	   comparable	  or	  higher	  percentages	  were	  reported.6,	   8,	   11,	   26	  The	  decrease	  in	  mean	  intraocular	  pressure	  after	  SOR	  was	   signigicant	   in	  the	   present	   study,	   in	  agreement	  with	  previous	   gindings.6,	   8,	   11,	   14	   It	   can	  be	   concluded	   that	   SOR	   may	   contribute	   to	   better	  intraocular	  pressure	   control.	   The	  mechanisms	   that	  underlie	  the	  development	  of	  chronic	  glaucoma	  after	  silicone	  oil	   tamponade	  are	  still	  poorly	  understood.	   It	  has	  been	  suggested	  that	   oil	   droplets	   in	   the	   anterior	   chamber,	   especially	   when	   the	   oil	   is	   emulsigied,	   with	  ingiltration	  and	  obstruction	  of	  the	  trabecular	  meshwork,	   is	  probably	  the	  most	  important	  causative	  factor	  in	  ocular	  hypertension.45,	   46	  Van	  Meurs	  et	  al7	   found	  a	  signigicantly	  higher	  incidence	   of	  glaucoma	   in	  patients	   with	   oil	   droplets	   in	   the	   anterior	  chamber	   angle.	   The	  duration	   of	   oil	   tamponade	   may	   play	   a	   crucial	   role	   in	   the	   process	   of	   emulsigication.7	  Although	  we	  could	  not	  gind	  a	  signigicant	  association	  between	  ocular	  hypertension	  and	  the	  duration	  of	  oil	   tamponade	  or	  emulsigication,	   there	  was	  a	  signigicant	  association	  between	  postoperative	   ocular	   hypertension	   and	   eyes	   that	   did	   not	   undergo	   retinectomy.	   This	  seems	   to	   support	   the	  hypothesis	   that	   retinectomy	   is	   a	   valuable	   treatment	   for	   therapy-­‐
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resistant	  glaucoma,47	  because	  it	  may	  help	  to	   lower	  the	  incidence	  of	  postoperative	  ocular	  hypertension	  in	  silicone-­‐gilled	  eyes.In	   conclusion,	   RD	   occurred	   in	   approximately	   20%	   of	   the	   present	   series	   of	   eyes	   after	  silicone	  oil	  removal,	  which	  was	  comparable	  with	  the	  rates	   in	   the	  Silicone	  Study	  Reports	  published	  approximately	  20	  years	  ago.	  An	  important	  difference	  in	  study	  design	  was	  that	  the	  present	   results	  were	   obtained	  in	  an	  unselected	  series	   of	  eyes,	   whereas	   the	   Silicone	  Study	  Reports	   employed	  patient	  selection	  so	   that	   less	  than	  50%	  of	  the	  eyes	  had	  SOR.	   In	  comparison,	   we	   obtained	   a	   higher	   overall	   anatomical	   success	   rate,	   mainly	   due	   to	  improved	  vitreoretinal	  surgical	  techniques.	  The	  following	  independent	  risk	  factors	  were	  found	  for	  recurrent	  RD	  after	  SOR:	  male	  gender,	   rubeosis	  and	  PDR.	  Risk	   factors	   for	  poor	  visual	   outcome	  after	   SOR	   were:	   male	   gender,	   preoperative	   Snellen	  visual	   acuity	   <	   0.1,	  PDR,	   three	   or	  more	   operations	  on	   the	  same	  eye,	   retinectomy	   (irrespective	   of	  size)	   and	  hypotony.
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Chapter
Corneal endothelial cell 
density after vitrectomy 
with silicone oil tamponade 
for complex retinal 
detachment




Background	  and	  purpose:	  To	  evaluate	  endothelial	  cell	  density	  (ECD)	  changes	  in	  eyes	  with	  silicone	   oil	   (SO)	   tamponade	   after	   vitrectomy	   for	   complex	   rhegmatogenous	   retinal	  detachment	  (RRD).
Methods:	  A	  prospective	  controlled	  study	  on	  81	  eyes	  with	  complex	  RRD	   that	  underwent	  vitrectomy	  and	  SO	  tamponade.	  Fellow	  eyes	  that	  fulgilled	  specigic	  inclusion	  criteria	  served	  as	  controls.	  Preoperative	  ECD	  (cells/mm2),	  coefgicient	  of	  variance	  (CV,	  SD/mean	  cell	  area	  x	   100),	   percentage	   of	   hexagonal	   cells	   and	   corneal	   thickness	   were	   documented	   and	  compared	   to	   values	   obtained	  at	   3,	   6	   and	  12	  months	   follow-­‐up.	   For	   the	   purpose	   of	   the	  analysis,	  the	  eyes	  were	  classigied	  into	  give	  groups	  according	  to	  their	  lens	  status	  during	  the	  study	  period:	   group	  1:	   phakic	   eyes	   that	   remained	  phakic;	   group	  2:	   pseudophakic	   eyes	  that	  remained	  pseudophakic;	   group	  3:	   phakic	   eyes	   that	  underwent	  phacoemulsigication	  with	   IOL	   implantation;	   group	   4:	   eyes	   that	   became	   aphakic;	   group	   5:	   fellow	   eyes	   that	  served	  as	  controls.	  
Results:	  High	  endothelial	  cell	  loss	  was	  found	  in	  group	  3	  and	  group	  4	  at	  12	  months	  follow-­‐up:	  mean	  cell	  loss	  was	  19%	  and	  39%,	  respectively	  (P	  <0.001).	  
Conclusions:	   An	   intact	   natural	   or	   artigicial	   lens-­‐iris	   diaphragm	   seemed	   to	   provide	   a	  protective	  barrier	  against	  corneal	  endothelial	  cell	  damage	  from	  long-­‐term	  SO	  tamponade.
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IntroductionIn	  more	  complex	  retinal	  detachment	  cases,	   pars	  plana	  vitrectomy	  (PPV)	  with	  silicone	  oil	  (SO)	   tamponade	   is	   recommended.1-­‐4	   However,	   many	   complications	   have	  been	   reported	  with	  the	  use	  of	  SO	  tamponade,5-­‐11	   such	  as	  glaucoma,12-­‐14	  hypotony,12	  cataract	  formation15	  and	  corneal	   endothelial	   cell	   (EC)	   loss6,	   16	   due	   to	   SO	   kerathopathy.17,	   18	   SO	   keratopathy	  often	  leads	  to	  corneal	  decompensation,	  which	  necessitates	  keratoplasty.	  This	  was	  shown	  in	  a	  study	  by	  Beekman	  et	  al,17	  who	  performed	  keratoplasty	  on	  a	  series	  of	  12	  patients	  with	  silicone	   oil	   keratopathy	   after	   PPV	   with	   SO	   tamponade.	   Previous	   studies	   have	  demonstrated	  EC	  loss	  in	  eyes	  that	  underwent	  PPV,	  but	  they	  did	  not	  include	  cases	  with	  SO	  tamponade.6,	   16	  However,	   in	  a	  smaller	  study	  on	  10	  eyes	  with	  permanent	   SO	   tamponade,	  high	  EC	  loss	  was	  reported.7	   To	   the	  best	   of	  our	  knowledge,	   no	   prospective	   studies	  have	  been	  published	  on	  EC	  counts	  and/or	  EC	  morphometry	  after	  PPV	  with	  SO	  tamponade.The	  goal	  of	  this	  study	  was	  to	  measure	  changes	  in	  ECD	  by	  means	  of	  specular	  microscopy	  in	  eyes	  that	  underwent	  PPV	  with	  temporary	  SO	  tamponade.	  We	  also	  evaluated	  risk	   factors	  for	  EC	  loss	  after	  PPV	  with	  SO	  tamponade	  in	  phakic,	  pseudophakic	  and	  aphakic	  eyes.	  
Subjects and methodsThis	   prospective	  study	  was	  performed	  on	   all	   consecutive	   patients	  who	   underwent	   PPV	  with	  SO	  tamponade	  for	  either	  complex	  RRD	  or	  recurrent	  RRD	  between	  November	  2006	  and	   November	   2008.	   We	   excluded	   patients	   with	   trauma	   and/or	   uveitis.	   Fellow	   eyes	  served	  as	  controls	   if	  they	  did	  not	  undergo	   ocular	  surgery	   during	   the	  study	   period.	   The	  study	  was	  approved	  by	   the	  Maastricht	  University	   institutional	   ethics	  committee.	  All	   the	  patients	   gave	   informed	   consent	   and	   the	   tenets	   of	   the	   declaration	   of	   Helsinki	   were	  followed.
Surgical	  history	  A	   comprehensive	   set	   of	   preoperative	   patient	   characteristics	   were	   noted:	   age,	   gender,	  prior	  intraocular	  surgery,	  prior	  scleral	  buckling	  surgery	  and	  the	  presence	  of	  proliferative	  vitreoretinopathy	   (PVR)	  graded	  according	  to	   the	  Retina	  Society	  Classigication	  of	  1983.19	  We	   also	   noted	   the	   cumulative	   duration	   of	   surgery	   and	   the	   presence	   of	   keratopathy,	  corneal	  oedema	  or	  SO	  emulsigication.	  All	  the	  patients	  were	  operated	  on	  by	  one	  of	  four	  experienced	  vitreoretinal	  surgeons	  (FH,	  ELH,	  AL,	  IL)	  at	  the	  Eye	  Clinic	  of	  the	  University	  Medical	  Centre	  Maastricht	  (tertiary	  referral	  centre).	   Indications	   for	  PPV	  in	  complex	  RRD	  cases	  were	  poor	   funduscopic	   view,	  miosis,	  extensive	  vitreous	  haemorrhage,	  central	  and	  complex	  tears	  near	  the	  vitreous	  base,	  PVR	  of	  at	  least	  grade	  C2,	  trauma	  with	  PVR	  and	  retinal	  re-­‐detachment.	  Our	  PPV	  technique	  with	  SO	  tamponade	   comprised:	   standard	   three-­‐port	   PPV	   with	   a	   trocar	   microcannular	   system	  (Grieshaber	   &	   Co,	   AG,	   Schafghausen,	   Switzerland)	   using	   a	   non-­‐contact	   wide	   angle	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panoramic	   viewing	   system	   (EIBOS,	   Möller-­‐Wedel,	   Wedel,	   Germany).	   In	   patients	   with	  existing	  scleral	  buckling	  surgery,	   the	  encircling	  band	  and	  buckle	  were	  always	  left	   in	  situ	  and	  as	  much	  vitreous	  as	   possible	  was	   removed,	   with	   shaving	  of	  the	  vitreous	   base.	   The	  retina	  was	  mobilized	  by	  excising	  all	  the	  epiretinal	  and	  subretinal	  membranes	  and	  strings,	  or	   by	   performing	   relaxing	   retinectomy	   as	   a	   last	   resort	   if	   the	   retina	   remained	   rigid.	  Lensectomy	  was	   carried	  out	   in	   eyes	   with	   anterior	   PVR,	   as	   described	   in	   Silicone	  Study	  Report	  10,20	  to	  completely	  clean	  the	  peripheral	  retina	  and	  vitreous	  base.	  All	  the	  eyes	  received	  pergluorocarbon	  liquid	  (DK-­‐line,	   Chauvin	  Opsia,	  France)	  which	  was	  subsequently	   exchanged	   for	   SO	   (Dimeticon	   1000	   centistokes,	   Dimeticon	   1000	   cs	   is	  manufactured	   by	   Dow	   Corning	   Ltd,	   Coventry	   (United	   Kingdom)	   under	   number	  0006488526,	   imported	  by	  Spruyt	  Hillen,	   Ijsselstijn	  (the	  Netherlands)	  and	  distributed	  to	  the	   University	   Medical	   Centre	   Nijmegen	   (UMCN),	   where	   it	   is	   sterilised	   at	   the	  Pharmacology	   Department.	   No	   further	   editing	   is	   performed	   at	   Spruyt	   Hillen	   or	   at	   the	  UMCN.	  The	  sterilised	  SO	  is	  transported	  to	  our	  hospital	  for	  use	  at	  the	  operating	  theatre).	  During	  PPV,	  we	  sometimes	   placed	  a	  silicone	   encircling	   band	   (240,	  MIRA	   Inc.	   Uxbridge,	  MA,	   USA)	   beneath	   the	   rectus	   muscles.	   The	   encircling	   band	   was	   attached	   10-­‐12	   mm	  posteriorly	  to	  the	   limbus	  with	  a	  mersilene	  5.0	  suture.	   The	  decision	  of	  whether	  or	  not	   to	  use	  an	  encircling	  band	  was	   based	  on	  the	  size	  and	  location	  of	  the	  retinal	   tear	  and	  on	  the	  lens	  status.	  Re-­‐operations	   were	   performed	   until	   stable	   attachment	   of	   the	   retina	   was	   achieved	  anteriorly	   to	   the	   encircling	   element.	   When	   partial	   peripheral	   retinal	   detachment	  occurred,	   i.e.	   anterior	   to	   the	  encircling	  scleral	   buckle,	   it	  was	   treated	   locally	  with	  argon	  laser	   conginement,	  as	  described	  previously,3,	   4	   until	   a	   stable	  situation	  was	   obtained	  that	  enabled	  SO	  removal	  (SOR).SOR	  was	  indicated	  when	  the	  retina	  was	  attached	  posteriorly	   to	   the	  encircling	  band,	  or	  if	  complications	  arose,	  such	  as	  ocular	  hypertension,	  keratopathy,	  or	  oil-­‐corneal	   touch.3	  Our	  SOR	  technique	  took	  place	  through	  two	  corneoscleral	  incisions	  in	  the	  aphakic	  patients,	   or	  through	   two	   pars	   plana	   sclerotomies	   in	   the	   phakic	   and	   pseudophakic	   patients.	   When	  additional	   procedures	  were	  necessary,	   such	  as	   endolaser	   photocoagulation,	   lensectomy	  by	  phacofragmentation,	  removal	  of	  epiretinal	  membranes,	   removal	  of	  ischaemic	  edges	  of	  former	  retinectomies,	   or	  air-­‐gluid	  exchange	  to	   remove	   surplus	  SO	  emulsigication,	   three-­‐port	  vitrectomy	  was	  performed.	  All	   the	   patients	   received	   routine	   postoperative	   treatment	   with	   antibiotic	   eye	   drops	   4	  times	   daily	   for	   14	   days	   (chloramphenicol	   5	   mg/ml,	   Ratiopharm,	   Zaandam,	   the	  Netherlands).	  Patients	  with	  phakic	  eyes	  also	  used	  mydriatic	  eye	  drops	  (atropine	  sulphate	  1%)	  2	  times	  daily	   for	  1	  week	  after	   the	  operation	   (Chauvin	  Pharmaceuticals	   Ltd	  Surrey,	  UK).	   Patients	  with	  pseudophakic	  eyes	  used	  additional	   tropicamide	  0.5%	  (Thea	  Pharma,	  Wetteren,	   Belgium)	  2	  times	  daily	   for	  1	  week	  and	  prednisolone	  eye	  drops	   (Pred	  Forte®,	  prednisolone	  acetate	  10	  mg/ml,	  Allergan	  BV,	  Nieuwegein,	   the	  Netherlands)	  3	  times	  daily	  for	  2	  months.
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Corneal	  endothelial	  cell	  density	  analysis	  Two	  independent	  investigators	  (FG	  and	  DC)	  performed	  all	  the	  ocular	  examinations.	  These	  included	  best-­‐corrected	  visual	  acuity	  (BCVA),	  slit-­‐lamp	  examination,	  intraocular	  pressure	  (IOP),	   dilated	   funduscopy,	   pachymetry	   (corneal	   thickness)	   and	   non-­‐contact	   specular	  microscopy	  of	  the	  corneal	  endothelium	  (Noncon	  Robo,	  SP	  8000,	  Konan,	  Hyogo,	  Japan).	  
ECD	  calculation	  At	   each	  examination,	   we	  evaluated	  endothelial	  cell	   density	  (ECD,	   cells/mm2),	   coefgicient	  of	   variance	   (CV,	   SD/mean	   cell	   area	   x	   100),	   percentage	   of	  hexagonal	   cells	   and	   corneal	  thickness.	   ECD	  was	  determined	  from	  the	   average	  cell	   area	  with	  the	  following	  equation:	  cell	  density	  =	  106	  /	  average	  cell	  area	  with	  cell	  density	  (cell/mm2),	  average	  cell	  area	  (μm2);	  the	  value	  106	  was	  used	  to	  convert	  units	  of	  measure.	  The	  cells	  in	  human	  corneal	  endothelium	  have	  various	  surface	  areas.	  Polymegathism	  value	  is	  the	  name	  given	  to	  a	  coefgicient	  that	  describes	  the	  variation	  in	  cell	  area.	  With	  increasing	  standard	  deviation	  of	  the	  average	  cell	  area,	  the	  accuracy	  of	  the	  estimated	  true	  cell	  density	  decreases.	  Therefore,	  increases	  in	  the	  polymegathism	  value	  decrease	  the	  accuracy	  of	  the	  average	  cell	  area.	  The	  following	  equation	  was	  used	  to	  calculate	  the	  polymegathism	  value:	  CV	  =	  SD	  cell	   area	  /	  mean	  cell	  area,	   μm2.	  CV	  is	  the	  coefgicient	  of	  variation,	  while	  SD	   is	   the	  standard	  deviation	  of	  the	  mean	  cell	  area.21,	   22	  We	  determined	  the	  gigure	  coefgicient,	  which	  is	   also	   a	  dimensionless	   index,	   using	  the	  equation:	  4	  A/P2,	  where	  A	   is	  the	  cell	   area	  (nm2)	  and	  P	   is	   the	  perimeter	   (μm).	   This	   value	   describes	   the	   degree	   to	   which	  the	   endothelial	  cells	   approach	   perfect	   hexagonality.	   A	   perfect	   hexagon	   has	   a	   value	   of	   0.907,	   but	  deviations	  from	  hexagonality	  reduce	  this	  value.	  The	  number	  of	  apices	  of	  each	  endothelial	  cell	   describes	  the	  cell	  shape.	  To	  reduce	  the	  sampling	  error,	  50	  cells	   in	  the	  centre	  of	  each	  specular	   microscopy	   image	   were	   analysed	   and	   the	   ECD,	   CV	   and	   the	   percentage	   of	  hexagonality	  of	   three	  measurements	  were	   averaged	   in	   each	   eye.	   Intra-­‐investigator	   and	  inter-­‐investigator	  measurements	   were	   tested	   in	   a	   group	   of	   39	   healthy	   patients,	   which	  yielded	  a	  small	  CV	  (5.0%	  ±	  3.6%).	  All	  the	  examinations	  were	  performed	  on	  the	  RD	  and	  control	  eyes,	  preoperatively	  and	  at	  3,	  6	   and	   12	   months	   follow-­‐up.	   Measurements	   were	   obtained	   after	   the	   instillation	   of	  tropicamide	  0.5%	  and	  phenylephrine	  2.5%	  (Thea	  Pharma,	  Wetteren,	  Belgium),	  except	  for	  IOP.	  
Lens	  status	  and	  deTinition	  of	  variables	  For	  the	  purpose	  of	  our	  analysis,	  the	  eyes	  were	  classigied	  into	  give	  groups	  according	  to	  lens	  status:	   group	   1:	   phakic	   eyes	   that	   remained	   phakic;	   group	   2:	   pseudophakic	   eyes	   that	  remained	  pseudophakic;	   group	  3:	   phakic	   eyes	   that	   underwent	  phacoemulsigication	  with	  IOL	  implantation;	  group	  4:	  aphakic	  eyes	  that	  were	  originally	  phakic	  or	  pseudophakic,	  but	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underwent	  lensectomy	  or	  IOL	  removal;	  group	  5:	   fellow	  eyes	  (control	  group)	  that	  did	  not	  undergo	  any	  intraocular	  procedures	  during	  follow-­‐up.Recurrent	   retinal	   detachment	   after	   SO	   removal	   referred	   to	   either	   complete	   retinal	   re-­‐detachment,	   or	   local	   retinal	   detachment	   if	   progression	   could	   not	   be	   congined	  by	   laser	  treatment.	   Anatomical	   success	   was	   degined	   as	   attachment	   of	   the	   retina	   within	   the	  photocoagulation	  barrier	  at	   the	  end	  of	   follow-­‐up.	   For	   glaucoma,	  we	  used	   the	   following	  deginition	  from	  Silicone	  Study	  Report	  6:	  an	  intraocular	  pressure	  of	  more	  than	  25	  mm	  Hg,	  or	   more	   than	   20	   mm	  Hg	  with	   antiglaucoma	  medication,	   measured	   at	   any	   time	  during	  follow-­‐up.23	  Our	  patients	  received	  anti-­‐glaucoma	  medication	  if	  their	  IOP	  was	  higher	  than	  25	  mm	  Hg	  and	  the	  treatment	  mostly	  continued	  until	  just	  after	  SO	  removal.	  Hypotony	  was	  degined	  as	  an	  intraocular	  pressure	  of	   less	   than	  5	  mm	  Hg.23	   Keratopathy	  was	  degined	  as	  bullous	  or	  band-­‐shaped	  keratopathy,	  epithelial	  or	  stromal	  oedema	  or	  localized	  opacities,	  in	  conformity	  with	  Silicone	  Study	  Report	  6.23
Statistical	  analysis	  Statistical	   analysis	  was	   performed	  with	  the	  SPSS	  software	  16.0	  (SPSS	  for	  Windows,	   Rel.	  13.0	  Chicago:	   SPSS	   Inc.,	   USA)	   using	   independent	   sample	   T-­‐test	   for	   univariate	   analysis.	  Multivariate	  analysis	  was	  performed	  by	  applying	  a	  linear	  mixed	  model	   to	  our	  data,	  with	  ECD	  as	  independent	  variable,	  time	  as	  covariate	  and	  assuming	  a	  random	  intercept	  per	  eye.	  Signigicance	   was	   degined	   as	   P	   <	   0.05.	   Snellen	   visual	   acuities	   were	   converted	   into	   a	  logarithmic	   scale	   (LogMAR,	   i.e.	   the	   logarithm	   of	   the	   minimal	   angle	   of	   resolution),	   as	  described	  previously.24	  In	  this	  study,	  poor	  visual	  outcome	  was	  degined	  as	  visual	  acuity	  of	  less	   than	  0.1	  Snellen	  at	  12	  months	  follow-­‐up.	  The	  linear	  mixed	  model	  was	  applied	  to	  all	  the	  eyes,	  including	  those	  that	  were	  excluded	  from	  our	  analysis	  and	  the	  control	  eyes	  (total,	  n=168),	  with	  ECD	  as	  the	  independent	  variable,	  time	  as	  covariate	  and	  assuming	  a	  random	  intercept	  per	  eye	  (2354.8	  ±	  70.1	  cells/mm2).	  Glaucoma,	  SO	  in	  the	  anterior	  chamber	  (AC)	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Table	  8.1:	  Patients	  lost	  to	  follow-­‐up
No.	  of	  patients	  
(n=11)
Reason
3 Patient	  could	  not	  or	  did	  not	  want	  to	  participate	  in	  the	  study	  	  
5 Inadequate	  postoperative	  specular	  micrographs	  because	  of	  punctate	  Epitheliopathy	  or	  haze	  due	  to	  poor	  recovery	  of	  an	  erosion
1 Corneal	  oedema	  due	  to-­‐cornea	  decompensation
2 Died	  during	  follow-­‐up	  
and	  cataract	  extraction	  during	  follow-­‐up	  were	  also	  included	  as	  gixed	  factors.	  We	  excluded	  various	  parameters	  from	  the	  linear	  mixed	  model	  that	  were	  not	   found	  to	  be	  signigicant	  in	  the	  multivariate	   analysis,	   such	   as	   cumulative	   surgical	   duration,	   emulsigication,	   erosion	  during	  follow-­‐up,	  IOP	  on	  the	  girst	  day	  and	  pergluorocarbon	  liquid	  in	  the	  AC.
ResultsBetween	  November	   2006	  and	  November	   2008,	   a	   total	   of	  92	  consecutive	  patients	  with	  RRD	  underwent	  vitrectomy	  and	  SO	  injection	  at	  our	   clinic.	   In	  81	  patients,	   follow-­‐up	  data	  were	  available	  over	  a	  minimum	  period	  of	  one	  year.	  Mean	  age	  of	  the	  81	  patients	  was	  61.1	  ±	   12.0	   years;	   there	   were	   70.4%	   men	   (n=57)	   and	  29.6%	  women	   (n=24).	   At	   3	  months	  follow-­‐up,	   96.3%	  of	   the	  eyes	   (n=78)	  still	   had	  SO	  tamponade;	   at	  6	  months	   this	   rate	  was	  58%	  (n=47)	  and	  at	  12	  months,	  this	  rate	  was	  only	  23.5%	  (n=19).	  The	  eleven	  excluded	  eyes	  (Table	  8.1)	  comprised	  72.7%	  (n=8)	  men	  and	  27.3%	  (n=3)	  women.	  Mean	  age	  was	  66.2	  ±	  14.7	  years;	  mean	  baseline	  ECD	  was	  2056.8	  ±	  532.1	  cells/mm2.	  This	  was	  not	  signigicantly	  different	   from	  the	  mean	  value	   in	   the	  study	   group	  of	   81	  patients	   (2309.4	  ±	  417.8	  cells/mm2).Ocular	  history	  of	  the	  81	  eyes	  at	  baseline	  was	  as	  follows:	  32.1%	  of	  the	  eyes	  (n=26)	  did	  not	  have	   any	   ophthalmological	   ocular	   history,	   46.9%	   (n=38)	   eyes	   had	   undergone	  phacoemulsigication	   with	   IOL	   implantation,	   21%	   (n=17)	   eyes	   had	   a	   history	   of	   scleral	  

















Figure	  8.1:	  Lens	  status	  of	  the	  patients	  during	  the	  follow-­‐up
buckling	   surgery,	   9.9%	   (n=8)	   eyes	   had	   undergone	   primary	   vitrectomy	   (SO	   or	   gas	  tamponade)	   for	   various	   reasons	   and	   4.9%	   (n=4)	   eyes	   had	  undergone	   vitrectomy	   with	  phacoemulsigication,	  or	  simultaneous	  scleral	  buckling	  surgery.	  The	  eyes	  were	  classigied	  into	   give	  different	  groups	  depending	  on	  their	  lens	  status	   (Table	  8.2):	   group	   1:	   phakic	   eyes	   that	   remained	   phakic;	   group	   2:	   pseudophakic	   eyes	   that	  remained	  pseudophakic;	   group	  3:	   phakic	   eyes	   that	   underwent	  phacoemulsigication	  with	  IOL	  implantation;	  group	  4:	  eyes	  that	  became	  aphakic;	  group	  5:	  fellow	  eyes	  that	  served	  as	  controls.No	  statistically	  signigicant	  preoperative	  /	  baseline	  differences	  were	  found	  between	  these	  give	  groups,	  except	  for	  intraocular	  pressure,	  which	  was	  signigicantly	  higher	  in	  the	  control	  eyes	   (15.4	   ±	   3.6	   mm	   Hg)	   than	   in	   the	   study	   eyes	   (13.4	   ±	   4.1	   mm	   Hg,	   P<0.001).	   Re-­‐operation	  applied	  to:	  25%	  (n=2)	  in	  group	  1,	  31%	  (n=10)	  in	  group	  2,	  46%	  (n=10)	  in	  group	  3	  and	  44%	  (n=8)	  in	  group	  4.	   No	  signigicant	  differences	  were	  found	  between	  the	  groups	  (P=0.566).	  Lens	  status	  changed	  in	  some	  of	  the	  patients	  during	  follow-­‐up	  (Figure	  8.1).	  After	  one	  year,	  seven	   out	   of	   the	   eight	   phakic	   eyes	   had	   undergone	   phacoemulsigication	   with	   IOL	  implantation;	   one	   patient	   refused	   cataract	   surgery	   because	   of	   her	   poor	   physical	  condition;	  one	  aphakic	   eye	  with	  an	  endothelial	  cell	   density	  of	   less	   than	  1500	  cells/mm2	  did	  not	  undergo	  secondary	  IOL	  implantation.	  
Endothelial	  cell	  density	  (ECD)Mean	  postoperative	  ECD	  change	  at	  12	  months	  varied	  between	  2.4%	  and	  -­‐39.2%	  (Table	  8.2).	   In	  group	  1	  (phakic	  eyes	  that	  remained	  phakic)	  and	  group	  2	  (pseudophakic	  eyes	  that	  remained	  pseudophakic)	  there	  was	  less	  than	  5%	  EC	  loss	  12	  months	  after	  vitrectomy	  with	  silicone	   oil	   tamponade	   for	   complex	   RRD	   (see	   Table	   8.2).	   In	   group	   3	   (phakic	   eyes	   that	  underwent	   phacoemulsigication	   with	   IOL	   implantation)	  mean	   EC	   loss	   was	   19%	   at	   12	  months	   (P<0.001).	   In	   group	   4	   (eyes	   that	   became	   aphakic	   after	   lensectomy	   or	   IOL	  removal)	  EC	  loss	  was	  even	  higher	  at	  3,	  6	  and	  12	  months	  (P=0.002,	  P=0.001	  and	  P<0.001)	  with	   a	   mean	   endothelial	   cell	   loss	   of	   39%	   at	   12	   months	   (Figure	   8.2,	   Table	   8.2).	   No	  signigicant	   differences	  were	   found	   in	   the	  mean	   percentage	  of	   hexagonal	   cells	   or	   in	   the	  coefgicient	  of	  variation	  between	  groups	  before	  or	  after	  surgery	  (Table	  8.2).	  During	  follow-­‐up,	   SO	  was	  found	  in	   the	  AC	  in	  10	  eyes.	  Mean	  EC	  loss	   in	  these	   eyes	   at	  12	  months	  was	   32%	  (712.7	  ±	  480.0	   cells/mm2,	   NS)	  compared	  to	   13%	  loss	   in	   the	  71	  eyes	  without	  SO	  in	  the	  AC	  (311.8	  ±	  490.8	  cells/	  mm2,	  P<0.001).	   In	  group	  4	  (eyes	   that	  became	  aphakic	  after	  lensectomy	  or	  IOL	  removal)	  EC	  loss	  in	  the	  four	  patients	  with	  SO	  in	  the	  AC	  at	  12	  months	  was	  52%	  (1182.5	  ±	  365.6	  cells/mm2,	   P=0.007),	  whereas	  in	  the	  other	  14	  eyes	  that	  did	  not	  have	  SO	  in	  the	  AC,	  EC	  loss	  was	  36%	  (857.3	  ±	  464.2	  cells/mm2,	  P<0.001).	  linear	  mixed	  model	   analysis	   showed	  that	   ECD	  was	   signigicantly	   lower	   in	  glaucomatous	  eyes	   (β=-­‐104,	   P<0.001)	   and	   also	   in	   eyes	   with	   SO	   in	   the	   AC	   (β=-­‐336,	   P<0.001).	   ECD	  decreased	  signigicantly	  more	  rapidly	  in	  group	  3	  (β=-­‐31	  per	  month,	  P<0.001)	  and	  group	  4	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(β=-­‐66	   per	   month,	   P<0.001)	   than	   in	   the	   controls	   (β=-­‐2.7	   per	   month,	   see	   Figure	   8.2).	  Linear	  mixed	  model	   analysis	  did	  not	  reveal	  any	  signigicant	  correlation	  between	  ECD	  loss	  and	   hypotony,	   cumulative	   duration	   of	   surgery	   and	   the	   number	   of	   operations	   after	  primary	   SO	   injection.	   Furthermore,	   SO	   in	   the	  AC	  was	   not	   found	   to	   be	   associated	  with	  hypotony.
Intraocular	  pressureMean	  preoperative	  IOP	  in	  the	  whole	  study	  group	  of	  81	  eyes	  with	  complex	  RRD	  was	  13.4	  ±	  4.2	  mm	  Hg.	  Five	  patients	  (6.3%)	  had	  a	  history	  of	  glaucoma	  and	  were	  receiving	  treatment	  with	  local	   antiglaucoma	  medication	  before	  primary	  vitrectomy.	   In	  the	  girst	   three	  months	  following	   surgery,	   58%	   of	   the	   patients	   (n=46)	   were	   on	   temporary	   antiglaucoma	  medication.	   Between	   3	  months	   and	   6	  months,	   40%	   (n=32)	   were	   using	   antiglaucoma	  medication.	   At	   12	  months,	   30%	   (24	   patients)	   were	   still	   on	   antiglaucoma	   medication.	  Compared	   to	   the	   preoperative	   values,	   EC	   loss	   at	   12	  months	   was	   19%	  in	   the	   glaucoma	  group	  (P<0.001)	  versus	  11%	  in	  the	  group	  without	  glaucoma	  (P=0.002).	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Figure	  8.2:	  Endothelial	  cell	  count	  during	  follow-­‐up	  Group	   1:	   phakic	   eyes	   that	   remained	   phakic;	   group	   2:	   pseudophakic	   eyes	   that	  remained	  pseudophakic;	  	  group	  3:	  phakic	  eyes	  that	  underwent	  phacoemulsigication	  with	  IOL	  implantation;	  group	  4:	  eyes	  that	  became	  aphakic;	  group	  5:	  fellow	  eyes	  that	  served	  as	  controls	  ECD	  was	  signigicantly	  lower	  in	  groups	  3	  and	  4	  at	  6	  months	  and	  12	  months	  (P=0.001	  and	  P<0.001)	  and	  at	  3,	  6	  and	  12	  months	  (P=0.002,	  P=0.001	  and	  P<0.001)	  
DiscussionIn	   the	  present	   study,	   EC	   loss	   was	   less	   than	  5%	  at	   12	  months	  after	  vitrectomy	  with	  SO	  tamponade	  for	  complex	  RRD	  in	  group	  1	  (phakic	  eyes	   that	  remained	  phakic)	  and	  group	  2	  (pseudophakic	   eyes	   that	   remained	   pseudophakic).	   Highest	   postoperative	   EC	   loss	   was	  found	  in	  the	  eyes	   that	  underwent	  an	  additional	   phacoemulsigication	  procedure	  with	  IOL	  removal.	  Glaucoma	  and	  direct	  oil-­‐corneal	  touch	  had	  further	  negative	  effects	  on	  ECD.	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Table	  8.2:	  Corneal	  endothelial	  cell	  assessment	  after	  vitrectomy	  with	  silicone	  oil	  tamponade





Endothelial	  cell	  density	  (cells/mm2)
Group	  1	  (n=8) 2367	  ±	  268 2425	  ±	  312 2345	  ±	  309 2425	  ±	  340 +2.4% NS
Group	  2	  (n=32) 2270	  ±	  433 2247	  ±	  440 2165	  ±	  419 2165	  ±	  422 -­‐4.6% NS
Group	  3	  (n=22) 2321	  ±	  467 2163	  ±	  556 2045	  ±	  471 1876	  ±	  515 -­‐19.2% <0.001
Group	  4	  (n=18) 2374	  ±	  386 1783	  ±	  691 1666	  ±	  649 1445	  ±	  437 -­‐39.2% <0.001
Group	  5	  (n=73) 2333	  ±	  409 2327	  ±	  470 2311	  ±	  503 2346	  ±	  400 +0.6% NS
Percentage	  of	  hexagonal	  cells	  (%)
Group	  1	  (n=8) 58.4	  ±	  10.0 61.8	  ±	  5.6 58.5	  ±	  6.1 54.1	  ±	  9.0 -­‐1.6% NS
Group	  2	  (n=32) 57.7	  ±	  9.6 58.1	  ±	  7.1 55.2	  ±	  8.7 59.3	  ±	  8.3 +2.8% NS
Group	  3	  (n=22) 61.4	  ±	  10.5 60.4	  ±	  10.9 56.1	  ±	  7.9 55.6	  ±	  8.8 -­‐9.4% NS
Group	  4	  (n=18)‡ 58.66	  ±	  8.6 55.5	  ±	  10.7 55.4	  ±	  9.1 56.5	  ±	  4.7 -­‐3.6% NS
Group	  5	  (n=73) 61.5	  ±	  9.3 59.4	  ±	  8.5 58.6	  ±	  10.1 59.6	  ±	  9.3 -­‐3.1% NS
Coef!icient	  of	  variation	  (%)
Group	  1	  (n=8) 29.5	  ±	  4.0 30.6	  ±	  4.0 31.1	  ±	  3.2 31.8	  ±	  5.1 +7.8% NS
Group	  2	  (n=32) 38.2	  ±	  23.5 30.7	  ±	  5.0 33.4	  ±	  7.2 33.1	  ±	  22.3 -­‐13.4% NS
Group	  3	  (n=22) 41.7	  ±	  38.9 29.4	  ±	  4.0 32.0	  ±	  4.9 31.2	  ±	  5.4 -­‐25.2% NS
Group	  4	  (n=18) 30.2	  ±	  3.9 32.0	  ±	  6.6 33.8	  ±	  7.9 32.4	  ±	  7.9 -­‐22.8% NS
Group	  5	  (n=73) 31.6	  ±	  5.1 33.1	  ±	  16.3 31.2	  ±	  6.1 26.1	  ±	  22.4 -­‐17.4% NSECD:	  endothelial	  cell	  density	   (cells/mm2),	  NS:	   	  not	  signigicant‡	  no	   signigicant	  difference	  was	   found	  with	  a	  non-­‐parametric	  test	  (wilcoxon)	  also	  no	  signigicant	  difference	  was	  found	  P	  value:	  signigicance	  was	  degined	  as	  
P	  <	  0.05	  Group	   1:	   phakic	   eyes	   that	   remained	   phakic;	   group	   2:	   pseudophakic	   eyes	   that	   remained	   pseudophakic;	  group	  3:	  phakic	  eyes	  that	  underwent	  phacoemulsigication	  with	  IOL	  implantation;	  group	  4:	  eyes	  that	  became	  aphakic;	  group	  5:	  fellow	  eyes	  that	  served	  as	  controls
In	  an	  earlier	   prospective	  study	   on	  ECD	   after	  PPV	   without	   SO	   tamponade,	   Friberg	  et	  al6	  reported	   signigicantly	   higher	   ECD	   loss	   in	   aphakic	   eyes	   and	   in	   eyes	   that	   underwent	  simultaneous	   lensectomy,	   with	   or	   without	   gas-­‐gluid	   exchange,	   than	   in	   patients	   who	  underwent	  scleral	  buckling	  alone.	   They	  also	   found	  lower	  percentages	   of	  EC	  loss	   in	  their	  aphakic	   group	   (8.5-­‐16.9%)	   than	   the	   levels	   in	   the	   present	   study.	   However,	   their	   ECD	  measurements	  were	  performed	  after	  shorter	  follow-­‐up	  (3.9-­‐6.7	  months).6	  No	  EC	  loss	  was	  found	   in	   phakic	   eyes	   that	   underwent	   PPV	   without	   lens	   removal.	   These	   authors	  hypothesized	   that	   an	   intact	   lens	  may	   protect	   the	   corneal	   endothelium	  during	   PPV	   and	  that	   gluid-­‐gas	   exchange	   may	   be	   harmful	   to	   aphakic	   eyes.6	   Rosenfeld	   et	   al16	   reported	  greater	   EC	   loss	   six	   months	   postoperatively	   in	   aphakic	   eyes	   (13%)	   and	   in	   eyes	   that	  underwent	  lensectomy	  combined	  with	  PPV	  (17%)	  than	  in	  phakic	  eyes	  (0.4%).16	  Although	  these	  authors	  did	  not	  study	  PPV	  with	  SO	  tamponade,	   they	  launched	  the	  idea	  that	  higher	  EC	  loss	  may	  be	  due	  to	  the	  use	  of	  SO.	  This	  was	  congirmed	  in	  the	  present	  study,	  because	  we	  found	  39%	  EC	  loss	  in	  aphakic	  eyes	  and	  52%	  EC	  loss	  in	  eyes	  with	  SO	  in	  the	  AC.	  An	  earlier	  study	  reported	  EC	  loss	  of	  up	  to	  83%	  when	  there	  was	  SO	  in	  the	  AC	  and	  when	  SO	  had	  been	  in	  direct	  contact	  with	  the	  corneal	  endothelium.25	  However,	   the	  latter	  study	  involved	  only	  four	   eyes	   and	   was	   not	   prospective.25	   Although	   oil-­‐corneal	   touch	  was	   a	   signigicant	   risk	  factor	   for	   EC	   loss	   in	   the	   present	   study,	   the	   cumulative	   duration	  of	   surgery	  was	   not	   a	  signigicant	  risk	  factor	  for	  EC	  loss.Szaglik	  et	  al26	  observed	  signigicant	  EC	  loss	  in	  the	  upper	  parts	  of	  the	  cornea	  in	  patients	  with	  SO	  in	  the	  AC.	  A	  mean	  difference	  of	  32%	  was	  found	  between	  the	  upper	  part	  and	  the	  central	  part	   of	  the	  cornea	  (985	  cells/mm2	  and	  1456	  cells/mm2,	   respectively).26	   All	   the	  patients	  had	   irregular	  cell	   shapes	  and	  EC	  lesions,	  while	   six	  patients	   showed	  aberrant	  ECs	   in	   the	  upper	   part	   of	   the	   cornea.26	   In	   contrast	   with	   Szaglik	   et	   al,26	   we	   performed	   our	  measurements	   in	   the	   centre	   of	  the	   cornea,	   according	   to	   a	  standard	  protocol	   described	  previously.27-­‐32	  Reduced	   frequency	   of	   hexagons	   with	   associated	   elevations	   in	   other	   cell	   shapes	   is	  indicative	   of	   increased	   cellular	   pleomorphism.	   Endothelial	   morphology	   is	   the	   best	  indicator	  of	  corneal	  endothelial	   stress	  or	   instability.	   As	  a	  general	   rule,	   stressed	  corneas	  have:	   %	  Hex	   <45	   and/or	   CV	   >45.	   ECD	   changes	   indicate	   cell	   damage	   that	   has	   already	  occurred,	   while	   EC	   morphology	   represents	   ongoing	   corneal	   endothelial	   cell	   stress	   or	  instability.22	  The	  size	  and	  shape	  of	  corneal	  ECs	  provides	  objective	  information	  on	  damage	  levels	  and	  corneal	  endothelial	   functioning.33-­‐35	  We	  did	  not	   gind	  any	  signigicant	  difference	  in	   the	   CV	   or	   the	   percentage	   of	   hexagonal	   cells	   between	  the	   groups.	   The	   latter	   ginding	  seems	   to	   indicate	   the	   absence	   of	   wound	  healing,	   despite	   high	  EC	   loss,	   which	   suggests	  unchanged	  EC	  function.	  On	  the	  other	  hand,	   there	  may	  not	  have	  been	  any	  variation	  in	  cell	  size	   (polymegathism)	   or	   irregularity	   in	   cell	   shape	   with	   a	   decreased	   percentage	   of	  hexagons	   (pleomorphism)	  at	   the	  central	   location	  where	  we	   took	   our	  measurements,	   in	  contrast	  with	  Szaglik	  et	  al.26	  In	  the	  study	  by	  Szaglik	  et	  al,26	   ten	  patients	  had	  direct	  silicone	  exposure	   to	   the	   upper	   part	   of	   the	   cornea.	   Confocal	   specular	   microscopy	   examinations	  were	   performed	  between	  3	  weeks	   to	   10	  months	   after	   detecting	   SO	   in	   the	  AC.	   Another	  difference	  between	  the	   latter	   study	   and	  our	   study	  was	   that	   they	  used	   the	  upper	  part	  of	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the	  cornea	  of	  the	  same	  eye	  as	  “control”,	  whereas	  in	  the	  present	   study,	   in	  which	  EC	  loss	  was	   up	  to	   52%	  in	  these	   cases,	   we	  obtained	  this	  percentage	  by	  comparing	  preoperative	  and	  postoperative	  values.	  In	  a	  more	  recent	  study,	  Friberg	  et	  al7	  showed	  that	  SO	  retention	  in	  the	  vitreous	  body	  made	  a	   signigicant	   contribution	   to	   EC	  loss.	   Compared	  to	   the	  fellow	   control	   eye,	   mean	  EC	  loss	  was	  69%	  in	  10	  eyes	  with	  SO	  retention	  after	  a	  mean	  follow-­‐up	  of	  10	  months.	  Mean	  EC	  loss	  was	   almost	  95%	   in	   three	  eyes	  with	  SO	  in	  the	  AC.7	   Pseudophakic	   eyes	  had	  52%	  EC	  loss	  compared	  to	  aphakic	  eyes	  (67%).7	  A	  major	  conclusion	  was	  that	  EC	  loss	  after	  vitreoretinal	  surgery	  may	  increase	  further	  due	  to	   long-­‐term	  SO	  retention.11	   Previous	  studies	  reported	  that	  high	  EC	  loss	   occurred	  in	  eyes	  without	  a	  barrier	  between	  the	  anterior	  segment	   and	  the	  vitreous	   cavity,6,7,16	   but	   that	   EC	   loss	  was	  highest	   in	   eyes	   in	  which	   SO	  was	   in	   direct	  contact	   with	   the	   endothelium.6,	   7	   The	   authors	   suggested	   that	   the	   original	   lens	   and	  artigicial	   IOL	  may	  have	  protected	  the	  endothelium	   from	   turbulence	  and	  from	  prolonged	  exposure	   to	   the	   irrigation	   solution	   and	   SO	   during	   vitreous	   surgery.16	   It	   has	   been	  hypothesized	   that	   EC	   damage	   is	   cumulative	   over	   repeated	   intraocular	   operations.7,	   36	  Although	  direct	  oil-­‐corneal	   touch	  was	  a	  signigicant	   risk	   factor	  for	  EC	   loss	   in	  the	  present	  study,	   the	   cumulative	   duration	   of	   surgery	   was	   not.	   Emulsigied	   oil	   droplets	   that	   pass	  through	  the	   zonular	  gibres	   of	  the	   lens	   may	  damage	   the	   corneal	   endothelium	  and	  cause	  long-­‐term	   EC	   loss.	   However,	   in	   the	   present	   study,	   we	   did	   not	   gind	   any	   association	  between	  EC	  loss	  and	  the	  degree	  of	  oil	  emulsigication.	  The	  eyes	  with	  glaucoma	  in	  our	  series	  had	  signigicantly	  higher	  EC	  loss	  at	  12	  months	  than	  the	  eyes	  without	  glaucoma	  (19%	  vs	  11%).	  In	  addition,	  30%	  of	  the	  patients	  were	  still	  on	  antiglaucoma	   medication	   at	   one	   year	   follow-­‐up.	   A	   negative	   relation	   was	   reported	  between	  ECD	  and	  glaucoma	  in	  patients	  with	  a	  history	   of	  acute	  angle	   closure	  glaucoma.37-­‐40	   High	   intraocular	   pressures,	   even	   for	   a	   minimal	   duration	   of	   3	   days,	   signigicantly	  lowered	  the	  central	  ECD.39	  Boscia	   et	   al8	   studied	  EC	  loss	   in	  eyes	   that	   underwent	   combined	  phacoemulsigication	  and	  SO	  removal	  (n=17).8	  They	  found	  that	  after	  6	  months,	  passive	  SO	  efglux	  from	  the	  AC	  caused	  signigicantly	   more	   EC	   loss	   (11.2%)	   than	   phacoemulsigication	   as	   a	   single	   procedure	  without	  simultaneous	  SO	  removal	  (8.3%).8	  These	  percentages	  of	  EC	  loss	  were	  comparable	  with	  our	  gindings	  after	  6	  and	  12	  months	  in	  the	  group	  with	  combined	  SO	  removal	  (through	  a	   pars	   plana	   approach)	   and	  phacoemulsigication:	   12%	   and	   19%	  EC	   loss,	   respectively.	  However,	  Boscia	  et	  al8	  used	  a	  different	  SO	  removal	  technique	  via	  the	  AC	  with	  a	  16-­‐gauge	  cannula	   through	   posterior	   capsulorhexis,	   which	   was	   performed	   at	   the	   end	   of	   the	  phacoemulsigication	  procedure.8	  However,	   in	  the	  present	  study,	   SO	  removal	  was	  always	  performed	  through	  a	  pars	  plana	  approach	  after	  the	  completion	  of	  phacoemulsigication.Mean	  preoperative	  ECDs	  were	  different	  in	  group	  1	  and	  group	  2:	  2367	  ±	  268.3	  and	  2269.6	  ±	  433.2,	  respectively.	  The	  difference	  was	  4%,	  which	  was	  comparable	  with	  the	  literature.41	  Much	  greater	  ECD	   loss	  was	   found	   in	  group	  3	  and	  group	  4.	   Group	  3	  underwent	   anterior	  segment	   surgery	   during	   follow-­‐up	   and	   became	   pseudophakic.	   EC	   loss	   was	   smaller	   in	  group	  3	   (phacoemulsigication	  without	   IOL	   implantation)	   than	  in	   group	  4	   (lensectomy).	  However,	   in	   some	  cases	  a	  secondary	   IOL	  was	   placed.	   Patients	  with	   low	  EC	  loss	   did	  not	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receive	  a	  secondary	  IOL.	  Faramarzi	  et	  al41	   found	  an	  ECD	  of	  6%	  after	  phacoemulsigication.	  This	   was	   comparable	   with	   our	   preoperative	   ECD	   in	   group	  2	   (pseudophakic	   eyes	   that	  remained	  pseudophakic).	   However,	   this	   did	  not	   explain	  why	   the	   group	   that	  underwent	  phacoemulsigication	  during	  follow-­‐up	  had	  much	  greater	  ECD	  loss.One	  of	  the	  limitations	  of	  the	  present	  study	  was	  that	  the	  patient	  population	  who	  required	  SO	  was	  quite	  heterogeneous,	  with	  eyes	  in	  various	  states.	  The	  effects	  of	  these	  confounding	  factors	  were	   not	   controlled	  for	   in	  the	   ginal	  analysis,	   but	   their	   inclusion	  would	  probably	  dilute	  the	  results	  to	  the	  point	  of	  insignigicance.A	  further	  problem	  was	  that	  the	  number	  of	  ECs	  that	  need	  to	  be	  counted	  in	  order	  to	  obtain	  reliable	   specular	  microscopy	  data	   is	   still	   controversial.	   Benetz	   et	   al42	   suggested	  that	   at	  least	   30	  ECs	   should	   be	   counted	   to	   obtain	  maximum	  accuracy,	   whereas	  Doughty	   et	   al43	  recommended	  a	  total	  of	  75	  cells	  for	  the	  highest	  precision.	  In	  this	  study,	  the	  number	  of	  ECs	  counted	   was	   sometimes	   lower	   than	   30,	   which	   should	   be	   taken	   into	   account	   when	  interpreting	  our	  results.	  We	  also	  determined	  the	  best	  case	  scenario	  with	  a	  single	  clinical	  site,	   single	   photographer	   and	  a	   single	   reader.	   Our	   reading	   precision	  was	   2%.	   Thus,	   in	  group	  1,	   the	  cell	   counts	  were	  within	  the	  noise	  of	  our	  measurement	  precision	  with	  non-­‐contact	  specular	  microscopy	  and	  the	  results	  were	  probably	  representative	  of	  no	   change	  in	  ECD.Another	   shortcoming	  was	   that	   this	   study	   did	   not	   incorporate	   a	  control	   group	  with	  gas	  tamponade	   and	   a	   comparable	   duration	   of	   surgery.	   Therefore,	   we	   could	   not	   establish	  whether	  the	  ECD	  changes	  were	  truly	  attributable	  to	  oil	  tamponade.	   It	  should	  also	  be	  kept	  in	  mind	  that	  EC	  loss	  may	  be	  even	  higher	  if	  patients	  are	  remeasured	  after	  longer	  follow-­‐up.In	  summary,	   less	  than	  5%	  EC	  loss	  was	  measured	  at	  12	  months	  follow-­‐up	  in	  eyes	  that	  had	  undergone	  vitrectomy	  with	  SO	  tamponade,	  without	  any	  additional	  surgical	  procedures	  to	  the	  anterior	  segment.	  Highest	  postoperative	  EC	  loss	  was	  found	  in	  eyes	  that	  underwent	  an	  additional	   phacoemulsigication	   procedure	   (mean	   -­‐19%	   change)	  or	   IOL	   removal	   (mean	  -­‐39%	  change)	  during	  the	  study	  period.	  Glaucoma	  and	  direct	  oil-­‐corneal	  touch	  had	  further	  negative	  effects	  on	  ECD	  counts.	  Our	  hypothesis	   is	  that	  the	  lens	  plays	  an	  important	  role	  in	  protecting	  the	  ECs	  in	  eyes	  that	  receive	  SO	  tamponade	  during	  the	  surgical	  management	  of	  complex	   retinal	   detachment.	   Apparently,	   the	   lens	   functions	   as	   a	   protective	   EC	   shield	  against	   turbulence	   and	   prolonged	   exposure	   to	   the	   irrigating	   solutions	   and	   SO.	  Lensectomy,	  i.e.	  removal	  of	  the	  barrier	  between	  the	  cornea	  and	  posterior	  segment	  during	  vitreoretinal	  procedures,	  possibly	  accelerates	  EC	  loss.	  It	  therefore	  seems	  justigied	  to	  avoid	  lensectomy	  whenever	  possible.To	   further	  protect	  the	  ECs	  and	  restrict	   the	  number	  of	  vitreoretinal	  procedures,	   primary	  retinectomy	   seems	   to	  be	  a	   good	  option	  for	   proliferative	  vitreoretinopathy.44	   In	  general,	  reducing	   the	   overall	   duration	   of	   surgery	   may	   decrease	   EC	   loss.	   To	   minimize	  intraoperative	  turbulence,	   high	  viscosity	  viscoelastics	  can	  be	  used,	  because	  they	  provide	  more	  EC	  protection	  than	  lower	  viscosity	  viscoelastics.45	  Owing	  to	   the	  fact	  that	  eyes	  with	  complex	   retinal	   detachment	   often	   need	   repeat	   vitreoretinal	   surgical	   procedures,	   the	  above-­‐mentioned	  techniques	  deserve	  consideration	  to	  maintain	  long-­‐term	  corneal	  clarity.	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Retinal	  detachmentPosterior	  vitreous	  detachment	  (PVD)	  is	  a	  common	  age-­‐related	  degenerative	  condition,1,	   2	  in	  which	  patients	  experience	  light	  gloaters	   and/or	  glashes.3	   These	  symptoms	  are	  specigic	  to	  PVD,	   but	  not	   all	   patients	  suffer	  from	  them.	   In	  the	  studies	  described	  in	  this	  thesis,	   the	  girst	  symptoms	  expressed	  by	   the	  patients	  were:	  gloaters	  (60.2%)	  and	  glashes	  (37.6%).	  A	  study	  by	   Hikichi	   and	  Trempe3	   reported	  89%	  sensitivity	   for	   gloaters	   and	   glashes,	   with	  a	  specigicity	  of	  25%.	   This	  congirms	  the	  statement	  made	  by	  Green	  and	  Sebag	  that	  posterior	  
vitreous	  detachment	  is	  one	  of	  the	  least	  accurate	  diagnosis	  employed	  by	  ophthalmologists	  on	  a	  daily	  basis.4	  Symptoms	  of	  rhegmatogenous	  retinal	  detachment	  (RRD)	  are	  glashes	  and	  visual	   gield	  reduction.5	  We	  observed	  that	  the	  median	  overall	  delay	  between	  the	  patients’	  girst	   subjective	   symptoms	   and	   the	   time	   of	   surgery	   was	   10	   days.	   Almost	   60%	   of	   this	  overall	  delay	  was	  caused	  by	  patient-­‐related	  delay	  and	  general	  practitioner	  (GP)	  delay.	   In	  addition,	   in	  more	   than	  50%	  of	  the	   patients,	   the	  delay	  was	   due	   to	   unawareness	  and/or	  unfamiliarity	  with	   the	   symptoms	   of	  PVD	   and/or	   RRD.	   For	   example,	   patients	   explained	  that	  they	  had	  not	  considered	  the	  glashes,	  gloaters	  or	  visual	  gield	  reduction	  to	  be	  serious,	  so	  they	  did	  not	  seek	  prompt	  medical	  attention.	  Mean	  patient-­‐related	  delay	  was	  signigicantly	  lower	  in	  the	  patients	  with	  vitreous	  haemorrhage	  and	  in	  the	  patients	  with	  a	  history	  of	  a	  RRD	   in	   the	   fellow	   eye.	   Acute	   visual	   function	   loss	   in	   the	   patients	   with	   vitreous	  haemorrhage	  was	  probably	   the	  reason	  why	   they	   sought	   immediate	   help.	   Patients	  who	  have	  been	  treated	  for	  RRD	  in	  the	  fellow	  eye	  are	  more	  likely	  to	  recognize	  the	  symptoms	  of	  impending	  retinal	  detachment	  and	  contact	  a	  doctor	  straight	  away.	  PVD	  is	  also	  associated	  with	  an	  increased	  risk	   of	  developing	  retinal	   tears.6	   The	  literature	  reports	  an	  incidence	  of	  7.3-­‐14%	  in	  patients	  with	  PVD.7	  Although	  RRD	  may	  be	  present,	   or	  it	  may	  develop	  following	  PVD,	  not	  all	  the	  patients	  experience	  glashes	  and/or	  gloaters.	  The	  annual	   incidence	   of	   retinal	   detachment	   is	   5	   to	  18.2	  per	   100,000	   persons.8-­‐16	   There	  are	  several	  treatment	  options,	  which	  all	  have	  advantages	  and	  disadvantages.17-­‐23
Results	  of	  scleral	  buckling	  surgeryAnatomical	  re-­‐attachment	  of	  the	  retina	  was	  achieved	  in	  76%	  of	  our	  series	  of	  consecutive,	  non-­‐selected	   patients	   after	   one	   scleral	   buckling	   (SB)	   procedure.	   Ultimate	   anatomical	  success	  was	  achieved	  in	  97%.	  These	  rates	  were	  comparable	  with	  earlier	  reports	  on	  RRD	  following	  SB	  surgery	  alone	  24-­‐34	  after	  a	  follow-­‐up	  of	  more	  than	  10	  years.In	  our	  series,	  32	  eyes	  (7%)	  and	  20	  eyes	  (5%)	  developed	  re-­‐detachment	  after	  more	  than	  six	   and	  twelve	  months	   follow-­‐up,	   respectively.	  Multivariate	  regression	  analysis	   showed	  that	   recurrent	   re-­‐detachment	   and	   more	   than	   seven	   days	   of	   visual	   gield	   loss	   were	  signigicant	   predictors	   of	   poor	   postoperative	   visual	   outcome	   at	   12	   months	   follow-­‐up.	  Furthermore,	   in	   recurrent	   RRD,	   a	   cumulative	   size	   of	   the	   tear	   of	   more	   than	   3	   disc	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diameters	   was	   a	   signigicant	   predictor	   of	   poor	   outcome.	   The	   predictors	   of	   poor	   visual	  outcome	  found	  in	  the	  present	  study	  corresponded	  with	  the	  risk	  factors	  reported	  in	  earlier	  studies.35-­‐38	   Late	   re-­‐detachment	   forms	   an	   argument	   to	   follow	   patients	   for	   at	   least	   6	  months	   after	   an	   SB	   procedure.	   Moreover,	   visual	   acuity	   may	   continue	   to	   improve	   for	  several	  months	  after	  SB	  surgery.	  Using	   foveal	  densitometry,	   Liem	  et	  al39	   showed	  that	   it	  may	   take	   several	  months	   for	   the	  foveal	   cone	  photopigments	   to	   recover	   after	  macular	  detachment.	   In	  addition,	   subfoveal	  gluid	   sometimes	   persists	   subclinically	   for	   several	   months	   following	   an	   SB	   procedure,	  which	  may	  explain	  the	  slow	  visual	  recovery	  in	  certain	  patients.40-­‐42	  The	   disadvantage	   of	   longer	   postoperative	   follow-­‐up,	   however,	   may	   be	   bias	   caused	   by	  visual	  acuity	  degeneration	  in	  the	  elderly	  patients	  (cataracts	  or	  macular	  problems).	   In	  the	  present	  study,	  the	  visual	  acuity	  results	  were	  therefore	  analysed	  after	  a	  gixed	  period	  of	  12	  months	  following	  the	  primary	  operation.Our	   studies	  demonstrated	  that	  anterior	  chamber	  depth	  (ACD)	  was	   signigicantly	  reduced	  until	  nine	  months	   after	  SB	  surgery.	   The	  ACD	  had	  returned	  to	   normal	   levels	  at	  one	  year	  follow-­‐up.In	  this	   thesis,	  we	  did	  not	   gind	  any	  signigicant	  differences	   in	  outcome	  between	  radial	   and	  segmental	   buckles.	   All	   the	   eyes	   treated	   in	   our	   series	   received	   an	  additional	   encircling	  band.	  This	  encircling	  element	  itself	  may	  have	  caused	  the	  decrease	  in	  ACD,	   which	  can	  be	  explained	   as	   follows:	   encircling	   elements	   may	   reduce	   the	   uveal	   or	   retinochoroidal	  circulation	   and	   cause	   ciliary	   body	   oedema.22	   This	   ciliary	   body	   oedema	   with	   forward	  rotation	   of	   its	   body	   and	   forward	   shift	   of	   the	   iris-­‐lens	   diaphragm,	   in	   combination	  with	  compression	   by	   the	  encircling	   element	   on	   the	   vitreous,	   may	   cause	   signigicant	   anterior	  chamber	   (AC)	  reduction.22	   In	   our	   opinion,	   this	   was	   probably	   the	   major	   reason	   for	   the	  decrease	   in	  ACD.	   This	   notion	  was	   supported	  by	   our	   ginding	  of	   increased	   lens	   rise.	   The	  axial	   length	   was	   signigicantly	   increased	   and	   continued	   to	   increase	   during	   follow-­‐up,	  which	  resulted	  in	  a	  mean	  myopic	  shift	  of	  2.6	  D	  three	  months	  after	  SB	  surgery.	  If	  a	  patient	  presents	  with	  a	  combination	  of	  myopic	  phakic	   intraocular	   lens	   (pIOL),	   RRD	  and	   an	   ACD	   of	   less	   than	   3.5	  mm,	   the	   vitreoretinal	   surgeon	  may	   consider	   performing	  primary	   vitrectomy	   instead	   of	   an	   SB	   procedure.	   Based	   on	   the	   ginding	   of	   a	   signigicant	  negative	   correlation	   between	   ACD	   and	   the	   loss	   of	   endothelial	   cells,	   Saxena	   et	   al8	  suggested	  stricter	   inclusion	  criteria	   for	  pIOL	   implantation	  surgery.	   They	   proposed	  that	  the	  ACD	  should	  be	  at	  least	  3.5	  mm,8	  measured	  from	  the	  corneal	  epithelium	  to	  the	  anterior	  pole	  of	  the	  crystalline	  lens	  or	  IOL,	  in	  order	  to	  prevent	  excessive	  endothelial	  cell	  loss	  after	  pIOL	   implantation.	  Marigo	  et	  al27	   showed	  that	  uncomplicated	  pars	  plana	  vitrectomy	  did	  not	   induce	  any	  long-­‐term	  changes	  in	  anterior	   segment	  morphometry.	   A	   disadvantage	  of	  performing	  vitrectomy	  in	  eyes	  with	  RRD	  and	  a	  pIOL	  may	  be	  the	  progressive	  development	  of	  cataract,	  which	  requires	  removal	  of	  the	  pIOL.28,	  29	  However,	  if	  a	  patient	  with	  a	  history	  of	  SB	  surgery	  wants	  to	  have	  a	  pIOL	  implanted,	  but	  the	  ACD	  is	   too	  shallow,	  it	  may	  be	  a	  good	  option	  to	  dissect	  the	  encircling	  element,	  as	  described	  by	  Kreissig	  et	  al.30In	  our	  study	  on	  the	  occurrence	  and	  pattern	  of	  binocular	  diplopia,	  we	  found	  that	  3.8%	  of	  the	  1030	  eyes	  that	  underwent	  SB	  surgery	  for	  RRD	  developed	  secondary	  diplopia	  during	  a	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mean	   follow-­‐up	  of	  more	   than	   six	  months.	   Orthoptic	   assessment	   congirmed	  mechanical	  restriction	  in	  2.7%	  of	  the	  cases.	  No	  signigicant	  correlation	  was	  found	  between	  the	  position	  of	   the	   buckle	   or	   the	   type	   of	   buckle	   and	   the	   incidence	   of	   diplopia	   or	   the	   pattern	   of	  strabismus.	   When	   two	   muscles	   were	   affected	   by	   the	   buckle,	   a	   moderately	   signigicant	  association	  was	   found	  with	  the	  incidence	  of	  diplopia.	  However,	   this	  association	  was	   not	  found	  when	   three	   or	   four	  muscles	  were	  affected,	   which	  was	   contrary	   to	   the	   expected	  trend	  of	   the	  more	  muscles	   affected,	   the	   higher	   the	   incidence	   of	   diplopia.	   It	   should	  be	  noted	  that	  we	  cannot	  rule	  out	  whether	  this	  was	  due	  to	  the	  small	  numbers	  in	  these	  groups.	  Based	  on	  our	  calculations	   and	  statistics,	  we	  concluded	   that	  in	  the	  present	   retrospective	  study,	   diplopia	   was	   only	   moderately	   associated	   with	   the	   number	   of	   muscles	   affected,	  whereas	   it	  was	  not	  associated	  with	  the	  buckle	  position.	   Furthermore,	   in	  the	  majority	  of	  cases	   in	  the	   diplopia	  group,	   the	  buckle	  was	   not	  positioned	  underneath	  the	  muscle	   that	  would	  be	  expected	  to	  be	  associated	  with	  the	  diplopia.	  Therefore,	  the	  incidence	  of	  diplopia	  was	  only	  predictable	  in	  a	  minority	  of	  the	  patients.In	  1973,	   Kanski	   et	  al4	   reported	  that	   25	   out	   of	   the	  30	  patients	   who	   developed	  diplopia	  after	   SB	   surgery	   (n=750)	   underwent	   a	   secondary	   procedure	   to	   mobilize	   the	  muscles,	  which	  was	   standard	  practice	   in	   those	   days.	   In	   the	   present	   study,	   however,	   we	  did	   not	  mobilize	  any	  of	  the	  muscles,	  or	  perform	  tendonectomy.	  Many	  causes	  for	  strabismus	  are	  described	  in	  the	  literature.	  Local	  anaesthetics7	  may	  cause	  anaesthetic	   myotoxicity,	   with	   temporary	   restrictive	   strabismus,	   as	   was	   reported	   by	  Salama	  et	  al.7	   This	  can	  be	  ruled	  out	   in	  the	  present	   series,	   because	  all	   the	  patients	  were	  operated	  on	  under	  general	   anaesthesia	  without	  any	  additional	   locoregional	   anaesthetic.	  Ischaemia	  of	  the	  rectus	  muscles	  may	  also	  be	  an	  explanation	  for	  diplopia	  after	  SB	  surgery.	  An	   ischaemic	   muscle	   has	   lost	   its	   function	   and/or	   strength.	   Ischaemia	   of	   the	   rectus	  muscles	   may	   develop	   due	   to	   muscle	   constraint,	   or	   arterial	   occlusion	   caused	   by	  compression	   from	   the	   encircling	   element.23	   In	   addition,	   if	   a	   muscle	   is	   constrained	   too	  aggressively,	   it	   may	   become	   seriously	   traumatized	   and	   result	   in	   haemorrhage	   and/or	  oedema	  of	  the	  muscle,	   but	   also	   ultimately	  to	   gibrosis	  and	  scarring,	  with	  restriction	  of	  its	  function.14	  This	  mechanism	  may	  be	  the	  explanation	  in	  some	  of	  our	  cases,	  as	  there	  was	  no	  apparent	   association	   between	   the	   position	   of	   the	   buckle	   and	   the	   pattern	   of	   diplopia.	  Strikingly,	  none	  of	  the	  buckles	   in	  the	  present	  study	  were	  beneath	  the	  muscles	   in	  the	  six	  cases	  with	  diplopia	  (21%).	  These	  were	  all	  cases	  with	  a	  fusional	  problem	  as	  result	  of	  de-­‐compensation	  of	  previous	  heterophoria	  caused	  by	  decreased	  visual	  acuity.	  Binocular	  single	  vision	  was	  ultimately	   restored	  in	  72%	  of	  the	  cases	  with	  diplopia	  in	   the	  present	   study.	   Re-­‐detachment	   was	   an	   additional	   risk	   factor	   for	   diplopia,	   because	   it	  diminished	  or	  eradicated	  the	  existing	  fusion	  due	  to	  further	  deterioration	  in	  visual	  acuity.	  It	  was	  not	   always	   possible	   to	   restore	   this	   fusion	   if	   sensory	   deprivation	  was	   caused	  by	  long-­‐term	  macular	  detachment.27-­‐29	  The	  only	  possible	  treatment	  in	  these	  cases,	   therefore,	  was	  occlusion	  of	  the	  eye.	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Results	  of	  vitrectomy	  in	  retinal	  detachment	  surgeryMany	  techniques	  have	  been	  described	  for	  the	  management	  of	  giant	  retinal	  tears	  (GRTs).43-­‐75	  In	  the	  present	  study,	  we	  found	  that	  pars	  plana	  vitrectomy	  (PPV)	  with	  the	  absence	  of	  an	   encircling	   scleral	   element	   was	   a	   signigicant	   risk	   factor	   for	   re-­‐detachment,	   which	  supported	   the	  results	   reported	  by	  Verstraeten	   et	   al.68	   Possible	  explanations	   are	   that	  an	  encircling	   scleral	   element	   reduces	   traction	   on	   the	   remaining	   vitreous	   and	   that	   the	  encircling	   scleral	   element	   exerts	   more	   pressure	   on	   the	   retina	   when	   silicone	   oil	   (SO)	  tamponade	  is	   involved.76,	  77	  An	  argument	  in	  favour	  of	  using	  an	  encircling	  narrow	   tyre	   is	  that	  local	  re-­‐detachment	  often	  occurs	   in	  the	  “intact”	  part	  of	  the	  retina	  and	  a	  360○	   buckle	  may	   prevent	   any	   further	   detachment.	   If	   a	   larger	   tyre	   is	   used	   over	   a	   portion	   of	   the	  circumference,	  one	  option	  is	  to	  place	  it	  over	  the	  GRT,	  or	  alternatively,	  it	  can	  be	  placed	  on	  the	  “intact”	  retina,	  as	  was	  done	  by	  Aylward	  et	  al73	  in	  more	  than	  half	  of	  their	  patients.	  In	   the	  present	   study,	   the	   re-­‐detachment	   rate	  after	   one	  PPV	  procedure	   in	  patients	  with	  GRT	  was	  30%;	   ultimately	  the	   retina	  was	   attached	  in	  98%	  of	  the	  eyes.	  Over	   the	  past	  10	  years,	   primary	   anatomical	   success	   rates	   in	   eyes	   treated	   for	   GRT	   have	   varied	   between	  50%	  and	  94%.43,	   54,	   55,	  65,	  66,	   68,	   72,	  74	  Ultimately,	   the	  success	  rate	  in	  most	  of	  the	  studies	  was	  approximately	   95%.43,	   54,	   55,	   65,	   66,	   72	   Anatomical	   success	   rates	   depend	   on	   the	   surgical	  technique,	   the	   inclusion	   or	   exclusion	   of	   eyes	   with	   traumatic	   GRT	   or	   proliferative	  vitreoretinopathy	  (PVR),	  the	  duration	  of	  follow-­‐up	  and	  whether	  or	  not	  the	  silicone	  oil	  has	  been	   removed	   from	   the	   eye	   at	   the	   end	   of	   follow-­‐up.	   Vitrectomy	   in	   combination	   with	  primary	   lensectomy,	   as	   described	   by	   Kreiger	   and	   Lewis56	   and	   Aylward	   et	   al,73	   was	  advocated	  to	  provide	  better	  access	  to	  the	  vitreous	  base	  and	  the	  extreme	  periphery	  of	  the	  retina.56,	   73	   Without	   lensectomy,	   it	   may	   be	   difgicult	   to	   reach	   the	   vitreous	   base.56,	   73	  However,	   an	   encircling	   scleral	   element	   or	   indentation	   might	   improve	   access.	   Primary	  lensectomy	  can	  be	  a	  traumatic	  event	  associated	  with	  endothelial	  cell	  loss.	   Earlier	  studies	  have	   demonstrated	   that	   aphakic	   eyes	   have	   a	   poor	   visual	   outcome	   after	   surgery	   for	  complicated	   RD.78,	   79	   In	   the	   present	   series,	   primary	   lensectomy	   was	   performed	   in	   a	  minority	  of	  the	  eyes.In	  our	  study,	   re-­‐detachment	   of	  the	   retina	  occurred	   in	  19%	  of	   the	  eyes	  after	   silicone	  oil	  removal	   (SOR).	  We	  did	  not	  make	  any	  prior	   patient	   selection	   in	  relation	   to	   SOR.	   This	   is	  contrary	   to	  Silicone	  Oil	  Study	  Report	  no.	  6,80	  in	  which	  the	  re-­‐detachment	  rate	  was	  20%,	  but	   only	  45%	  of	  the	  eyes	  underwent	  SOR	   and	  patient	  selection	  did	   take	  place:	   the	  best	  eyes,	  with	  better	  visual	  acuity,	  fewer	  preoperative	  interventions	  and	  fewer	  complications.80	   Nowadays,	  we	  have	  far	  more	  sophisticated	  equipment	  and	  surgical	   techniques	  at	  our	  disposal,81,	   82	   such	   as	   wide-­‐angle	   viewing	   systems83	   and	   pergluorocarbon	   liquids	   (DK-­‐line),84-­‐87	   which	   have	   contributed	   to	   improving	   the	   overall	   outcome	   of	   vitreoretinal	  surgery	  compared	  to	  20	  years	  ago	  when	  the	  Silicone	  Oil	  Study	  Report	  was	  published.80	  The	  overall	   anatomical	   success	   in	  our	  study	  was	  higher	   (94%)	  than	   that	  in	  Silicone	  Oil	  Study	  no.	  6	  (81%).80	   In	  the	  present	  study,	   re-­‐detachment	  occurred	  after	  a	  median	  of	  7.5	  weeks	   (range	   0	  days	   to	   108	  weeks).	   Within	   the	   girst	   three	  months	   after	   SOR,	   26	   eyes	  (68%)	  developed	  retinal	   re-­‐detachment,	   which	  was	  mostly	  due	   to	   PVR.	  Within	  the	   girst	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six	   months,	   87%	   developed	   re-­‐detachment.	   In	   the	   eyes	   with	   recurrent	   RRD,	   8%	  developed	  the	  re-­‐detachment	  more	  than	  one	  year	  after	  SOR.	  Our	  results	  were	  comparable	  with	  those	  of	   earlier	   studies,	   which	   reported	  a	   re-­‐detachment	   rate	  of	   between	  9%	  and	  25%	   after	   SOR.88-­‐99	   In	   the	   present	   series,	   a	   history	   of	   three	   or	   more	   operations	   and	  aphakia	  were	  identigied	  as	  signigicant	  risk	   factors	  for	  the	  development	  of	  keratopathy,	  in	  agreement	  with	  earlier	  studies.95,	   96	  We	  found	  signigicantly	  more	  keratopathy	  in	  patients	  with	   aphakia	   and/or	   a	   history	   of	   repeated	   ocular	   surgery,	   including	   anterior	   segment	  surgery,	   as	   has	   also	   been	   reported	   in	   the	   literature.78,	   88,	   89,	   99	   These	   two	   variables	   are	  known	   to	   be	   associated	   with	   (cumulative)	   damage	   to	   the	   corneal	   endothelial	   cells,78	  which	  may	  lead	  to	  keratopathy.This	   thesis	   also	   analysed	   postoperative	   endothelial	   cell	   (EC)	   loss	   after	   PPV	   with	   SO	  tamponade.	  The	  highest	  postoperative	  EC	  losses	  were	  found	  in	  the	  eyes	  that	  underwent	  an	  additional	  phacoemulsigication	  procedure,	  with	  or	  without	  IOL	  removal	  during	  follow-­‐up.	  Glaucoma	  and	  direct	  contact	  of	  the	  SO	  with	  the	  endothelial	  cells	  had	  further	  negative	  effects	  on	  endothelial	  cell	  density	  (ECD)	  counts.	  No	  EC	  loss	  was	  found	  in	  phakic	  eyes	  that	  underwent	  PPV	  without	   lens	   removal.	   Rosenfeld	   et	   al78	   reported	  greater	  reductions	   in	  ECD	   at	   six	   months	   follow-­‐up	   in	   aphakic	   eyes	   (13%)	   and	   in	   eyes	   that	   underwent	  lensectomy	  combined	  with	  PPV	  (17%)	  than	  in	  phakic	  eyes	   (0.4%).78	   Although	   they	  did	  not	   study	  eyes	   after	  PPV	   with	   SO	   tamponade,	   they	   proposed	  the	   theory	   that	   higher	  EC	  losses	  may	  be	  due	  to	   the	  use	  of	  SO.	   The	  present	  study	  congirmed	  this	  hypothesis:	   in	  the	  aphakic	   eyes,	   EC	  loss	   was	  39%,	   whereas	   in	  the	   eyes	  with	  SO	   in	   the	  AC,	   EC	   loss	  was	   as	  much	  as	  52%.	   An	  earlier	   study	  reported	  an	  EC	  loss	   of	  up	  to	   83%	  when	  SO	   gilled	   the	  AC	  and	  when	   SO	  had	  been	   in	   direct	   contact	   with	   the	   corneal	   endothelium.88	   However,	   the	  latter	  study	  only	  involved	  4	  eyes	  and	  it	  did	  not	  have	  a	  prospective	  design.88
Recommendations for further researchRecurrence	   and	   complications:	   the	   treatment	   procedures	   for	   retinal	   detachment	  described	   in	   this	   thesis	   were	   not	   free	   from	   recurrence	   and	   complications.	   Therefore,	  further	  research	   is	   required	  into	  preventive	  measures	   for	   recurrence.	   It	  is	  believed	  that	  recurrence	   on	   the	   basis	   of	   proliferative	   vitreoretinopathy	   occurs	   due	   to	   excessive	  vitreous	  humour.	  Prior	  to	  surgery,	  measures	  could	  be	  taken	  to	   condense	  and	  liquefy	   the	  vitreous	   humour,	   such	  as	   the	  administration	  of	  ocriplasmin.100-­‐103	   If	  vitreous	  humour	   is	  still	  in	  situ,	  PVR	  can	  develop.104	  Thus,	  some	  researchers	  are	  in	  favour	  of	  removing	  all	   the	  vitreous	  humour.105Tamponade:	   it	   would	   be	   worthwhile	   to	   develop	   an	   alternative	   form	   of	   tamponade.	  Silicone	   oil	   is	   associated	  with	  complications	   such	  as	   EC	   loss,	  which	  can	   lead	   to	   bullous	  keratopahty,	   band-­‐shaped	   keratopathy106,107	   or	   ocular	   hypertension	   due	   to	  emulsigication.95,96,108-­‐110	  A	   new	   tamponade	  must	  be	  a	   gluid	  with	  a	  large	  surface	  tension,	  such	  as	  pergluorocarbon	  liquid.	  70,71,11-­‐114	  It	  should	  be	  clear,	  without	  a	  breaking	  index	  and	  resorbable	   within	   three	   months	   in	   the	   same	   way	   as	   an	   expandable	   gas,	   but	   not	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retinotoxic.	   In	   addition,	   it	   must	   not	   emulsify	   in	   order	   to	   avoid	  ocular	   hypertension	  or	  endothelial	  cell	  loss	  in	  patients	  with	  aphakia.	  Medication	  may	  be	  added	  to	  the	  tamponade	  to	  prevent	  PVR	  for	  instance	  as	  a	  slow-­‐release	  drug	  system.Corneal	  decompensation	  due	  to	  EC	  loss	  after	  succesfull	  vitreoretinal	  surgery	  for	  complex	  detachments	  is	  a	  serious	  problem.	  The	  question	  of	  whether	  EC	  loss	  is	  caused	  by	  SO	  could	  be	  addressed	  by	  counting	  the	  endothelial	  cells	   in	  patients	  with	  retinal	   detachment	  who	  are	  scheduled	  for	  PPV	  with	  gas	  tamponade.	  Moreover,	   the	  development	  of	  more	  purigied	  forms	  of	  endotamponade	  with	  less	  emulsigication	  and	  /or	  less	  toxic	  effects	  to	  endothelial	  cells	  would	  diminish	  this	  complication.The	  development	   of	  retinal	   chip	   implants	  may	   in	   the	   far	   future	   be	   of	  help	   in	  replacing	  deceased	  retinal	  neuronal	  cells	  in	  anatomic	  attached	  retinas	  with	  low	  visual	  outcome.	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Summary Retinal	  detachment	  is	  a	  sight-­‐threatening	  condition,	  which	  requires	  immediate	  treatment	  in	  order	  to	  prevent	  blindness.	  This	  thesis	  aimed	  to	  determine	  the	  best	  possible	  treatment	  by	   answering	   the	   following	   questions:	   Why	   do	   patients	  with	   retinal	   detachment	   delay	  consulting	  a	  doctor?	  What	  is	  the	  best	  treatment	  for	  patients	  with	  rhegmatogenous	  retinal	  detachment	  (RRD)?	  Does	  the	  treatment	  have	  side-­‐effects	  and	  what	  are	  the	  consequences	  for	  the	  rest	  of	  the	  eye?In	  Chapter	  2,	   we	  quantigied	   the	  treatment	   delay	   in	  patients	  with	  RRD	  who	   underwent	  retinal	  detachment	   surgery	  and	  evaluated	   the	  causes	  for	  this	  delay.	  A	   total	   of	  186	  eyes	  were	  included	   in	  the	  analysis,	   with	  a	  follow-­‐up	  of	  1	  year.	  Median	  overall	  delay	   between	  the	  patients’	  girst	  symptoms	  and	  RRD	  surgery	  was	  10	  days.	  The	  major	  reason	  for	  patient	  delay	  was	  their	  unawareness	  and	  unfamiliarity	  with	  the	  symptoms	  of	  retinal	  detachment.In	  Chapters	  3	  to	  5,	  we	  analysed	  the	  results	  of	  scleral	  buckling	  (SB)	  surgery.	  In	  Chapter	  3,	  we	  found	  that	  after	  a	  mean	  follow-­‐up	  of	  51	  months,	  anatomical	   re-­‐attachment	  had	  been	  achieved	   in	   76%	  of	   the	  eyes	   after	  one	   SB	   procedure.	   The	   ginal	   re-­‐attachment	   rate	  was	  97%	   after	   additional	   vitreoretinal	   procedures.	   A	   total	   of	   104	   eyes	   developed	   re-­‐detachment	  during	  follow-­‐up.	   After	  more	  than	  six	  and	  twelve	  months	  follow-­‐up,	  32	  eyes	  (7%)	  and	  20	  eyes	   (5%)	  developed	  re-­‐detachment,	   respectively.	   Multivariate	   regression	  analysis	   showed	  that	  recurrent	  re-­‐detachment	   and	  more	  than	  seven	  days	  of	  visual	  gield	  loss	   were	   signigicant	   predictors	   of	   poor	   postoperative	   visual	   outcome	   at	   12	   months	  follow-­‐up.	   Furthermore,	   a	   signigicant	   predictor	  of	   recurrent	   RRD	  was	   a	  cumulative	  tear	  size	  of	  more	  than	  3	  disc	  diameters.	  Conventional	   SB	   surgery	   proved	  to	  be	  a	   reliable	  procedure	  in	  a	   selected	  group	  of	  eyes	  with	  primary	  RRD.	  However,	   in	  eyes	  with	  a	  retinal	   tear	  with	  a	  cumulative	  size	   of	  more	  than	  3	  disc	   diameters,	   primary	   vitrectomy	   should	  be	   considered.	   Based	   on	  our	   ginding	  that	  7%	  of	  the	  eyes	  developed	  re-­‐detachment	  after	  6	  months,	  a	  longer	  follow-­‐up	  period	  seems	  necessary	  to	  evaluate	  the	  anatomical	  and	  visual	  outcomes	  after	  SB	  surgery.	  In	  Chapter	  4,	  we	  analysed	  the	  anterior	  chamber	  depth	  (ACD)	  in	  38	  eyes	  after	  SB	  surgery.	  ACD	  was	   signigicantly	   reduced	  compared	   to	   the	  preoperative	   levels	   at	   up	   to	   9	  months	  follow-­‐up.	   Depths	   had	   returned	   to	   normal	   one	   year	   after	   surgery.	   Axial	   length	   was	  signigicantly	  enlarged	  during	  the	  total	  observation	  period.	  No	  signigicant	  differences	  were	  found	  between	  the	  use	  of	  radial	  or	   segmental	   buckles.	   In	  patients	  with	  prior	  SB	  surgery	  who	  plan	  to	  have	  myopic	  pIOL	   implantation,	   dissection	  of	  the	  encircling	  element	  may	  be	  considered	  if	  the	  anterior	  chamber	  has	   become	   too	  shallow,	  with	  the	  aim	  of	  preventing	  high	  endothelial	  cell	  loss.	  In	   Chapter	   5,	   we	   analysed	   diplopia	   after	   SB	   surgery.	   In	   the	   1030	   eyes,	   secondary	  strabismus	  developed	  in	  39	  eyes	  (3.8%)	  during	  a	  mean	  follow-­‐up	  of	  6.4	  ±	  6.3	  months;	  28	  patients	   (2.7%)	   developed	   strabismus	   due	   to	   mechanical	   restriction	   of	   one	   of	   the	  muscles.	   No	   association	   was	   found	   between	   the	   position	   of	   the	  buckle,	   i.e.	   the	  muscle	  affected,	  and	  the	  incidence	  of	  diplopia.	  In	  28	  out	  of	  the	  39	  patients,	  binocular	  single	  vision	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was	   restored	   at	   the	   end	   of	   follow-­‐up.	   This	  was	   accomplished	  with	   conventional	   prism	  treatment	  in	  the	  majority	  of	  cases.In	  Chapters	  6	  to	  8,	   we	   analysed	   the	  results	   of	  vitrectomy	   procedures	  with	  silicone	   oil	  (SO)	  tamponade	  for	  the	   treatment	  of	  retinal	   detachment.	   In	  Chapter	  6,	  we	  analysed	  the	  functional	   and	   anatomical	   results	   in	   patients	   with	   giant	   retinal	   tear	   (GRT)	   retinal	  detachment	  who	   had	  been	  treated	  with	  pars	  plana	  vitrectomy	  (PPV)	  with	  or	  without	  an	  encircling	  element	  and	  SO	  tamponade.	   In	  a	  series	  of	  30	  eyes,	  the	  re-­‐detachment	  rate	  was	  30%	  (n=9)	  after	  one	  PPV	   procedure.	   Ultimately,	   the	   retina	  was	   attached	  in	  29	   (96.7%)	  eyes.	   Multivariate	   analysis	   showed	   that	   the	   absence	   of	   an	   encircling	   scleral	   buckle	  (P=0.008)	   was	   signigicantly	   associated	   with	   re-­‐detachment.	   Visual	   acuity	   improved	   in	  54%	  of	  the	  eyes.	  PPV	  with	  an	  encircling	  scleral	  buckle	  and	  SO	  tamponade	  seemed	  to	  be	  a	  successful	  treatment	  for	  GRT	  retinal	  detachment.In	  Chapter	  7,	  we	  analysed	  the	  anatomical	  and	  functional	  results	  after	  silicone	  oil	  removal	  (SOR)	   in	   patients	   who	   had	   undergone	   vitrectomy	   with	   SO.	   Anatomical	   success	   was	  achieved	  in	  81%	  of	  the	  eyes	  after	  SOR.	  The	  overall	   anatomical	   success	   rate	  at	  the	  end	  of	  follow-­‐up	  was	   94%.	   Postoperative	   ocular	   hypertension	   was	   found	   in	   8%	   of	   the	   eyes,	  hypotony	  in	  6%	  of	  the	  eyes	  and	  keratopathy	   in	  29%	  of	  the	  eyes.	  After	  SOR,	  visual	  acuity	  had	  improved	  by	  at	  least	  2	  Snellen	  lines	  in	  43%	  of	  the	  eyes.	  Multivariate	  analysis	  showed	  that	   male	   gender,	   preoperative	   rubeosis	   and	   proliferative	   diabetic	   retinopathy	   (PDR)	  were	  risk	  factors	  for	  recurrent	  retinal	  detachment.	  Furthermore,	  poor	  visual	  outcome	  (i.e.	  Snellen	  visual	  acuity	  	  of	  <0.1)	  was	  associated	  with	  male	  gender,	  preoperative	  visual	  acuity	  of	  <0.1	  Snellen	  lines,	  PDR,	  three	  or	  more	  surgical	  procedures,	  any	  size	  of	  retinectomy	  and	  hypotony.	  In	  Chapter	  8,	   we	   analysed	   the	   endothelial	   cell	   density	   (ECD)	  after	   vitrectomy	  with	  SO	  tamponade.	   Mean	   postoperative	   ECD	   change	   at	   12	   months	   follow-­‐up	   varied	   between	  2.4%	  and	  -­‐39.2%	  compared	  to	  the	  preoperative	  values.	  Less	  than	  5%	  endothelial	  cell	  (EC)	  loss	  was	  found	  in	  patients	  with	  a	  native	  lens	  or	  pseudophakia.	  In	  the	  eyes	  that	  underwent	  an	  additional	  phacoemulsigication	  procedure	  and	  in	  the	  eyes	  that	  underwent	  lens	  and/or	  IOL	  removal,	  postoperative	  ECD	  was	  signigicantly	  reduced	  at	  12	  months	  follow-­‐up,	  with	  a	  mean	  cell	  loss	  of	  19%	  and	  39%,	  respectively	  (P	  <0.001).	  ECD	  was	  also	  signigicantly	  lower	  in	  the	  eyes	  with	  glaucoma	  (β=	  -­‐104,	   P<0.001)	  and	  in	   the	  eyes	   in	  which	  the	  SO	  gilled	  the	  anterior	  chamber	  (β=	  -­‐336,	   P<0.001).	  Mean	  postoperative	  percentage	  of	  hexagonal	  cells	  and	  the	  coefgicients	  of	  variation	  did	  not	  differ	  signigicantly	  from	  the	  preoperative	  values.
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SamenvattingNetvliesloslating	  is	  een	  visus	  bedreigende	  ziekte	  waarbij	  behandeling	  noodzakelijk	  is	  om	  niet	   blind	   te	   worden.	   Om	   een	   zo	   goed	  mogelijke	   behandeling	   te	   realiseren	   beoogt	   dit	  proefschrift	  de	  volgende	  vragen	  te	  beantwoorden:	  Waarom	  gaan	  patiënten	  niet	  eerder	  naar	  de	  dokter	  wanneer	  zij	  symptomen	  hebben	  van	  een	  netvliesloslating,	  zoals	  glitsen,	  vlekjes	  of	  gezichtsvelduitval?Wat	  is	  de	  beste	  behandeling	  voor	  patiënten	  met	  een	  rhegmatogene	  netvliesloslating	  ?	  Wat	  zijn	  de	  bijwerkingen	  van	  de	  behandeling	  en	  wat	  zijn	  de	  consequenties	  voor	  de	  rest	  van	  het	  oog?In	  Hoofdstuk	  2	  wordt	  de	  eerste	  vraag	  over	  het	  behandelingsuitstel	  besproken.	  Patiënten	  met	   een	   rhegmatogene	   netvliesloslating	   die	   netvlieschirurgie	   ondergaan	   werden	  gevraagd	  naar	  de	  redenen	  waarom	  zij	  niet	  direct	  naar	  de	  dokter	  gingen.	  Gedurende	  een	  periode	   van	   één	   jaar	   hebben	   wij	   186	   patiënten	   geïnterviewd.	   Het	   mediaan	  behandelingsuitstel	  tussen	  het	  moment	  waarop	  de	  eerste	  symptomen	  door	  de	  patiënten	  werden	   ervaren	   en	   de	   netvlieschirurgie	   bedroeg	   10	   dagen.	   Behandelingsuitstel	  veroorzaakt	   door	   de	   patiënten	   zelf	   kwam	   hoofdzakelijk	   door	   hun	   onwetendheid	   en	  onbekendheid	  met	  de	  symptomen	  van	  een	  netvliesloslating.
Hoofdstukken	   3	   t/m	   5	   onderzoeken	  de	   resultaten	   van	   een	   behandeling	  met	   cerclage	  plombe	  chirurgie	  bij	  patiënten	  met	  een	  netvliesloslating.	  
Hoofdstuk	  3	  toont	  aan	  dat	  gedurende	  een	  gemiddelde	  controle	  periode	  van	  51	  maanden	  anatomisch	  herstel	  werd	  bereikt	  bij	  76%	  van	  de	  ogen	  na	  één	  operatie.	  Uiteindelijk	  werd	  anatomisch	  herstel	  bereikt	  bij	  97%	  na	  extra	  vitreoretinale	  chirurgische	  ingrepen.	  Recidief	  netvliesloslating	  werd	  bij	  104	  ogen	  tijdens	  de	  controle	  periode	  gevonden.	  Na	  een	  controle	  periode	  van	  meer	  dan	  6	  maanden	  en	  meer	  dan	  12	  maanden	  ontwikkelde	  zich	  een	  recidief	  bij	   respectievelijk	   32	   ogen	  (7%)	  en	   20	   ogen	   (5%).	   Multivariate	   regressieanalyse	   werd	  gebruikt	   om	  risicofactoren	  voor	   een	   verminderd	  gezichtsvermogen	   12	  maanden	  na	  de	  operatie	  op	  te	  sporen.	   De	  volgende	  factoren	  bleken	  een	  signigicant	  voorspelbare	  waarde	  te	  hebben:	   een	   recidief	  netvliesloslating	   en	  een	  gezichtsvelduitval	   die	  langer	  dan	  zeven	  dagen	  bestond.	  Een	  signigicante	  risicofactor	  voor	  een	  recidief	  netvliesloslating	  bleek	  een	  defect	   in	   het	   netvlies	   van	  meer	  dan	  drie	   papil	   groottes	   te	   zijn.	   Conventionele	   cerclage	  plombe	  chirurgie	  bleek	  een	  betrouwbare	  procedure	  te	  zijn	  voor	  een	  bepaalde	  groep	  ogen	  met	   primaire	   rhegmatogene	   netvliesloslatingen.	   Voor	   ogen	  met	   een	   defect	   grootte	   van	  meer	   dan	   drie	   papil	   diameters	   in	   het	   netvlies	   dient	   primaire	   vitrectomie	   te	   worden	  overwogen.	   Op	   basis	   van	   onze	   bevinding	   dat	   7%	   van	   de	   ogen	   een	   recidief	  netvliesloslating	  ontwikkelden	  na	  zes	  maanden,	   lijkt	  een	  langere	  controle	  periode	  nodig	  om	   anatomisch	   herstel	   en	   het	   gezichtsvermogen	   te	   beoordelen	   na	   cerclage	   plombe	  chirurgie.
Hoofdstuk	   4	   analyseert	   de	   diepte	   van	   de	   voorste	   oogkamer	   bij	   38	   ogen	   na	   cerclage	  plombe	  chirurgie.	  Na	  een	  controle	  periode	  van	  9	  maanden	  was	  de	  diepte	  van	  de	  voorste	  oogkamer	  signigicant	  minder	  diep	  dan	  voor	  de	  operatie.	   Een	  jaar	  na	  de	  operatie	  was	  de	  diepte	  van	  de	  voorste	  oogkamer	  bijna	  hersteld	  tot	  de	  normale	  waarde.	  De	  aslengte	  was	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signigicant	  vergroot	  tijdens	  de	  gehele	  observatie	  periode.	  Er	  was	  geen	  verschil	  tussen	  het	  gebruik	  van	  een	  radiaire	  of	  een	  limbus-­‐parallelle	  plombe.Voor	   patiënten	   die	   cerclage	   plombe	   chirurgie	   hebben	   ondergaan	   en	   van	   plan	   zijn	  refractiechirurgie	   door	   middel	   van	   een	   fake	   kunststof	   voorste	   oogkamerlens	   te	   laten	  implanteren,	  kan,	  als	  de	  diepte	  van	  de	  voorste	  oogkamer	  te	  ondiep	  is	  geworden,	  dissectie	  van	  het	  cerclage	  element	  overwogen	  worden	  om	  het	  verlies	  van	  endotheelcellen	  tegen	  te	  gaan.
Hoofdstuk	   5	   onderzoekt	   hoe	   vaak	   dubbelbeelden	   voorkomen	   na	   cerclage	   plombe	  chirurgie.	   Secundaire	   dubbelbeelden	   werd	   gevonden	   bij	   39	   van	   de	   1030	   ogen	   (3,8%)	  tijdens	   een	   gemiddelde	   controle	   periode	   van	   6,4	  ±	   6,3	  maanden;	   28	   patiënten	   (2,7%)	  kregen	  dubbelbeelden	  door	   mechanische	  restrictie	   van	   een	   van	   de	   oogspieren.	   Er	  was	  geen	   relatie	   tussen	   de	   positie	   van	   de	   plombe	   (t.o.v.	   de	   aangedane	   spier)	   en	   het	  voorkomen	  van	  dubbelbeelden.	   Aan	  het	  einde	  van	  de	  controle	  periode	  was	  enkelvoudig	  binoculair	   zien	  hersteld	  bij	   28	   van	  de	  39	  patiënten.	   In	   het	  merendeel	   van	   de	   gevallen	  werd	  dit	  met	  een	  prismacorrectie	  bereikt.
Hoofdstukken	  6	  t/m	  8	  analyseren	  de	  uitkomsten	  van	  een	  vitrectomie	  behandeling	  met	  silicone	  olie	  tamponade	  voor	  patiënten	  met	  RRD.	  Hoofdstuk	  6	  beschrijft	  de	  functionele	  en	  anatomische	   uitkomsten	   bij	   patiënten	  met	   een	  reuzescheur	   netvliesloslating	  na	  een	  pars	  plana	  vitrectomie	  procedure	  met	  of	  zonder	  een	  cerclage	  en	  silicone	  olie	  tamponade.	  Recidief	  netvliesloslating	   trad	  op	   bij	   negen	  van	   de	   30	   ogen	  (30%)	   na	   één	  vitrectomie.	  Uiteindelijk	   is	   het	   netvlies	   weer	   aanliggend	   bij	   29	   ogen	   (96,7%).	   Met	   multivariate	  regressieanalyse	   werd	   een	   signigicante	   (P=0,008)	   relatie	   aangetoond	   tussen	   het	  ontbreken	   van	   een	   cerclage	   en	   recidief	   netvliesloslating.	   Verbetering	   van	   het	  gezichtsvermogen	   werd	   gemeten	   bij	   54%	   van	   de	   ogen.	   Vitrectomie	   met	   cerclage	   en	  silicone	   olie	   tamponade	   bleek	   een	   succesvolle	   behandeling	   te	   zijn	   voor	   reuzescheur	  netvliesloslating.
Hoofdstuk	   7	   inventariseert	  de	   anatomische	  en	   functionele	  uitkomsten	  bij	   patiënten	  na	  vitrectomie	   met	   silicone	   olie	   tamponade	   na	   het	   verwijderen	   van	   de	   silicone	   olie.	  Anatomisch	  herstel	  werd	  bereikt	  bij	  81%	  van	  de	  ogen	  na	  het	  verwijderen	  van	  de	  silicone	  olie.	  Het	  uiteindelijke	  succespercentage	  was	  94%	  aan	  het	  einde	  van	  de	  controle	  periode.	  Na	  de	  operatie	  werd	  een	  verhoogde	  oogdruk	  gevonden	  bij	  8%	  van	  de	  ogen,	  een	  verlaagde	  oogdruk	  bij	  6%	  van	  de	  ogen	  en	  keratopathie	  bij	  29%	  van	  de	  ogen.	  Het	  gezichtsvermogen	  verbeterde	  met	  meer	  dan	  2	  Snellen	  lijnen	  bij	  43%	  van	  de	  ogen	  na	  het	  verwijderen	  van	  de	  silicone	   olie.	   Multivariate	   analyse	   werd	   gebruikt	   om	   risicofactoren	   voor	   een	   recidief	  netvliesloslating	  aan	  te	  tonen.	  De	  volgende	  factoren	  bleken	  een	  signigicant	  voorspellende	  waarde	   te	   hebben:	   mannelijk	   geslacht,	   preoperatieve	   rubeosis	   en	   proliferatieve	  diabetische	   retinopathie.	   Ook	   werd	   er	   een	   relatie	   gevonden	   tussen	   een	   verslechterd	  gezichtsvermogen	  (Snellen	   <0,1)	  en	  mannelijk	   geslacht,	   preoperatief	   gezichtsvermogen	  van	  <0,1	  Snellen	  lijnen,	  proliferatieve	  diabetische	  retinopathie,	  drie	  of	  meer	  chirurgische	  interventies,	  gedeeltelijke	  retinectomie	  (ongeacht	  de	  grootte)	  en	  verlaagde	  oogdruk.
Hoofdstuk	  8	   onderzoekt	  de	  endotheelceldichtheid	  in	  het	  hoornvlies	  na	  vitrectomie	  met	  silicone	   olie	   tamponade.	   Twaalf	   maanden	   na	   de	   operatie	   lag	   de	   gemiddelde	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endotheelceldichtheid	   verandering	   tussen	   de	   2,4%	   en	   -­‐39,2%	   vergeleken	   met	   de	  preoperatieve	  endotheelceldichtheid.	  Minder	  dan	   5%	  verlies	   aan	   endotheelceldichtheid	  werd	   gezien	  bij	   patiënten	  met	   een	   eigen	   lens	   of	   een	  kunstlens.	   Bij	   de	  12-­‐maandelijkse	  controle	   was	   het	   gemiddelde	   endotheelceldichtheid	   verlies	   in	   de	   ogen	   met	   een	  gecombineerde	  phaco-­‐emulsigicatie	  procedure	  en	  de	  ogen	  met	   een	  (kunst)lens	   extractie	  signigicant	   hoger:	   respectievelijk	   19%	   en	   39%	   (P	   <0,001).	   Ook	   was	   de	  endotheelceldichtheid	  signigicant	   lager	  bij	  de	  ogen	  met	  glaucoom	  (β=	  -­‐104,	  P<0,001)	  en	  de	   ogen	   met	   silicone	   olie	   in	  de	   voorste	   oogkamer	   (β=	   -­‐336,	   P<0,001).	   Het	   percentage	  hexagonale	  cellen	  en	  de	  variatie	  coëfgiciënten	  veranderen	  na	  de	  operatie	  niet	  signigicant.
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DankwoordDit	  proefschrift	  was	  nooit	  tot	  stand	  gekomen	  zonder	  de	  hulp	  van	  anderen.	  Bij	  deze	  wil	   ik	  dan	   ook	   iedereen	   bedanken	   die	   bijgedragen	   hebben	   bij	   het	   tot	   stand	   komen	   van	   dit	  proefschrift.	  En	  wat	  is	  het	  heerlijk	  om	  een	  dankwoord	  te	  mogen	  schrijven,	  immers	  zonder	  proefschrift	  geen	  dankwoord.	  Er	  zijn	  een	  aantal	  mensen	  die	  ik	  in	  het	  bijzonder	  wil	  bedanken.
Als	   eerste	   wil	   ik	   mijn	   promotoren	   bedanken.	   Prof.	   dr.	   F	   Hendrikse,	   u	   heeft	   alle	  vertrouwen	  in	  mij	   gehad	  en	  het	  mogelijk	   gemaakt	   dat	   ik	  mijn	  proefschrift	  tot	   een	  goed	  einde	  kon	  brengen.	   Verder	  was	  u	  ook	  mijn	  opleider,	  die	  er	  voor	  gezorgd	  heeft	  dat	  ik	  me	  kon	  ontwikkelen.	  U	  heeft	  me	  letterlijk	  en	  giguurlijk	  uit	  Amsterdam	  weggehaald,	  om	  me	  in	  het	  Zuiden	  de	  oogheelkunde	  te	  leren.	  Verder	  weet	  ik	  dat	  dit	  uw	  laatste	  promotie	  is	  en	  ben	  ik	  zeer	  vereerd	  dat	  ik	  de	  laatste	  mag	  zijn.Prof.	  dr.	  C.A.B.	  Webers,	  Carroll,	  jou	  wil	  ik	  bedanken	  voor	  de	  steun	  en	  het	  vertrouwen	  dat	  je	  in	  me	  hebt	  en	  de	  plek	  die	  je	  me	  gegeven	  hebt	  in	  je	  staf.	  Verder	  wil	  ik	   je	  bedanken	  voor	  de	  super	  motiverende	  woorden	  rond	  het	  beëindigen	  van	  mijn	  promotie	  en	  hierbij	  ook	  de	  hulp	  bij	   kleine	   en	   grote	  beslissingen.	   Verder	   vind	  ik	   het	   fantastisch	  dat	   je	  ook	   een	  van	  mijn	  promotoren	  bent.
Natuurlijk	   wil	   ik	   vooral	   ook	   mijn	   co-­‐promotor,	   dr.	   E.C.	   la	  Heij	   bedanken.	   Ellen,	   jij	   bent	  degene	  die	  er	  voor	  gezorgd	  heeft	  dat	  dit	  boekje	  tot	  stand	  is	  gekomen.	   In	  de	  kofgiekamer	  van	  de	  klinische	  OK	  vroeg	  je	  me	  om	  onderzoek	  te	  doen	  (ik	  was	  nog	  maar	  net	  een	  maand	  in	  opleiding).	   Ik	  sloeg	  het	  af	  want	  ik	  wilde	  eerst	  de	  oogheelkunde	  leren.	   Iets	  minder	  dan	  een	  jaar	  later	  ben	  ik	  naar	  je	  toe	  gekomen	  en	  ging	  ik	  mijn	  eerste	  onderzoek	  naar	  cerclage	  plombe	  chirurgie	  van	  start.	   In	  Annadal,	   tijdens	  de	  phaco’s	   vroeg	   je	  of	  ik	  geen	  interesse	  had	  om	  te	  promoveren.	  Jij	  hebt	  me	  altijd	  gesteund,	  vertrouwd	  en	  me	  alle	  vrijheid	  gegeven	  die	   ik	   nodig	   had	   om	   onderzoek	   te	   kunnen	   doen.	   Door	   met	   je	   te	   praten	   over	   de	  netvlieschirurgie	   kwamen	   we	   steeds	   weer	   tot	   nieuwe	   onderwerpen	   voor	   een	   nieuw	  onderzoek	   en	  zo	   ook	   het	   volgende	  artikel.	   Je	  hebt	  me	   zeer	  veel	   geleerd,	   niet	  alleen	  het	  onderzoek,	  je	  hebt	  me	  de	  hele	  netvlieschirurgie	  bijgebracht	  en	  me	  gemaakt	  tot	  wie	  ik	  nu	  ben.	   Voor	  dit	  alles	  wil	   ik	   je	  bedanken,	   je	  stond	  en	  staat	  nog	  altijd	  voor	  me	  klaar,	  hoever	  weg	  je	  ook	  bent.	  
Ing.	  A.	   Hacking,	   Astrid,	   jou	  wil	   ik	  bedanken	  omdat	   ik	  bij	   jou	  altijd	  kan	  binnenlopen	  met	  mijn	   verhalen	   die	   je	   altijd	   wil	   aanhoren,	   wat	   ik	   ook	   te	   zeggen	   heb.	   Verder	   heeft	   je	  vertrouwen	  en	  hulp	  er	  voor	  gezorgd	  dat	  dit	  een	  perfect	  boekje	  is.
Hooggeleerde	   heren	   en	   vrouwe	   van	   de	   beoordelingscommissie:	   Prof.	   dr.	   H.W.M.	  Steinbush	  (voorzitter),	   Prof.	   dr.	   J.M.M.	  Hooymans,	  Prof.	  dr.	   J.C.	   van	  Meurs,	   Prof.	   dr.	  F.C.S.	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Ramaekers	   en	  Prof.	   dr.	   P.M.	   Steijlen	  wil	   ik	   bedanken	  voor	   het	   lezen	  en	  beoordelen	  van	  mijn	  proefschrift	  en	  het	  zitting	  nemen	  in	  deze	  commissie.
Verder	  wil	  ik	  de	  patiënten	  bedanken,	  waar	  ik	  uren	  naast	  gezeten	  heb	  om	  endotheelcellen	  te	  tellen,	  de	  voorste	  oogkamerdiepte	  te	  meten,	  de	  aslengte	   te	  meten,	   een	  OCT	   te	  maken	  en/of	  papilfoto’s.	  Toch	  bleven	  jullie	  interesse	  in	  mijn	  proefschrift	  houden.	  
Veel	   dank	   wil	   ik	   uiten	   aan	   alle	   stagleden,	   arts-­‐assistenten,	   paramedici,	   polikliniek-­‐medewerkers,	   operatiekamermedewerkers	  en	  onderzoekers	   van	  de	  Universiteitskliniek	  voor	  Oogheelkunde	  en	  het	  Atrium	  Medisch	  Centrum.	  Met	  name	  veel	   dank	   voor	   Prof.	   dr.	   Aize	   Kijlstra	   voor	   het	   kritische	  beoordelen	  van	  een	  groot	  aantal	  artikelen,	  en	  je	  interessante	  ideeën	  waarvan	  de	  resultaten	  in	  dit	  proefschrift	  zijn	  weergegeven.	  Ook	  dank	  aan	  Albert	  Liem	  en	  Igor	  Lundqvist	  voor	  het	  aanleveren	  van	  vele	  patiënten	  voor	  mijn	  onderzoek	  en	  voor	  het	   vertrouwen	  van	   jullie,	   waardoor	   ik	   die	   patiënten	  erna	  kon	  opvolgen.
Verder	   dank	   voor	   Tos	   Berendschot,	   ik	   kon	   altijd	   bij	   je	   aankloppen	   voor	   statistische	  vragen.	  Toen	  je	  er	  net	  was,	  was	  ik	  een	  van	  de	  drie	  mapjes	  op	  je	  PC,	  bij	  mijn	  laatste	  artikel,	  was	  ik	  een	  van	  de	  vele.	  
Ook	   wil	   ik	   Diana	   Cals	   bedanken.	   Diana,	   jij	   hebt	   tijdens	   mijn	   zwangerschapsverlof	   een	  hoop	  van	  mijn	  patiënten	  opgevangen	  en	  onderzocht.	  Tijdens	  de	  inclusie	  van	  een	  patiënt	  kreeg	   ik	   een	   mailtje	   en	   een	   fax	   met	   alle	   gegevens,	   en	   kon	   ik	   alle	   gegevens	   meteen	  invoeren,	  dank	  je	  wel.	  
Medeauteurs,	  Esther	  van	  Daal,	  Roselie	  Diederen,	  Sacha	  Gast,	   Juliette	  Hoevenaars,	  Lieneke	  Janssen,	   Alfons	  Kessels,	   Leonoor	  Koetsier,	   Rudy	  Nuijts	   en	  Nayyirih	  Tahzib	  dank	   ik	   voor	  hun	  bijdrage	  aan	  de	  artikelen.	  
Ook	   Ingrid	  Lutt	  wil	   ik	  bedanken	  voor	  de	  bijdrage	  aan	  het	  artikel	  over	  de	  dubbelbeelden,	  je	  kritische	  opmerkingen	  hebben	  de	  kwaliteit	  van	  het	  artikel	  doen	  toenemen.Mariette,	  Tonny	  en	  Nicky	  wil	   ik	  bedanken	  voor	  de	  steun	  en	  hulp	  van	  het	  verzamelen	  van	  de	   data	   op	   de	   OK.	   Als	   ik	   jullie	   wat	   vroeg	   was	   het	   nooit	   te	   veel.	   Hele	   boekjes	  worden	  bijgehouden,	   en	   als	   ik	   een	  vraag	   had	  over	   een	  materiaal	   lieten	   jullie	   giguurlijk	   alles	   uit	  jullie	  handen	  vallen	  om	  het	  op	  te	  zoeken,	  heel	  erg	  bedankt	  hiervoor.	  Ellen	   Vrancken	   en	   Suzanne	   Colen	   wil	   ik	   bedanken	   voor	   hun	   administratieve	  ondersteuning.	   Ellen,	   als	   jij	   er	   niet	  was	   geweest,	  was	   ik	   niet	   gepromoveerd.	   Je	   hebt	  me	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fantastisch	  op	  weg	  geholpen	  met	  de	  brieven	  en	  iedereen	  iedere	  keer	  weer	  aangespoord.	  Verder	  hielp	  je	  bij	  alles	  wat	  op	  dit	  gebied	  gedaan	  moest	  worden	  en	  kon	  je	  ook	  goed	  naar	  mij	   luisteren,	   bedankt.	   Suzanne,	   ook	   jij	   was	   een	   grote	   hulp.	   Je	   hebt	   door	   soms	   kleine	  dingen	  voor	  met	  te	   doen,	  me	  heel	   groots	  geholpen.	   Ik	  kon	  altijd	  een	  beroep	  op	  je	  doen,	  bedankt	  hiervoor.	  Ook	  de	  andere	  medewerkers	  van	  het	  secretariaat	  bedankt,	  Veronique,	  Sandra,	  Marianne,	  Marian	  en	  Margo.
Verder	  wil	   ik	  Geertjan	  van	  Zonneveld	  bedanken	  voor	  de	  mooie	   illustraties	  en	  het	  werk	  dat	  jij	  hieraan	  gehad	  hebt.	  Je	  bent	  nu	  een	  echte	  deskundige	  op	  het	  gebied	  van	  de	  anatomie	  van	  het	  oog	  	  ;).En	  mijn	  “roomie”,	  MIB	  Roel	  Erckens.	  Je	  motivatie	  was	  groot	  om	  me	  te	  stimuleren	  om	  het	  boekje	  af	  te	  maken	  en	  het	  “S-­‐je”	  weg	  te	  schaven.	  Al	  was	  het	  maar	  om	  het	  “feesie”.	  Ik	  vind	  het	  ook	  leuk	  dat	  jij	  mijn	  paranimf	  bent.	  Verder	  hoop	  ik	  nog	  lang	  “lekkere	  kofgie”	  met	  je	  te	  kunnen	  drinken.	  Nu	  verdien	  ik	  een	  plekje	  in	  de	  kamer,	  toch?Ook	   iedereen	   die	   bij	   de	   laatste	   loodjes	   hebben	   meegeholpen,	   nagelezen	   en/of	  gecorrigeerd.	   Dank	   hiervoor	   Agnes,	   Annelie,	   Hellen,	   Isabelle,	   Lukas,	   Margriet,	   Mor	   en	  Pieter.Anke,	  “Anti”	  wil	  ik	  bedanken	  voor	  de	  gezelligheid	  en	  de	  ontspanning	  in	  mijn	  leven.	  Verder	  wil	   ik	   je	   bedanken	   voor	   je	  motivatie	   om	  me	   hier	   in	  het	   zuiden	   te	   houden,	   voor	   onze	  shopweekenden	   rond	   de	   kerst	   en	   ook	   nog	   tussendoor	   in	   Oberhausen	   en	   de	   gezellige	  dagen	  samen	  met	  de	  kinderen.	  Anja,	   als	  zusje	  kan	  ik	   altijd	  bij	   je	  aankloppen	  en	  wil	   je	  altijd	  naar	  me	  luisteren,	   bedankt	  hiervoor.
Loes,	   Lieve	   Mam,	   dank	   je	   wel	   voor	   je	   steun	   en	   het	   vertrouwen	   dat	   je	   me	   altijd	   hebt	  gegeven,	  en	  waarbij	  je	  altijd	  in	  me	  geloofd	  hebt,	  wetende	  dat	  het	  me	  weer	  zou	  lukken.	  Eric	  wil	  ik	  ook	  bedanken	  voor	  je	  aanhoudende	  interesse	  in	  mijn	  proefschrift.
En	   dan	  de	   allerbelangrijkste,	   Luuk	   en	  Nina.	   Mijn	  kleintjes,	   die	  me	   het	   leven	   o	   zo	   leuk	  maken,	   jullie	  zorgen	  er	  voor	   dat	   ik	   iedere	  dag	   graag	  naar	   huis	  ga,	   ik	  ben	  trots	   op	  jullie,	  bedankt.	  Aan	  jullie	  draag	  ik	  daarom	  ook	  mijn	  boekje	  op.En	   natuurlijk	   evenzo	   belangrijk	   Dennis,	   ontzettend	   bedankt	   voor	   je	   steun,	   je	   hulp,	   je	  interesse,	  je	  geduld	  en	  vooral	  je	  liefde.	  Verder	  vind	  ik	  het	  ook	  leuk	  dat	  je	  mijn	  paranimf	  op	  deze	  dag	  bent.	  Ik	  hou	  van	  je,	  met	  jou	  wil	  ik	  zo	  graag	  oud	  worden.
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Curriculum vitae
De	   auteur	   van	   dit	   proefschrift	   werd	   geboren	   op	   22	  februari	   1974	   te	   Amsterdam	   als	   Fleur	   Goezinne.	   Ze	  groeide	   op	   in	   Vinkeveen.	   Het	   voortgezet	   onderwijs	  werd	   in	  Amsterdam	   gevolgd.	   Na	  het	   behalen	   van	  het	  examen	  voorgezet	  wetenschappelijk	  onderwijs	  aan	  het	  Amsterdamse	   Fons	   Vitae	   Lyceum	   in	   1994	   begon	   ze	  met	   de	   studie	   medische	   biologie	   aan	   de	   Universiteit	  van	  Amsterdam.	   Tijdens	  deze	  studie	  werd	  zij	   ingeloot	  voor	   geneeskunde,	   ook	   aan	   de	   Universiteit	   van	  Amsterdam.	   Na	   het	   behalen	   van	  haar	   artsexamen	  23	  mei	  2003	  en	  doctoraal	  medische	  biologie	  ging	  zij	  haar	  specialisatie	  oogheelkunde	  doen	  in	  Maastricht.	  In	  2008	  werd	   ze	   ingeschreven	   in	  het	  BIG	   register	   als	   oogarts,	  en	   volgde	   ze	   een	   fellowship	   vitreoretinale	   chirurgie	  eveneens	  in	  Maastricht.	  Tot	  op	  heden	  werkt	  ze	  daar	  als	  netvlieschirurg.
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